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The current study reviewed mechanisms through which obesity influences 
cognitive performance as well as explored the dynamic relationship between body 
weight, physical performance, and cognition in the Advanced Cognitive Training for 
Independent and Vital Elderly (ACTIVE) trial over a 10-year period.  
Findings from the study highlight the complex relationship between physical 
health and cognitive performance in older adults and suggest that higher body mass index 
(BMI) at baseline was associated with both cognitive and functional performance. Results 
from Aim 1 suggest that better performance on multiple cognitive domains was 
associated with attenuated declines in BMI over 10 years. Furthermore, attenuated 
cognitive declines were associated with a greater increase in BMI.  
Analyses from Aim 2 explored the mediated effect of grip-strength on weight-
related changes in BMI. Findings revealed that a higher BMI at baseline was associated 
with better grip strength at baseline and accelerated declines in grip strength over time; 
whereas higher grip strength at baseline was associated with slower declines in cognition 
over time. Slower declines in grip strength were associated with slower declines in 
memory and reasoning. There was an indirect effect of BMI on cognition through 
changes in grip strength in the memory and reasoning outcomes, such that, a higher BMI 
was associated with accelerated declines in grip strength, which in turn were associated 
with accelerated declines in cognition. These findings are provocative given the large 
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Chapter 1. Introduction 
The US is currently in the midst of a profound demographic shift as the 
population rapidly ages. Within 20 years, older adults will comprise almost one-quarter 
of the population (US Census Bureau, 2011). Unlike their predecessors, this group of 
older adults will be better educated, more racially diverse, and less impoverished 
compared to previous generations. Despite these advantages, individual’s quality of life 
may be significantly diminished by deteriorating cognitive abilities as a result of chronic 
conditions, poor diets, and sedentary lifestyles. In fact, evidence suggests recent cohorts 
of older adults are experiencing more disability compared to previous cohorts (Lin, Beck, 
Finch, Hummer, & Master, 2012; Palacios-Ceña et al., 2012). Furthermore, these 
increases coincide with rapidly increasing rates of cognitive impairments. It has been 
estimated that by the year 2050 the incidence of dementia will increase by 100% 
(Brookmeyer & Gray, 2000). This has huge public health implications given the 
astronomical healthcare costs associated with the disorder; in 2010 the cost of dementia 
in the US ranged from $157 billion to $215 billion (Hurd, Martorell, Delavande, Mullen, 
& Langa, 2013). 
Rates of chronic conditions associated with disability and cognitive impairment 
are increasing. In 2009-2010, 38% of adults aged 65 and older were obese, compared 
with only 22% in 1988-1994 (Federal Interagency Forum on Aging-Related Statistics, 
2012). Research has shown obesity is related to diabetes mellitus (DM) (Barnes, 
Alexopoulous, Lopez, Williamson, & Yaffe, 2006; Kivipelto et al., 2001a, 2001b; 
Notkola et al., 1998; Whitmer, 2007), which is a risk factor for all-cause dementia 




1997-1998, 13% of adults over the age of 65 were diagnosed with DM and that number 
had almost doubled to 21% in 2009-2010 (Federal Interagency Forum on Aging-Related 
Statistics, 2012). Overweight body mass index (BMI) has been associated with a 35% 
increased risk of Alzheimer’s disease (Anstey, Cherbuin, Budge, & Young, 2011). The 
proportion of any dementia attributable to obesity was 12%, whereas 21% of Alzheimer’s 
disease (AD) risk was attributable to obesity (Beydoun, Beydoun, & Wang, 2008). 
In spite of a strong association with age, some types of dementia are still 
considered preventable through a number of potentially modifiable risk factors (e.g., 
cognitive and physical activity, DM, obesity, and hypertension). Moreover, cognitive 
impairments associated with chronic conditions account for approximately 24% of 
cognitive impairment without dementia (Plassman et al., 2008). Research in this area of 
modifiable risk factors is very exciting given that delaying the onset of AD by five years 
could cut its incidence in half (Pasinetti, Wang, Porter, & Ho, 2011). Almost three 
million cases of AD in the US are attributable to modifiable risk factors and are known to 
increase risk of disability (Alley & Chang, 2007; Beavers, Miller, Rejeski, Nicklas, & 
Krichesvsky, 2013; Fried & Guralnik, 1997). Reducing these factors by 10-25% could 
prevent almost 500,000 cases of AD in the US alone (Table 1; Barnes & Yaffe, 2011). 
This could result in substantial benefits through improved quality of life, prolonged 
independence, and reduced cost to the health care system (Larson et al., 2006).  
Some have argued that up to 33% of life expectancy gains attributable to public 
health interventions are negated by the increasing prevalence of obesity (Neovius, 
Rasmussen, Sunstrom, & Neovius, 2010; Stewart, Cutler, & Rosen, 2009). The World 




public health concerns, like under-nutrition, as the most significant cause of poor health 
(Loscalzo et al., 2008). Given the current obesity crisis, it is imperative to understand 
how obesity is related to negative health outcomes including functional and cognitive 
impairments in older adults.  
Table 1. Alzheimer’s disease cases attributable to modifiable risk factors 
  Population prevalence 
PAR (confidence 
range) 
Number of cases attributable 
(confidence range) 
Diabetes  8.7% 3.3% (1.5-5.4) 1,740 (770-2,880) 
Midlife hypertension 14.3% 8.0% (2.2-15.1) 4,250 (1,190-7,980) 
Midlife obesity 13.1% 7.3% (4.3-10.8) 3,860 (2,260-5,700) 
Physical inactivity 32.5% 21.0% (5.8-36.6) 11,150 (3,080-19,420) 
Low education 13.3% 7.3% (4.4-10.3) 3,860 (2,360-5,440) 
Table adapted from Barnes & Yaffe, 2011; PAR: Population Attributable Risk 
 
Although most research has focused on functional declines that occur after 
cognitive impairment, in light of current obesity trends, it is important to explore how 
obesity-related functional limitations increase the risk of cognitive impairments. 
Dramatic increases in chronic conditions independently associated with cognition suggest 
that the risks faced by today’s older adults may be substantially different from those of 
previous generations. It is therefore, worthwhile to explore how obesity and physical 
performance are associated with cognition in older adults.  
Cognitive Health 
Cognitive health in older adults is not merely the absence of disease, but rather 
the preservation of multi-dimensional cognitive abilities that allow older adults to 
maintain independent living and social relationships, recover from illness, and cope with 




cognitive health is a relatively new concept with no agreed upon definition, important 
caveats must be mentioned. Unlike physical health parameters (e.g., blood pressure) in 
which there exist gold standards of measurement (e.g., sphygmomanometer) and absolute 
standards across individuals (e.g., 120/80mmHg is considered normal blood pressure 
across individuals), the parameters of cognitive health are less easily defined. Large 
interindividual differences in baseline levels of cognitive ability make it difficult to 
define what is normal. Moreover, longitudinal studies consistently report that while mean 
scores on cognitive tests decline over time, the standard deviation around the mean 
increases (Christensen, 2001; Hendrie, Purnell, Wicklund, & Weintraub, 2010) which 
may be exacerbated by health conditions (Salthouse, 2000).  
To define ‘normal’ cognitive aging one must take into account interindividual 
differences in trajectories of cognitive decline along with interindividual differences in 
premorbid abilities (Hendrie et al., 2010). For example, for a 75-year-old with a 
premorbid ability in the 90th percentile, test scores in the average range (e.g., 50th 
percentile) represent a significant decline; whereas a 75-year-old with a premorbid ability 
in the 40th percentile, test scores in the average range may represent stable cognitive 
functioning. Twin studies suggest genetics may explain a significant portion of variability 
in individuals’ cognitive performance with heritability estimates (i.e., the proportion of 
observable differences between people that is due to genetic influences) ranging from 
68% for monozygotic twins to 56% for dizygotic twins (Carmelli, Swan, DeCarli, & 





Table 2. Factors influencing later life cognitive health 
Physical Cognitive Emotional Behavioral 
Cardiovascular disease Cognitive reserve Anxiety Alcohol use 
Diabetes Education Depression Cognitive engagement 
Hyperlipidemia AD Self-efficacy Diet/nutrition 
Hypertension MCI Self-esteem Exercise/physical activity 
Frailty Vascular dementia Stress Social engagement 
Obesity   Substance Use 
Osteoporosis   Tobacco Use 
Sarcopenia    
Stroke    
Adapted from Rebok, Parisi, & Kueider, 2014 
 
To further complicate the issue, multiple factors influence cognition (Table 2). 
Higher educational attainment and socioeconomic status, greater physical activity, and a 
healthy diet positively affect cognitive functioning (Angevaren, Aufdemkampe, Verhaar, 
Aleman, & Vanhees, 2008; Blankevoort et al., 2010; Colcombe & Kramer, 2003; Kramer 
et al., 2006). Conversely, diabetes, hypertension, obesity, and negative affective states 
(e.g., depression and anxiety) are all negatively associated with cognitive functioning 
(Bourdel-Marchason et al., 2010; Hughes & Ganguli, 2009; Kivipelto et al., 2001a, 
2001b, 2005; Notkola et al., 1998; Solomon et al., 2009; Spira et al., 2011; Sullivan et al., 
2008; Whitmer, Sidney, Selby, Johnston, & Yaffe, 2005). 
Cognition in later life  
Cognition encompasses multiple processes including attention, executive 
function, language, memory, processing speed, and visuospatial abilities. Even in the 
absence of pathology, aging is associated with changes in cognition as well as structural 
and functional changes in the brain (Driscoll et al., 2009; Rebok & Folstein, 1993). 
Cognitive performance, even in healthy older adults, may diminish as a result of 




speed (Salthouse, 2000) associated with normal aging. However, normal aging does not 
affect specific cognitive abilities to the same degree. By age 40 processing speed declines 
by approximately 20%; it declines by 40-60% by age 80 (Christensen, 2001). Semantic 
memory, or crystallized intelligence, is not as affected by normal age-related declines and 
may even improve with accumulated experience. In fact, older adults may depend on 
their accumulated knowledge to compensate for deficits in other cognitive domains. On 
the other hand, episodic memory (i.e., for recent events or stimuli) is the most affected by 
normal aging, and it is common for many older adults to report problems with their 
memory (Palmer & Dawes, 2010). Craik (2008) also noted that older adults often have 
difficulty with tasks that require the retrieval of specific information (e.g., word list 
recall) as opposed to general knowledge (e.g., vocabulary). 
Cognitive impairments 
Whereas some individuals remain relatively cognitively healthy well into old age, 
others develop more severe cognitive impairments, including dementia. The most 
common forms of dementia are Alzheimer’s disease (AD), which accounts for almost 
70% of all dementias, and vascular dementia (VaD), which accounts for about 15% all of 
all dementias (Duron & Hanon, 2008). Dementia prevalence is around 6.4% while the 
incidence rate in North America is 10.5 per 1,000 (Ferri et al., 2005) and ranges from 
18.2 to 30.4 per 1,000 in middle-income countries (Prince et al., 2012). The incidence of 
AD doubles with every 5-year increase in age and between the ages of 90-95 may be as 
high as 30-40% (Kukull & Ganguli, 2000).  
Mild cognitive impairment (MCI) is a symptomatic non-dementia phase of 




MCI is often associated with mild problems in memory and other cognitive abilities that 
do not interfere with everyday functioning. Individuals with these problems are less 
efficient, require more time to complete tasks, and make more errors when performing 
these tasks compared to the past (Albert et al., 2011). Typically persons with MCI score 
1.0 to 1.5 standard deviations below the mean for their age- and education-matched peers 
on neuropsychological tests (Albert et al., 2011). Persons with MCI who have deficits in 
memory and other cognitive domains are a particularly high risk group for developing 
AD. In fact, episodic memory impairments are highly predictive of which individuals 
with MCI convert to AD (Albert et al., 2011); approximately 10-15% of persons with 
MCI will convert to AD annually (Tabert et al., 2006). The high conversion rates taken 
together with the overlapping neuropathological and genetic features of MCI, suggest a 
strong link between MCI and AD (Kensinger, 2009). 
Briefly, AD is a pathological form of aging in the brain marked by the build-up of 
extracellular amyloid plaques and development of intracellular neurofibrillary tangles, 
which appear first in the entorhinal cortex of the limbic system, followed by the 
hippocampus, the temporal and parietal cortices, and finally the frontal lobes (Braak & 
Braak, 1991). Understanding the pathogenesis of AD has been a major focus of research, 
and significant progress has been made in the last 20 years. One of the most consistent 
findings is the deposition of amyloid-β (Aβ), resulting in neuritic plaques that are a 
hallmark of the disease. This has led many researchers to hypothesize that the 
accumulation of Aβ in the brain is the key abnormality driving AD. Amyloid precursor 
proteins (APP), which result in the production of Aβ, also play an important role. APP is 




liver, as well as neurons and fibroblasts (Selkoe et al., 1988). Previous research has 
linked Aβ levels directly with BMI in young, non-demented individuals (Balakrishnan et 
al., 2005).  
Cognitive deficits associated with AD parallel structural declines and may begin 
with memory impairments. Deficits in episodic memory are considered a core sign in 
early-onset AD because the earliest pathological changes in the disease process destroy 
neurons in the hippocampus and entorhinal cortex. Mild-to-moderately impaired 
individuals with AD have deficits in executive function, language, and visuospatial 
abilities (Albert, 2011; Brandt et al., 2009).  
Increasing age (Hughes & Ganguli, 2009), race (Tang et al., 2001), lower 
educational attainment (Albert et al., 1995; Bennett et al., 2003; Schaie, 2005), lower 
socioeconomic status (Hughes & Ganguli, 2009), depression (Bebbington et al., 2003; 
Spira et al., 2011), and ApoE ε4 (Ballard et al., 2011; Cosentino et al., 2008; Duron & 
Hanon, 2008; Kozauer et al., 2008; Notkola et al., 1998) are associated with an increased 
risk of cognitive impairment and AD. Cognitive reserve, the ability to handle age- and 
pathologically-related changes in the brain without developing clinical signs or symptoms 
of disease (Fratiglioni & Wang, 2007), helps to explain the relationship between 
educational attainment and risk of dementia. Epidemiological studies have reported a 
higher prevalence of dementia (Gurland et al., 1999) and higher incidence of AD (Tang et 
al., 2001) in older African Americans compared to older Whites. Even in the absence of 
ApoE ε4, African Americans are 4-times more likely to develop the disease than their 
White counterparts (Tang et al., 2001). Research suggests that ethnic differences in rates 




be driven by differences in cardiovascular factors and cognitive reserve (Ng, Leong, 
Chiam, & Kua, 2010).  
Physical Health 
Epidemiological studies have found both vascular and metabolic conditions 
increase the risk of cognitive decline and AD, with the presence of more risk factors 
associated with greater risk (Kivipelto et al., 2005). In addition, vascular disease has been 
suggested as a possible mechanism by which depression increases the risk of cognitive 
decline (Kohler, van Boxtel, Jolles, & Verhey, 2011). Chronic conditions have been 
causally related to neuronal loss, and are thought to contribute to cognitive decline 
(Whitmer et al., 2005). In fact, results from the ACTIVE study revealed that hypertension 
was associated with faster declines on logical reasoning tasks, while diabetes was 
associated with accelerated declines on processing speed (Kuo et al., 2005). However, in 
cross-sectional studies, medical conditions only explain a small fraction of variance in 
cognitive test scores (Verhaeghen, Borchelt, & Smith, 2003; Zelinski & Gilewski, 2003).  
Compared to Whites, African Americans generally have a higher incidence and 
prevalence of chronic health conditions (e.g., diabetes, hypertension, stroke, and vascular 
disease) placing them at a disproportionately greater risk for cognitive, functional, and 
physical impairments (Carson et al., 2011; Clark, Mungai, Stump, & Wolinsky, 1997; 
Evans et al., 2003; Tang et al., 2001; Whitfield, Allaire, & Wiggins, 2004). 
Obesity 
Obesity is a serious health problem resulting from excess body fat which 




estimates for body mass index (BMI) range from 16-85% (Yang, Kelly, & He, 2007), 
indicating that although genetic influences are important to consider when studying 
obesity, they are not sufficient to explain the current obesity epidemic. Negative health 
consequences of obesity fall into two categories: effects attributable to the increased 
adipose tissue (e.g., Type 2 DM, cardiovascular disease, and hyperlipidemia), the largest 
endocrine gland in the body, and those attributable to increased weight, like arthritis and 
osteoarthritis (Bourdel-Marchason et al., 2010; Kivipelto et al., 2001a, 2001b, 2005; 
Notkola et al., 1998; Solomon et al., 2009; Sullivan et al., 2008; Whitmer et al., 2005).  
On average, body weight tends to decrease after age 60, while at the same time fat 
is redistributed toward more abdominal regions. Obesity is generally defined using BMI 
which is a measure of weight adjusted by height and is thought to capture overall 
adiposity. However, BMI does not adequately define obesity across the life span. The 
loss of lean body mass and height that occurs with aging can make BMI cut points 
inappropriate in older adults because the loss of height results in an overestimation of fat, 
whereas a decrease in lean body mass underestimates fat (Waters & Baumgartner, 2011). 
Accuracy of BMI depends on whether subjective or objective measurements are taken. 
Many adults are unsure of their actual weight and height and have a tendency to 
overestimate height (Haboubi, Hudson, & Pathy, 1990; Vailas & Nitzke, 1998). 
Unreliability of self-reported height and weight increases with age (Kuczmarski, 
Kuczmarski, & Najjar, 2001). 
BMI is also affected by sex and ethnicity (Ho et al., 2010; Jeong et al., 2005). 
Women tend to be overrepresented in the highest BMI categories (Flegal et al., 1998; 




between adiposity and cognitive function. For example, findings from the Framingham 
study (Elias et al., 2005) showed that obese men, but not women, performed significantly 
worse on some cognitive tasks. However, other studies report no sex differences in the 
association between weight and cognitive function (Hassing et al., 2010).  
Two sex hormones, testosterone and estrogen, may explain differences. In men, 
there is a bidirectional relationship between adiposity and testosterone levels such that 
low levels of testosterone and central obesity are both predictors and consequences of 
each other (Pelusi & Pasquali, 2012). Not only are low testosterone levels linked with 
obesity risk, they have also been implicated in reduced cognitive functioning in older 
men (Beauchet, 2006). In both men and women, the production of estrogen by adipose 
tissue constitutes a significant proportion of total estrogen production. Estrogen regulates 
synaptic connectivity and neuronal structure in the brain (Kramarova, Wright, & 
Pongratz, 2009). 
Obesity is rapidly increasing in the US; in those aged 60 and older around 72% 
are overweight or obese, while over 35% are obese (Beydoun, Beydoun, & Wang, 2008). 
This is a relatively new trend in the US; from 1960 to 1980 the prevalence of overweight 
and obesity among adults was relatively constant and only began to increase around the 
mid-1980s (Flegal, 2005). These increases were seen across all demographic groups 
regardless of smoking status (Pasinetti et al., 2011). As with AD, obesity has placed a 
huge burden on the health care system, with an estimated 10% of all medical spending 
US adults attributable to obesity. Individually, obese adults spend 36% more annually on 





Obesity and cognition 
Studies of obesity and cognition in children and adolescents provide substantial 
evidence that obesity is associated with impaired cognitive functioning, independent of 
cardiovascular and socioeconomic risk factors (Smith et al., 2011). Poorer cognitive 
functioning in childhood has been linked with obesity and Type 2 diabetes in adults 
(Osika & Montgomery, 2008). Nine cross-sectional studies examined the effects of 
obesity in children aged 4-18 years with fairly consistent findings showing poorer 
cognitive functioning in obese children compared with their normal weight counterparts. 
Deficits were noted in areas of memory, attention, executive function, global functioning, 
and verbal abilities (Smith et al., 2011). Executive function, a higher order cognitive 
ability which facilitates initiation, planning, regulation, and achievement of goal-directed 
behaviors, is one of the most consistent cognitive deficits reported in obese children and 
adolescents (Cserjesi, Molan, Luminet, & Lenard, 2007; Li, Dai, Jackson, & Zhang, 
2008; Lokken, Boeka, Austin, Gunstad, & Harmon, 2009; Mond, Stich, Hay, Kraemer, & 
Baune, 2007; Reinert, Po’e, & Barkin, 2013; Verdejo-García et al., 2010).  
A study by Li et al. (2008) which included over 2,000 children found overweight 
BMI (≥95th percentile) was independently associated with worse performance on tests 
global functioning, working memory, and attention even after adjustment for 
socioeconomic status and other potential confounders. To further support these findings, 
a longitudinal cohort of 7,990 children followed from age 7 to 33 revealed that poor 
performance on measures of executive and motor abilities at age seven predicted obesity 
at age 33, even after adjusting for sex, social class, general motor disability, mental 




was not responsible for the observed differences in executive and motor abilities (Osika 
& Montgomery, 2008). These findings could suggest a predisposition to obesity which 
includes dysregulation in neural circuits associated with the orbital-frontal cortex, an area 
of the brain associated with inhibitory control, a component of executive function 
(Willeumier, Taylor, & Amen, 2011). The negative association between obesity and 
executive function in adolescents may be driven by the disposition of body fat, such that 
fat stored viscerally is more detrimental than fat stored elsewhere (Schwartz et al., 2013).  
Obesity is associated with structural and functional changes in the brain. Brain 
imaging studies have revealed that obesity is associated with lower brain volumes in 
older adults who are cognitively normal (Raji et al., 2010) as well as those with MCI and 
AD (Ho et al., 2010). Obese older adults show atrophy in the frontal lobes, anterior 
cingulate cortex, hippocampus, and thalamus (Raji et al., 2010). Furthermore, obese 
individuals have significantly lower gray matter in areas of the brain associated with 
taste, reward, and behavioral control (Pannacciulli et al., 2006). 
 Research suggests there is a possible link between obesity and dopamine, brain-
derived neurotrophic factor (BDNF), and brain morphology. Obesity and cognition have 
been associated with dopaminergic genes (Ariza et al., 2012) and dopamine pathway 
dysregulation (Ariza et al., 2012; Skoranski et al., 2013; Volkow, Wang, & Baler, 2011; 
Wang, & Baler, 2011). Imaging findings corroborated this; reductions in dopamine 
receptors have been associated with decreased metabolism in the prefrontal regions in 
obese adults, where an inverse relationship between dopamine receptors and BMI has 
been described (Volkow et al., 2008; Wang et al., 2001). In otherwise healthy 




et al., 2008; Willeumier, Taylor, & Amen, 2011). BDNF, found in high concentrations in 
the cerebral cortex and hippocampus, is important for long-term memory (Bekinschtein et 
al., 2008) and has recently been link to regulation of body weight (Rios, 2013). These 
mechanisms may account for the association between obesity and cognitive performance. 
Older adults with higher systolic or diastolic blood pressure in the presence of a high 
BMI or greater waist circumferences showed an impaired ability to initiate motor 
responses (Waldstein & Katzel, 2006). The supplementary motor areas in the brain are 
affected by hypertension (Gąsecki et al., 2013) which may explain why obese older 
adults are slower to initiate motor responses. 
Several mechanisms have been proposed to explain how obesity may influence 
cognitive functioning. These mechanisms include elevated triglycerides and blood 
pressure, impaired insulin regulation, and systemic inflammation. Obesity can impact 
cognition through direct and indirect pathways. Direct pathways involve adipose tissue 
and its effects on the brain which will be discussed in greater detail in Chapter 2.  Indirect 
pathways can result from poor dietary choices that lead to weight gain and/or increased 
risk of multiple disorders associated with obesity which have all been independently 
associated with decreased cognition functioning. In older adults research has shown that 
overweight and obesity are related to self-reported functional limitations (Jensen & 
Friedman, 2002), performance-based functional disability (Davis et al., 1998), DM, 
hypertension, and hyperlipidemia (Bourdel-Marchasson et al., 2010; Cheng et al., 2012; 
Sullivan et al., 2008). 
Moreover, BMI is a strong predictor of muscle mass. Using data from NHANES 




as independent predictors of lower muscle strength and also modified the relationship 
between muscle mass and obesity. For instance, older adults with diabetes had poorer 
muscle quality relative to non-diabetics suggesting that greater muscle mass does not 
always indicate greater muscle strength (Chen, Nelson, Zhao, Cui, & Johnston, 2013). 
Sarcopenia is a degenerative loss of muscle mass and strength associated with aging 
(Cruz-Jentoft et al., 2010) and impaired cognitive functioning (Nourhashémi et al., 2002). 
Functional complications of sarcopenia include the loss of muscle strength which can 
lead to disabilities in mobility and IADLs and increases the risk of falls (Baumgartner et 
al., 2004). Results from the Health ABC Study reported older adults aged 70-79 with low 
muscle strength were more likely to develop mobility limitations (Visser et al., 2005). 
Sarcopenic obesity, a combination of low lean body mass and high fat mass, is rapidly 
increasing in older adults (Baumgartner et al., 2004; Bouchard, Dionne, & Brouchu, 
2009) and affects 9-15% of men and 7-22% of women (Zamboni et al., 2005; Zoico et al., 
2004). 
Dementia has a long prodromal phase in which appetite is severely decreased 
leading to significant weight loss and under nutrition. A meta-analysis (Anstey et al., 
2011) found older adults who were underweight or obese had the highest risk of 
developing AD in later life compared to those with normal weight (Risk Ratio ~ 2.0). 
Overweight BMI was associated with a 35% increased risk of AD, 33% increased risk of 
VaD, and a 26% increased risk of any dementia. Some research suggests slightly 
overweight older adults are protected against cognitive decline (Atti et al., 2008).The 
inclusion of individuals in a preclinical phase of dementia muddies the relationship 




weight in the early stages of disease (Stewart et al., 2005; White, Pieper, & Schmader, 
1998). 
Results from longitudinal studies suggest obesity and underweight in midlife are 
also associated with lower cognitive function. A cohort study with over 20 years of 
follow-up reported individuals with long-term obesity or long-term underweight had 
lower cognitive functioning in late midlife (Sabia et al., 2009). Similar results were noted 
in the population-based Cardiovascular Risk Factors, Aging, and Dementia (CAIDE) 
study. Although the association was somewhat attenuated after adjusting for 
sociodemographic variables and midlife vascular risk factors (i.e., blood pressure, total 
cholesterol level, smoking status, ApoE genotype, and history of vascular disorder), the 
association still remained significant. Midlife obesity, high total cholesterol levels, and 
high systolic blood pressures were all found to be significant risk factors for dementia 
with odds ratios around two for each factor. A combination of these midlife risk factors 
increased the risk of dementia and AD additively; an individual with all three factors had 
an odds of AD 6.2 times higher than those without those factors (Kivipelto et al., 2005). 
Furthermore, a prospective study using the Swedish Twin Registry reported that midlife 
BMI predicted cognitive functioning 30 years later in a dementia-free sample. Even after 
controlling for lifestyles factors (i.e., smoking and alcohol use), midlife physical activity 
and vascular disorders, midlife BMI was a significant predictor of all cognitive domains 
measured (i.e., short- and long-term memory, speed, verbal and spatial ability); however, 
with the exception of verbal abilities, higher midlife BMI was not associated with faster 
rates of cognitive decline (Hassing et al., 2010). Additional analyses indicated that twin 




obese (OR = 3.88; 95% CI: 2.12-7.11) in midlife had an increased risk of dementia, 
independent of diabetes and other vascular risk factors indicating early-life environmental 
factors and genetics play a role in the midlife obesity-dementia association (Xu et al., 
2011). 
Disability 
The concepts of impairment, functional limitation, and disability are based on the 
work of Nagi (1965) and Verbrugge and Jette (1994) in which the disablement process 
was defined as an avoidable trajectory from injury to disablement. Impairment can be 
defined as deviation from what is considered normal function. A functional limitation is 
the loss of the ability to carry out an activity. In the broadest sense, disability can be 
thought of as the difference between an individual’s abilities and environmental demands 
or the inability to perform a social role. Disability is an indicator of health status, a major 
determinant of quality of life, and an indirect indicator of morbidity in older adults 
(Sauvaget, Tsuji, Aonuma, & Hisamichi, 1999).  
The onset of disability can be ascribed to two distinct processes; one the result of 
underlying chronic diseases associated with aging, and the other results from acute events 
such as stroke or hip fracture. The most commonly used measures of disability are self-
reports of basic activities of daily living (ADLs) and instrumental activities of daily 
living (IADLs). In the disablement process, these domains are affected in a hierarchical 
manner such that mobility loss occurs first and is then followed by mobility issues plus 
difficulties with IADLs, and finally, the accumulation of difficulties in mobility, IADLs, 




Differential risk by sex and race 
Cognitive functioning, age, sex, race, and education can modify the impact of 
disease on disability (Fried & Guralnik, 1997). Consistently, the prevalence of disability 
is higher in women aged 65 years and older than in men (Fried & Guralnik, 1997; 
Friedman, Elasy, & Jensen, 2001; Wray & Blaum, 2001); however this sex difference 
may disappear in the oldest-old (Berlau et al., 2012). Higher disability prevalence in 
women, coupled with women’s longer life expectancies, means older women, on average, 
spend more years living in a disabled state (Dunlop, Hughes, & Manheim, 1997). 
Furthermore, it appears that the onset of disability occurs earlier in women (Dunlop et al., 
1997).  
These sex differences could have several possible explanations. First, a higher 
prevalence of fatal conditions in men and non-fatal conditions in women may explain sex 
differences (Gold et al., 2002). Hammond’s (1995) theory of “multiple jeopardy” has 
been used to describe how women with a combination of disadvantages, including lower 
income, less education, and widowhood, have a higher risk for negative health outcomes 
compared to older men. Second, socio-cultural roles may be driving these differences. 
Several researchers have suggested that IADL items related to household activities 
should be excluded for men because these activities are usually performed only by 
women (Avlund, 1997; Lawton & Brody, 1969). Dropping these IADL items would lead 
to a more homogenous measure that is less influenced by sex-roles and is more sensitive 
to actual functional limitations.  
With aging comes increased heterogeneity. Cumulative advantage and/or 




in later life. Cumulative advantage can be traced to the late 1960s when Merton (1968) 
coined the phrase “the Matthew effect.” The theory has been broadly applied to multiple 
domains of research but in general states that early advantaged leads to accelerating 
advantage over time. Early advantages could include many factors such as access to 
education, higher socioeconomic status, or identifying as part of the racial majority. 
Older adults can experience a cascade of health and social disadvantages over the course 
of their life. An individual’s cognitive and physical health trajectories are then influenced 
by the accumulation of these events.  
African Americans have a greater risk of disability compared to Whites (Clark, 
1997; Clark & Maddox, 1992; Clark et al., 1997; Kelley-Moore & Ferraro, 2004; Mendes 
de Leon et al., 2005). Although African Americans have a greater risk of disability, 
Whites are more likely to suffer from compromised bone strength predisposing them to 
an increased risk of fracture (Cauley, 2011; Hochberg, 2007). These findings would 
suggest that the increased risk of disability in African Americans is not due to 
compromised bone strength but rather chronic diseases and/or genetic predispositions. 
There is still debate as to whether racial disparities disproportionately affect African 
American women. A number of studies have shown that racial disparities in risk factors 
for disability tend to be greater in African American women compared to African 
American men. For instance, African American women have a higher prevalence of 
cardiovascular disease, diabetes, and obesity compared to White women, and these 
differences are larger than those observed between African American and White men 




2002; Kelley-Moore & Ferraro, 2004; Mendes de Leon et al., 2005; Whitfield, Allaire, & 
Wiggins, 2004).  
Mobility disability 
Mobility disability is the most common form of disability in community samples, 
has dramatic effects on activities in everyday life (Ebrahim, Wannamethee, Whincup, 
Walker, & Shaper, 2000), and is associated with physical, sensory, and cognitive deficits 
(Anstey, Wood, Lord, & Walker, 2005). Mobility encompasses a broad spectrum that 
ranges from simple tasks like the ability to move one’s body, to more complex tasks that 
involve life- and driving-space (Wood et al., 2005). Mobility impairments refer to the 
lack of muscle strength required to ambulate, lift heavy objects, or grasp items. Lower 
body mobility impairments may require the use of an assistive device, such as a cane, 
wheelchair, or walker. Multiple tests have been proposed as a measure of mobility 
impairments, large-scale epidemiological studies have included both subjective measures, 
like the SF-36, ADLs, and IADLs, as well as objective measures like chair-stands, 
muscle strength (e.g., handgrip strength, arm and leg abduction, flexion, and extension), 
and gait speed (Buchman, Wilson, Boyle, Bienias, & Bennett, 2007; Choquette et al., 
2010; Clouston et al., 2013; Mijnarends et al., 2013).  
Grip strength, which will be used in the current proposal as a measure of physical 
functioning, has long been thought of as a proxy for overall body strength (Choquette et 
al., 2010; Rantanen et al., 1999; Sallinen et al., 2010; Shinkai et al., 2000). Attractive 
features of the handgrip strength measure, including ease of administration and low cost, 




like the Short Physical Performance Battery (Guralnik et al., 1994), which take longer to 
administer and score.  
Grip strength is also implicated in the disablement process. Handgrip strength has 
been used in multiple studies to predict future ADL disability in community-dwelling 
older adults. Men and women in the lowest quartiles of handgrip strength have a higher 
risk of overall disability (Giampaoli et al., 1999; Gill, Murphy, Barry, & Allore, 2009) as 
well as ADL disabilities compared to those with better handgrip strength (Al Snih, 
Markides, Ottenbacher, & Raji, 2004; Ishizaki, Watanabe, Suzuki, Shibata, & Haga, 
2000; Shinkai et al., 2003). Furthermore, handgrip strength has been associated with an 
increased risk of AD. Buchman and colleagues (2007) examined handgrip strength in 
relation to cognitive and physical performance. They found that for each 1-lb annual 
decline in grip strength the risk of AD increased 9%. Participants were screened for AD 
at baseline and those who developed the disease during the first five years of follow-up 
were excluded from all analyses. These results suggest that not only does higher grip 
strength at baseline protect against AD, but more importantly, physical declines may in 
fact, precede the onset of cognitive declines. It is possible that both grip strength and 
cognitive decline share similar etiopathogenesis, like impaired neural circuits.  
The SF-36, a measure of health-related quality of life, has been used to measure 
disability in older adults (Syddall et al., 2009). Specifically, the Physical Functioning 
(PF) subscale has been validated as a measure of mobility disability in epidemiologic 
studies of older adults (Syddall et al., 2009). In the ACTIVE study hypertension and 
diabetes, both independently associated with obesity and an increased risk of disability, 




To our knowledge, the association between BMI, grip strength, and cognitive 
performance has not been examined in longitudinal cohorts of older adults. 
Obesity may be strongly linked with mobility limitations and disability because 
added weight makes it more difficult to ambulate. In fact, results from the Health, Aging 
and Body Composition study suggest higher BMI was associated with increased risk of 
mobility limitations (Lee et al., 2005). The Longitudinal Study of Aging (LSOA), a 
prospective survey of 5,000 community-dwelling older adults aged 70 years and older, 
explored patterns of change and a hierarchy of disability in ADLs. The progression of 
incident disability began with difficulties in walking and was followed by difficulties in 
bathing, transferring, dressing, toileting, and feeding (Dunlop et al., 1997).  
Disability and weight  
The increasing prevalence of obesity in older adults has a profound impact on 
mobility disability. During 1988-2004 the likelihood of functional impairment increased 
over 40% in obese older adults (Alley & Chang, 2007). Consequently, disability rates are 
predicted to dramatically increase (Sturm, Ringel, & Andreyeva, 2004). Data from 
NHANES III highlight this trend; among obese individuals 37% reported disability in 
1994, whereas in 2004, 42% reported disability and functional impairments (Alley & 
Chang, 2007). A meta-analysis of obesity and mobility disability in older adults reported 
consistent findings linking high BMI (especially those ≥ 35 kg/m2) with an increased risk 
of mobility disability (Vincent, Vincent, & Lamb, 2010). These results were extended to 
the disability domains of IADLs and ADLs, in which obese (BMI ≥ 30 kg/m2) older 
adults aged 65 and older had the highest risk of disability compared with normal weight 




the relationship between BMI and physical disability is curvilinear. There is a beneficial 
effect associated with older adults being slightly overweight (i.e., BMI 25-29.9 kg/m2; 
Rejeski, March, Chmelo, & Rekeski, 2010); however, once older adults cross the Class II 
obesity threshold (BMI ≥ 35 kg/m2), the risk of physical disability increases significantly 
(Al Snih et al., 2007; Ferraro, Su, Gretebeck, Black, & Badlay, 2002; Mendes de Leon, 
Hansberry, Bienias, Morris, & Evans, 2006; Rejeski et al., 2010).  
There are multiple pathways in which obesity can increase the risk of disability in 
older adults. Direct effects are attributable to the increased risk of musculoskeletal 
conditions, like arthritis, which make it more difficult to successfully navigate the 
environment. Among a nationally representative sample, the odds of arthritis and 
osteoarthritis were seven times higher for obese individuals compared to their normal 
weight peers. Furthermore, of those with arthritis or osteoarthritis, obese individuals 
reported more pain and stiffness, poorer function, greater disease severity, and lower 
health-related quality of life (Ackerman & Osborne, 2012).The increased risk of diabetes 
and cardiovascular disease caused by obesity can indirectly influence disability risk. 
Although it was previously noted that BMI may not be the best indicator of adiposity in 
older adults, a recent study of multiple adiposity measures (i.e., BMI, waist and hip 
circumference, fat mass, fat-free fat mass, and percentage fat) found that for both men 
and women, BMI was the single best predictor for multiple types of disability (Wong et 
al., 2012).   
Weight loss in older adults remains controversial and is due to concerns regarding 
loss of lean muscle mass and physical function (Miller & Wolfe, 2008). Data from three 




examine the association between changes in fat and lean mass and changes in physical 
function in overweight and obese individuals (Beavers et al., 2013). Intentional weight 
loss was associated with significant improvements in self-reported mobility disability. 
Importantly, fat mass loss was a stronger predictor of changes in physical function 
compared to lean mass loss (Beavers et al., 2013). However, others suggest that weight 
loss is not protective against the development of mobility limitations in overweight and 
extremely obese older adults (Lee et al., 2005). Although weight loss is important when 
discussing the link between weight and cognition, the ACTIVE study was not able to 
differentiate between intentional and unintentional weight loss. Intentionality of weight 
loss is an important factor which can help to determine if weight loss is the result of 
disease/unrecognized health problems or due to changes in diet and/or exercise (Lee et 
al., 2005). Because the ACTIVE study is unable to determine intentionality of weight 
change, weight loss was not explored in the current proposal.  
With normal aging comes a progressive loss of muscle mass and an increase in fat 
mass (Schultz, Kyle, & Pichard, 2002). Accumulation of fat within muscle leads to lower 
quality muscle that is less capable of generating strength and power for mobility-related 
tasks (Marks, 2007) significantly increasing the risk of disability in older adults. A meta-
analysis of over 135,000 middle-aged and older adults (Backholer, Wong, Freak-Poli, & 
Peeters, 2011) revealed a stepwise increased risk of ADL limitations in overweight 
(OR=1.04; 95% CI 1.00-1.08), Class I obese (1.16, 95% CI 1.11-1.21), and Class II (or 
higher) obese (1.76; 95% CI 1.28-2.41) individuals, relative to normal weight individuals. 
Longitudinal analyses revealed similar findings, but the magnitude was larger for each 




adults, obese older adults were more likely to report disabilities in multiple domains 
including mobility, IADLs, and ADL after adjustment for sociodemographic 
characteristics (Larrieu et al., 2004).  
Although Jack and colleagues’ (2010) hypothetical model of the Alzheimer’s 
pathological cascade suggests that physical function does not begin to decline until after 
declines in memory, there is evidence to suggest that IADL impairments may start earlier 
in the disease process. Four IADL items (i.e., ability to use the phone, use of means of 
transportation, responsibility for medication, and ability to handle finances) were 
associated with current Mini-Mental State Exam (MMSE) score and predicted 1-year 
dementia incidence in a sample of community-dwelling older adults (Barberger-Gateau, 
Dartigues, & Letenneur, 1993). These results suggest that individuals with IADL-specific 
impairments may have a higher risk of dementia because of psychological or physical 
factors associated with both impairment and dementia. Another possibility is that 
impairment on these four IADLs is an early sign of dementia that does not meet the 
diagnostic threshold. It is possible that for a high risk group of older adults, especially 
those who are obese and have multiple chronic conditions, functional impairments may 
be present long before a diagnosis (Barberger-Gateau et al., 1993).  
Disability and cognition 
Intact cognitive functioning is necessary to complete complex tasks (e.g., 
managing finances) as well as the ability to successfully navigate the environment and 
maintain independent living status. In fact, even simple tasks like walking require a 
complex network of cognitive abilities (Li, Lindenberger, Freund, & Baltes, 2001). For 




attentional impairments are independently associated with future falls, postural 
instability, and impairment in ADLs (Woollacott & Shumway-Cook, 2002). Several 
groups have proposed that with increasing age, walking requires increasing amounts of 
cognitive and attentional processing (Li et al., 2001; Lindenberger, Marsiske, & Baltes, 
2000). 
Cognitive impairments, even in the absence of a dementia diagnosis, are 
associated with decreased quality of life and increased disability (Tabert et al., 2002). In 
the oldest-old (age greater than 90) cognitive impairment doubles the risk of disability 
(Berlau et al., 2012), whereas studies in younger cohorts have reported smaller effects 
(Johnson, Lui, & Yaffe, 2007). 
Gill et al. (1997) demonstrated that the orientation and memory items of the 
MMSE had the strongest predictive value of functional status. Cognitive data from the 
Second Longitudinal Study of Aging (LSOA II) were used to predict functional disability 
in later life. Individuals with lower scores on measures of mental status and memory were 
more likely to die or become disabled on IADLs and ADLs (OR=1.58; 95% CI: 1.15-
2.16) compared to those with higher scores (McGuire, Ford, & Ajani, 2006). In a 
nationally representative study of older adults, prevalent and incident IADL and ADL 
limitations were independently associated with lower baseline cognitive scores but not 
faster rates of decline. This suggests disabilities negatively affect cognitive performance 
at the time of their onset but may not lead to deterioration over time (Chodosh, Miller-
Martinez, Aneshensel, Wight, & Karlamangla, 2010). Executive functioning, which 
involves planning and execution of goal-directed behaviors, is necessary to successfully 




had significantly worse IADL and ADL function compared to women with no 
impairments. In contrast, women with impairments in global cognitive functioning (i.e., 
MMSE) did not have an increased risk of IADL or ADL dependence (Johnson, Lui, & 
Yaffe, 2007). In fact, executive function was a better predictor of IADL performance than 
depression or demographic characteristics in older adults (Cahn-Weiner, Malloy, Boyle, 
Marran, & Salloway, 2000). Processing speed may also play an important role in 
functional abilities (Birren, Woods, & Williams, 1980). Measures of processing speed 
predict IADLs (Owsley, Sloane, McGwin, & Ball, 2002) and mobility specific outcomes, 
such as limited life-space (Stalvey, Owsley, Sloane, & Ball, 1999).  
Although physical limitations and disabilities may increase the risk of cognitive 
decline, the independent effects of weight and physical functioning on cognitive function 
and changes in cognition have not been quantified. The ACTIVE study is a unique data 






Chapter 2. Mechanisms of Obesity 
Traditionally, episodic memory is impaired in late-onset Alzheimer’s disease 
(AD), whereas vascular dementia (VaD) is characterized by deficits in executive 
function/attention or frontal-lobe abilities (e.g., impaired function in social situations). 
Although there is great overlap in risk factors for AD and VaD, distinctive cognitive and 
behavioral profiles in both disorders suggest chronic health conditions with established 
negative effects on specific areas of the brain would differently affect risk of AD and/or 
VaD. Risk factors which negatively affect regions of the brain responsible for episodic 
memory retrieval and encoding, including the hippocampus, medial-temporal lobe and 
prefrontal cortex (PFC; Cabeza & Nyberg, 2009), are likely to have a stronger association 
with AD; whereas factors which negatively affect regions of the brain associated with 
attention and executive function, including the PFC and parietal lobes (Cabeza & Nyberg, 
2000; Pa et al., 2010), are likely to have a stronger association with VaD. Obesity and its 
sequelae (i.e., hypertension, diabetes) are known to have negative effects on brain 
structure and function as well as cognition.  
Although there is strong evidence to support a link between body weight and 
cognitive performance across the life span (see Smith, Hay, Campbell, & Trollor, 2011 
for a review), there is still debate regarding the causal nature of the relationship and the 
influence of mediators (e.g., diabetes, hypertension). Studies have shown an association 
between obesity and cognitive performance in otherwise healthy children (Smith et al., 
2011; Taras & Potts-Datema, 2005) and adults (Gunstad et al., 2007, 2008), suggesting 
that the association between body weight and cognition is not due only to the increased 




and obese children have had time to develop the sequelae associated with long-term 
obesity such as atherosclerosis, hypertension, coronary heart disease, or metabolic 
syndrome suggesting that obesity alone may influence cognitive functioning. 
Interestingly, there is evidence that impaired executive functioning may increase future 
risk of obesity. Findings in young children (aged 2-7 years) suggest that impaired 
inhibitory control, a component of executive function, is predictive of higher BMI at a 
later age (5.5-15 years; Reinert, Po’e, & Barkin, 2013). Dysregulation in neural circuits in 
the orbito-frontal cortex, an area associated with aspects of executive function, may 
predispose individuals to an increased risk of obesity (Willeumier et al., 2011). It is 
therefore possible that a bi-directional relationship between obesity and certain cognitive 
abilities exists. 
There is clear evidence to support the link between obesity measured in early- or 
midlife and cognitive decline and/or dementia (Kivipelto et al., 2005; Sabia et al., 2009; 
Smith et al., 2011; Xu et al., 2011); however studies of obesity in later life have shown 
mixed (Buchman et al., 2007) or even protective results (Corley, Gow, Starr, & Deary, 
2010; Elias, Elias, Sullivan, Wolf, & D’Agostino, 2005; Kuo et al., 2006). Discordant 
results may be attributable to differences in study design according to the choice of 
cognitive tests and different cognitive domains measured, length of follow-up period, 
definition of risk factors, type of dementia, and/or age of participants. 
In conjunction with behavioral deficits, obesity has been associated with 
structural and functional changes in the brain. Obese individuals who are cognitively 
normal (Raji et al., 2010; Ward et al., 2005) as well as those with mild cognitive 




gray matter in areas of the brain associated with taste, reward, and behavioral control, 
including the PFC and the hippocampus (Pannacciulli et al., 2006; Raji et al., 2010; Ward 
et al., 2005).  
Higher BMI is associated with less neuronal integrity (as measured by N-acetyl-
aspartate) in the frontal, temporal, and parietal lobes, with the largest effects noted in the 
frontal regions (Gazdzinksi et al., 2010; 2008). Frontal regions of the brain are most 
affected by aging which could suggest that obesity accelerates age-related changes in the 
brain. Decreased neural activity in the PFC has been observed in obese, but otherwise 
healthy individuals (Willeumier et al., 2011) and has been associated with performance 
on measures of memory and executive function (Volkow et al., 2009). Given the 
importance of the PFC and the hippocampus in cognition, the observed structural and 
functional changes may contribute to cognitive deficits observed in obese individuals.  
Although a vast amount of research suggests that body mass is associated with 
cognitive functioning, the degree to which body mass is directly associated with 
cognitive and contributes to cognitive deficits across the life span is contentious and an 
area of active research. This review will focus on several potential inter-connected 
mechanisms through which obesity influences cognitive performance. These mechanisms 
involve elevated blood pressure and triglycerides, impaired insulin regulation, and 
systemic inflammation. Figure 1 highlights how these mechanisms are associated with 
cognitive functioning. Some argue that obesity does not directly influence cognition 
(Sellbom & Gunstad, 2012); instead, a number of related factors including insulin 
dysregulation and inflammation mediate the effects of obesity on brain changes and 




associated with cognitive deficits in young children with no history of inflammation or 
insulin dysregulation. Research does not support this notion. In fact, obesity has been 
associated with cognitive deficits in children less than 10 years old (Reinert et al., 2013; 
Smith et al., 2011). 
Figure 1. Obesity-related mechanisms influencing cognitive changes. 
 
Blood Pressure 
Blood pressure is considered a marker of cerebrovascular health (Gąsecki, 
Kwarciany, Nyka, & Markiewicz, 2013) and even in individuals who remain 
normotensive throughout their life, both systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) increase with age. However, increased blood pressure is not an inevitable 
part of aging and likely results from environmental factors including lifestyle choices and 
social influences (Cherubini et al., 2010). The effects of blood pressure on cognition vary 
across the life span, where high blood pressure in middle age is associated with impaired 




increased risk of dementia (Gąsecki et al., 2013; Kivipelto et al., 2005); whereas later in 
life, it is associated with a decreased risk of dementia (Ruitenberg et al., 2001). 
Longitudinal data show an inverted u-shaped relationship between cognitive decline and 
blood pressure. In the Honolulu Asia Aging Study almost 18% of dementia cases were 
attributable to pre-hypertensive SPB levels (120-140mmHg); whereas 27% of dementia 
cases were attributable to untreated midlife SPB levels ≥120mmHg (Launer et al., 2010). 
Other findings suggest that maintaining a normal blood pressure is necessary for optimal 
cognitive functioning. Low SBP has been associated with impaired performance on 
measures of executive attention in older adults over the age of 70 (Mahoney, Verghese, 
Goldin, Lipton, & Holtzer, 2010) as well as poorer cognitive (i.e., MMSE) and functional 
(i.e., Katz IADLs) abilities in two samples of centenarians (Richmond, Law, & Kay-
Lambkin, 2011; Szewieczek et al., 2011).  
Age of hypertension onset also influences the risk of dementia. Several 
longitudinal studies with large samples find no association between hypertension and risk 
of AD if the diagnosis occurs after the age of 65 (Kimm et al., 2011; Posner et al., 2000); 
whereas a diagnosis prior to age 65 conferred a higher risk for all types of dementia 
(Kimm et al., 2011). These studies suggest that the negative effects of hypertension on 
cognition may operate with a considerable time lag. A longitudinal study of Medicare 
beneficiaries aged 65 and older suggests hypertension is more closely linked with 
vascular-related dementias and the effects on dementia risk differ according to specific 
comorbid vascular risk factors. History of only hypertension was associated a 2-fold 
increased risk of VaD, whereas a history of hypertension plus heart disease or diabetes 




2000). In contrast, a population-based study of individuals aged 85 years or older 
reported that over nine years, those with a history of hypertension had a lower probability 
of dementia (Rastas et al., 2010).  
The apparent protective effect of hypertension in very old adults may be due 
several factors. First, a drop in blood pressure precedes clinical manifestations of 
dementia in older adults, (Gąsecki et al., 2013), negatively affecting cognitive 
performance (Stewart, Prince, & Mann, 1999). Second, survivor bias may explain 
protective effects; younger individuals with poorly controlled hypertension may die 
sooner and therefore not live long enough to be at risk for dementia. Another possible 
explanation involves vascular changes associated with normal aging. A natural 
consequence of aging is the elongation of cerebral vessels which increases the minimal 
blood pressure necessary for perfusion of the white matter, increasing the risk of ischemia 
(Cherubini et al., 2010). 
Several possible mechanisms have been explored to explain the association 
between midlife blood pressure and cognition later in life including high blood pressure 
leading to stroke (MacMahon et al., 1990), atherosclerosis (Duron & Hanon, 2008), white 
matter lesions (WMLs; Razay, Williams, King, Smith, & Wilcock, 2009), as well as 
increased hippocampal atrophy and plaques and tangles (Bourdel-Marchasson, Lapre, 
Laksir, & Puget, 2010). Evidence clearly shows that hypertension causes stroke 
(MacMahon et al., 1990) and atherosclerosis (Li & Chen, 2005), increasing the risk of 
vascular damage in the brain along with concurrent impairments in mobility and 
cognition (Hajjar et al., 2011). High blood pressure is also associated with progression of 




WML progression compared with those with uncontrolled treated hypertension. Cerebral 
WMLs are prevalent in older adult populations and increase the risk of both dementia and 
stroke (Verhaaren et al., 2013). 
To summarize, the link between blood pressure and cognition is a complex non-
linear relationship. Both high and low levels of DBP (a marker for atherosclerosis) were 
related to faster declines in cognition over 5 years (Razay et al., 2009), whereas low 
levels of SBP were associated with impaired executive attention (Mahoney et al., 2010), 
global cognition and functional abilities (Richmond, Law, & Kay-Lambkin, 2011; 
Szewieczek et al., 2011). Chronic hypertension that begins in middle age increases the 
risk of cognitive decline later in life; however decreases in blood pressure are observed 
prior to and after the onset of dementia. 
Cholesterol 
Cholesterol plays a vital role in neuronal function and plasticity (van Vliet, 2012). 
In fact, the brain contains 25% of the total lipids in the body even though it makes up 
only 2% of total body weight (Dietschy & Turley, 2001). Similar to hypertension, high 
levels of cholesterol in midlife increase the risk of cognitive impairment and dementia; 
whereas in later life the association between cholesterol and cognition attenuates. A 
longitudinal study found that after controlling for multiple confounders (i.e., age, sex, 
race, education, and midlife vascular risk factors), midlife cholesterol in those aged 40-45 
was associated with AD and VaD three decades later. The risk of AD increased with 
higher levels of cholesterol; compared to those with normal cholesterol levels (< 
198mg/dl), individuals in the third quartile (221-248 mg/dl) had a hazard ratio (HR) of 




the highest risk of AD (HR = 1.58, 95% CI: 1.22-2.06). Additionally, higher cholesterol 
is associated with worse performance on episodic memory and category fluency in later 
life (Solomon, Kivipelto, Wolozin, Zhou, & Whitmer, 2009). These results were 
replicated in the Finish cohort of the Cardiovascular Risk Factors, Aging and Dementia 
(CAIDE) study even after controlling for ApoE genotype and other vascular risk factors 
(Kivipelto et al., 2002, 2005). A notable exception comes from the Prospective 
Population Study of Women, which followed women aged 38-60 at baseline over three 
decades and found no association between baseline cholesterol levels and incident AD 
(Miekle et al., 2010). One possible explanation for these discrepant findings is that the 
diagnosis of dementia was obtained using only medical records making it likely that 
cases of dementia were missed. 
Later in life, the association between cholesterol and cognitive function/dementia 
becomes somewhat less clear and opposing results are common (Kuusisto et al., 1997; Li 
et al., 2005; Merched, Xia, Visvikis, Serot, & Siest, 2000; Mielke et al., 2005; Reitz et 
al., 2008; Reitz, Luchsinger, Tang, Manly, & Mayeux, 2005; Reitz, Tang, Luchsinger, & 
Mayeux, 2004; Romas, Tang, Berglung, & Mayeux, 1999; Tan et al., 2003; van den 
Kommer et al., 2009). Some studies report no association between cholesterol measured 
in later life and incidence of dementia (Li et al., 2005; Tan et al., 2003); whereas others 
find that lower levels of cholesterol are associated with an increased risk of dementia 
(Kuusisto et al., 1997; Reitz et al., 2004; Romas et al., 1999; Zuliani et al., 2010) and 
worse performance on measures of global cognition and processing speed (van den 
Kommer et al., 2009). Inflammation may account for some of these findings; community-




period had lower levels of cholesterol and higher levels of interleukin (IL)-6, a marker of 
systemic inflammation (Zuliani et al., 2010).  
Sex, ethnic, and genetic factors further complicate the picture. In a study of native 
Africans aged 70 and older living in the US, the prevalence of AD increased with 
increasing levels of cholesterol (Hall et al., 2006), while ApoE ε4 carriers with lower 
cholesterol levels showed faster declines in processing speed (Evans et al., 2000). 
Interesting sex differences were noted in the NHANES III study; low cholesterol was 
associated with slower visuomotor speed only in young and middle-age men, but not 
women (Zhang, Muldoon, & McKeown, 2004). In post-menopausal women, those within 
the highest quartile of cholesterol had the highest odds of cognitive impairment compared 
to women in the three lowest quartiles (Yaffe, Barrett-Connor, Lin, & Grady, 2002). 
High cholesterol levels are related to cardiovascular and cerebrovascular 
disorders, both of which are independent risk factors of AD, and are a hypothesized 
mechanism to explain the link between cholesterol levels and cognitive function. 
Although, Solomon et al. (2009) found a relationship between cholesterol levels and 
dementia even after controlling for several vascular risk factors, suggesting that other 
mechanisms might explain the association. In addition, mechanisms that account for low 
cholesterol levels in those with dementia still need to be further explored. Low levels of 
cholesterol are a risk factor for atherosclerosis (Duron & Hanon, 2008) and stroke 
(MacMahon et al., 1990), which have been associated with dementia. Systemic 
inflammation, overall poor health associated with dementia, and survivor bias may 




Animal studies with obese rats suggest that elevated triglycerides disrupt leptin 
transport across the blood-brain barrier (BBB; Banks et al., 2004). Leptin, a hormone 
produced by adipose tissue which regulates appetite and metabolism, is beneficial to 
brain regions important for memory function, including the hippocampus (Banks, 2008; 
Harvey, Solovyoa, & Irving, 2006). During times of both starvation and obesity 
triglycerides increase in the blood. As a result, levels of leptin in the blood decrease and 
BBB transport is inhibited by triglycerides. This signals the brain to redirect calories from 
“non-essential” activities, like immune function and cognition, to essential activities, like 
appetite, necessary for survival (Banks, 2008). Leptin has been implicated in AD 
pathogenesis. In obese, but otherwise healthy individuals, leptin transport across the BBB 
is significantly impaired affecting Aβ production (Elmquist & Flier, 2004). In addition, 
evidence suggested that Aβ is associated with inflammatory biomarkers (C-reactive 
protein) and high levels of HDL cholesterol. This implicates proteins associated with 
inflammation, cardiovascular disease, and diabetes in the association between BMI and 
Aβ levels (Balakrishnan et al., 2005). High expression of amyloid precursor protein 
(APP) is found in adipose tissues, and is up-regulated in obese people which is linked to 
insulin resistance and hyperinsulinemia (Lee, Martin, Maple, Tharp, & Pratley, 2009). 
APP is also important for synapse formation and neural plasticity and is the primary 
component of amyloid plaques found in AD (Priller et al., 2006). 
Diabetes Mellitus 
Insulin is critical for regulating carbohydrate and fat metabolism in the body as 
well as regulating brain and cognitive functions. Insulin resistance develops when the 




studies, DM is a risk factor for all types of dementia and is a relatively common chronic 
disease that affects about 8% of the total US population (CDC, 2005) and over 25% of 
adults over the age of 60 (Kirkman et al., 2012). The vast surge in the number of 
individuals with Type 2 DM is clearly linked with increasing rates of overweight and 
obesity. Older adults have a high risk of developing Type 2 DM due to the effects of 
increasing insulin resistance and impaired islet functioning associated with aging 
(Kirkman et al., 2012). Diabetes negatively affects certain cognitive abilities and these 
deficits being to appear in the very early stages of the disease (Ruis et al., 2009). 
Cognitive performance in those with diabetes declines 20% to 70% faster than those 
without the disorder (Strachan, Price, & Frier, 2008). Specifically, cognitively healthy 
older adults with DM showed faster declines in attention, psychomotor speed, and short-
term memory compared to those in other glucose metabolism groups (i.e., normal or 
impaired fasting glucose); effects did not attenuate after adjustment for other vascular 
risk factors (Fontbonne, Berr, Ducimetiere, & Alperovitch, 2001). The most recent meta-
analysis of Type 2 DM and dementia risk, which pooled data from 19 studies with over 
40,000 individuals, reported a combined overall relative risk (RR) for dementia of 1.51 
(95% CI 1.31-1.74). When specific dementia diagnoses were analyzed the RR for VaD 
was stronger (RR=2.48; 95% CI 2.08-2.96) compared to AD (RR=1.46; 95% CI 1.20-
1.77; Cheng et al., 2012). Diabetes may also accelerate conversion from MCI to 
dementia. In people with MCI, diabetes was associated with a 1.5 – 3 times higher 
conversion rate to dementia (Li et al., 2011; Xu et al., 2010).  
Unlike blood pressure and cholesterol, in which there is a non-linear relationship 




cognition across the life span. Duration of the disease is an important determinate of the 
magnitude of the impact of DM on cognition. A case-control population-based study 
suggested that earlier onset, longer duration, and greater severity of DM was more 
important when exploring the association between MCI and DM. MCI was associated 
with an onset of DM prior to age 65 (OR = 2.20, 95% CI: 1.29-3.73), DM duration 
greater than 10 years (OR = 1.76, 95% CI: 1.16-2.68), and the presence of DM-related 
complications (OR = 1.80, 95% CI 1.13-2.89) even after adjusting for age, sex, and 
education (Roberts et al., 2008).  
Structural changes in the brain have also been linked to diabetes. Insulin at 
optimal doses with adequate glucose availability facilitates memory. However, when 
there is an imbalance of glucose availability, glucose metabolism issues can occur. AD 
has often been referred to as “type 3 diabetes” because insulin signaling is impaired and 
is associated with an accumulation of Aβ and tau proteins. Increased insulin resistance 
and diabetes have been associated with hippocampal atrophy as well decreased cerebral 
blood glucose levels (Bourdel-Marchasson et al., 2010). Structural and functional 
neuroimaging studies find that individuals with Type 2 DM have reduced gray matter and 
glucose metabolism in fronto-temporal brain regions (García-Casares et al., 2014). These 
abnormalities may underlie the transition to MCI in persons with Type 2 DM. Compared 
to older adults without Type 2 DM, individuals with Type 2 DM (both with and without 
MCI) showed decreased total gray matter volume. Significant differences were also 
observed in the temporal, frontal, and occipital lobes when Type 2 DM individuals were 




Several pathological mechanisms are thought to explain the link between DM and 
dementia. One possible mechanism comes from studies which report DM was associated 
with brain infarcts and changes in microvasculature (Peila, White, Masaki, Petrovitch, & 
Launer, 2006). In addition, DM could cause dementia indirectly through cerebrovascular 
disease (Kimm et al., 2011). Insulin resistance has been implicated in AD (Kuusisto et 
al., 1997; Morris et al., 2014). Impaired insulin secretion, glucose intolerance, and insulin 
resistance were associated with an increased risk of AD 35 years later after adjusting for 
several confounders (Rönnemaa et al., 2008). Morris and colleagues (2014) compared 
insulin resistance in aging and age-related neurodegenerative disorders (i.e., AD, 
Parkinson’s disease, and cognitively healthy older adults). They found that insulin 
resistance was increased in individuals with AD and Parkinson’s and was associated with 
reduced gray matter volume in multiple regions including the PFC, hippocampus and the 
temporal and parietal lobes (Morris et al., 2014). Hyperglycemia (high blood sugar), a 
symptom of diabetes, can lead to increased oxidative stress. The constant production of 
free radicals, a product of oxidative stress, places a huge burden on an individual’s body. 
Indeed, both hypo- and hyper-glycemia negatively affect multiple cognitive domains 
including memory, psychomotor speed, attention, and executive functioning (Brands, 
Kessels, deHaan, Kappelle, & Biessels, 2004).  
Systemic Inflammation - A Common Link 
Obesity is often characterized as a low-grade, chronic systemic inflammatory 
condition commonly caused by excess consumption of nutrients and is distinct from 
classical inflammation due to infection, pain, or heat which is acute in nature and only 




resistance in adipocytes through a number of inhibitory signal pathways. The effects of 
inflammation on adipose tissue are complex but all appear to alter the normal adipocyte 
processes and active stress responses (Gregor & Hotamisligil, 2011).  
The immune system’s inflammatory response has also been implicated in AD and 
is a hallmark of hypertension, hyperlipidemia, and DM. The risk of developing many 
disorders, including diabetes and atherosclerosis, is significantly increased with high 
levels of inflammation (Yaffe et al., 2004). Pro-inflammatory cytokines, like IL-6 and 
tumor-necrosis factor-α, as well as C-reactive protein, are associated with systemic 
inflammation and increased susceptibility to illness and infection. These inflammatory 
factors have been associated with diabetes and vascular risk factors of AD (Haan, 2006). 
After five years of follow-up, individuals with metabolic syndrome and high levels of 
inflammation had a higher risk of cognitive impairment compared to those without 
metabolic syndrome (RR = 1.66, 95% CI: 1.19-2.32; Yaffe et al., 2004). 
Metabolic syndrome is a cluster of associated cardiovascular risk factors 
including obesity, hypertension, hypercholesterolemia, and impaired glucose tolerance 
(NCEP, 2001), thought to negatively affect cognition. There is controversy surrounding 
this construct and many have argued that the metabolic syndrome offers little additional 
prediction of negative health events and mortality beyond its components (Khoshdel, 
Carney, & Gillies, 2012). Although definitions of metabolic syndrome have changed 
many times over the last 40 years, all have included some measure of impaired glucose 
metabolism, elevated blood pressure and triglycerides, and central obesity (Snow, 2010). 
Complications associated with metabolic syndrome (e.g., atherosclerosis, heart attack, 




Hanon, 2008; Hughes & Ganguli, 2009; Kimm et al., 2011). Metabolic syndrome may 
increase dementia risk because it summarizes the joint effects of these risk factors.  
In a sample of well-educated middle-aged and older adults, those with metabolic 
syndrome had a significantly lower IQ compared to those without the diagnosis 
(Hassenstab, Sweat, Bruehl, & Convit, 2010). Large negative effects on cognition were 
noted in areas of learning and recall (ηp2 = 0.12). These results are especially striking 
because lower education is often associated with metabolic syndrome, as well as an 
increased risk of dementia, and this sample contained only well-educated adults. By 
removing educational attainment as a possible explanation for the differences in 
cognition, it suggests that metabolic syndrome itself, and not education, is associated 
with cognitive impairments (Hassenstab et al., 2010).  
Several conclusions can be drawn regarding the mechanisms linking obesity with 
cognitive function. Perhaps most important is the fact that the described mechanisms are 
strongly influenced by age and measurement timing. For instance, diagnosis of 
hypertension or diabetes prior to age 65 appears to confer greater risk for cognitive 
impairments and/or dementia when compared to a diagnosis after age 65. Age-related 
normative changes in blood pressure and cholesterol levels may explain the age-
dependent relationship between these disorders and cognition. A review of research on 
cholesterol and later-life cognitive function reported that cholesterol levels decrease with 
increasing age (van Vliet, 2012). Furthermore, a natural consequence of aging is the 
elongation of cerebral vessels. Higher blood pressure in late life ensures adequate 




Regions of the brain that are particularly vulnerable to age, including the PFC, 
hippocampus, and the temporal and parietal lobes, are also vulnerable to the negative 
effects of conditions associated with metabolic syndrome. Of particular importance, areas 
of the brain that are less vulnerable to age, like the supplementary motor areas, and 
thalamus, are negatively affected by hypertension (Gąsecki et al., 2013). 
Furthermore, none of these diseases operate in isolation. Comorbidities which 
become more prevalent with age, have profound effects on an individual’s ability to self-
care and are important in obesity, disability, and cognition. Substantial evidence 
implicates obesity as a major cause of comorbidities which can lead to functional 
impairments (Ackerman & Osborne, 2012; Al Snih et al., 2007; Alley & Chang, 2007; 
Backholer et al., 2011; CMMS, 2012; Ferraro et al., 2002; Friedman et al., 2001). 
Cross-sectional studies report that the number of chronic conditions increases the 
risk of difficulties in ADLs (Guralnik, LaCroix, Everett, & Kover, 1989), IADLs (Fried, 
1996), and mobility disability (Verbugge, Lepkowski, & Imanaka, 1989) in a linear 
fashion. In fact, the presence of a single chronic condition was a significant predictor of 
functional declines (Guralnik et al., 1993). Given that 82% of Medicare beneficiaries 
aged 65 and older had one or more chronic conditions in 1999 (Wolff, Starfield, & 
Anderson, 2002) and in 2010 almost 53% had at least three chronic conditions (CMMS, 
2012), disability is a major concern for older adults. Healthcare costs of people with 
difficulties in 5-6 ADLs are almost 30-times higher than those with no ADL difficulty. 
This number dramatically increases in individuals with both cognitive impairment and 
disability; healthcare costs have been estimated to be over 50-times greater in these 




In summary, considerable research is still needed to elucidate the mechanisms by 
which obesity is associated with cognitive impairments and dementia risk. To date, there 
is considerable evidence for increased dementia risk and specific cognitive impairments 
in obese persons. The cause of obesity-related cognitive dysfunction is difficult to 
establish because of the prevalence of comorbidities (diabetes, hypertension), each of 
which influence cognitive functioning. Longitudinal studies are needed to investigate the 
pathophysiological mechanisms which lead to cognitive- and brain-related changes 





Chapter 3. Dynamic Relationship between Longitudinal BMI and Cognition  
Obesity is often referred to as one of the most serious health problems of the 21st 
century (Barness, Opitz, & Gilbert-Barness, 2007), accounting for an estimated 400,000 
deaths each year in the US (Mokdad, Marks, Stroup, & Gerberding, 2004), and has 
serious implications for an aging population. In fact, obesity is the second leading cause 
of preventable death in the US (Ogden, Carroll, McDowell, & Flegal, 2007).  
Studies of obesity and cognition in children and adolescents provide substantial 
evidence that obesity is associated with impaired cognitive functioning, independent of 
cardiovascular and socioeconomic risk factors (Smith et al., 2011). One of the most 
consistent findings in obese children and adolescents are deficits in executive function, 
followed by deficits in short-term memory, global cognition, and verbal abilities when 
compared to their normal weight peers (Krombholz, 2013; Smith et al., 2011). Some 
research suggests that executive dysfunction is a risk factor for increased body mass 
index (BMI) which may induce a bidirectional relationship between obesity and cognitive 
performance. One longitudinal study found that poor executive function at age 4 
predicted a high BMI at age 6 (Guxens et al., 2009); whereas another study followed 
around 8,000 individuals from age 7 to age 33 and found that poor hand control and 
coordination at age 7 predicted obesity at age 33 even after taking into account multiple 
confounders (Osika & Montgomery, 2008). Aspects of executive functioning may have a 
direct effect on self-monitoring and goal-directed behavior which are necessary to 
monitor and maintain energy balance. If this is true, normative age-related declines in 




increases dramatically in later life (Ogden et al., 2007; Salthouse, Atkinson, & Berish, 
2003). 
A consistent finding across multiple studies is the u-shaped association between 
BMI and dementia risk (Anstey et al, 2011; Beyound, Beyound, & Wang, 2008; 
Fitzpatrick et al., 2009; Gustafson, 2006, 2008; Hassing et al., 2010; Kivipelto et al., 
2005; Kuo et al., 2006; Sabia et al., 2009; Smith et al., 2011; Stewart et al., 2005), where 
both low and high BMI increase risk of dementia. Higher BMIs have been associated 
with an increased risk of chronic conditions like hypertension and diabetes, both of which 
are independently associated with an increased risk of cognitive decline and Alzheimer’s 
disease; while lower BMIs have been associated with wasting diseases and frailty (Fulop 
et al., 2010; Gill et al., 2002). The picture becomes less clear when examining the 
association between BMI and cognitive functioning in later life. Low (Green et al., 1994; 
Buchman, WIilson, Bienias, Shah, Evans, & Bennet, 2005) and high BMI (Corley, Gow, 
Starr, & Deary, 2010; Elias, Elias, Sullivan, Wolf, & D’Agostino, 2003, 2005; Kuo et al., 
2006) as well as weight loss (Bagger, Tanko, Alexandersen, Qin, & Christiansen, 2004; 
Bruhbacker, Monsch, & Stähelin, 2004; Buchman et al., 2005) and weight gain (Bagger 
et al., 2004) have been associated with lower cognitive scores. 
Although evidence supports a u-shaped association between BMI and dementia 
risk, less is known about concurrent trajectories of BMI and cognitive performance. The 
goal of the current study was to investigate the dynamic longitudinal relationship between 
cognitive performance and BMI among older adult participants of the Advanced 
Cognitive Training for Independent and Vital Elderly (ACTIVE) trial. Specifically, over 




associated with changes in BMI; 2) determine whether baseline BMI was associated with 
changes in cognitive performance; and 3) examine if change in cognitive performance is 
associated with longitudinal changes in BMI. 
Methods 
The ACTIVE trial is a randomized, controlled trial designed to evaluate the 
effectiveness of three cognitive training interventions (i.e., memory, reasoning, and 
processing speed) on cognitive abilities and functioning of independently-living 
cognitively healthy older adults. Details on the screening, eligibility criteria, and 
recruitment have been previously reported in the literature (Ball et al., 2002; Jobe et al., 
2001). Persons were excluded if they 1) had a Mini-Mental State Exam (MMSE) score of 
<22; 2) had a diagnosis of Alzheimer’s disease; 3) were functionally impaired, (requiring 
assistance in dressing, personal hygiene, or bathing three or more times in the prior 
week); 4) had medical conditions that would predispose them to imminent functional 
decline (e.g., stroke within the last year, certain cancers); 5) previously participated in 
cognitive training interventions; 6) or had vision, hearing, or communication 
impairments. 
ACTIVE recruited 2,832 participants in 1998, of whom 2,802 were randomized to 
one of four groups: 1) memory training (n=703); 2) reasoning training (n=699); 3) 
processing speed training (n=702); or 4) a no-contact control (n=698). At baseline 
participants were between 65-94 years of age and 73% of the sample reported White race 
(African American 26%). The sample was re-contacted for subsequent follow-up 




annual), 2000-2002 (2nd annual), 2001-2002 (3rd annual), 2003-2004 (5th annual), and 
2008-2009 (10th annual). 
The current study analyzed the association between body weight and cognitive 
function over 10 years in ACTIVE participants. 
Measures 
Classification of Body Weight. Body weight status was classified based on body 
mass index (BMI), a measure of weight adjusted by height. BMI was not measured at 
post-test or the first annual follow-up in the ACTIVE study. 
Cognitive Function  
Trained assessors administered the test battery, which included a global cognitive 
measure and standardized neuropsychological tests to evaluate memory, reasoning, and 
processing speed. Each primary outcome was standardized to its baseline values. A 
composite measure of performance was computed for each of the three cognitive domains 
targeted by an ACTIVE intervention arm (i.e., memory, reasoning, processing speed), by 
equally weighting each measure within that domain, pooling total scores, and performing 
a Blom transformation (Blom, 1958) to normalize distributions. Following 
transformation, distributions of outcomes were normal. Test scores were then summed to 
form baseline cognitive composite scores that were standardized to the mean and 
standard deviation of the entire sample. If one or more tests of a composite measure were 
missing, the composite score was calculated as the average of the non-missing tests. 
Memory. A memory composite score was created using the Rivermead Behavioral 




Verbal Learning Test (HVLT) and the Rey Auditory Verbal Learning Test (AVLT). 
These measures include an immediate learning component. To reduce practice effects, 
the ACTIVE study design used parallel, but not equivalent forms of the memory tests at 
each visit. When alternate forms are not of equivalent difficulty, analyses of intra-
individual changes may be unintentionally biased (Gross et al., 2012). Alternate forms 
were placed on an equivalent metric using equipercentile equating procedures (Kolen & 
Brennan, 1995). A higher memory composite score indicated better memory function. 
Reasoning. For the reasoning composite three tests, Word Series (Gonda & 
Schaie, 1985), Letter Series (Thurstone & Thurstone, 1949), and Letter Sets (Erkstrom, 
French, Harman, & Dermen, 1976) were used. Word Series and Letter Series require 
participants to identify a pattern in a set of words or letters, and then select the next 
stimulus in the series from a list of possible answers. The Letter Set task requires 
participants to identify a common rule among four to five letter sets, marking the set that 
does not follow the rule. A higher reasoning composite score indicated better 
performance. 
Processing Speed. The processing speed composite score was derived from four 
Useful Field of View (UFOV) tasks. The UFOV is a measure of information processing 
speed and selective and divided attention, and is related to IADLs and indices of mobility 
(Edwards et al., 2009). The test is administered on a touch-screen computer and consists 
of four increasingly complex subtests composed of multiple trials that vary in duration 
from 17 to 500ms. Lower scores on the UFOV indicated better performance. 
Digit Symbol Substitution Task. The Digit Symbol Substitution Test (DSST) is a 




sensitive to virtually all neurocognitive impairments and depression (Dickinson, Ramsey, 
& Gold, 2007). A key at the top of the form pairs a number (1-9) with a symbol. The 
form consists of boxes of numbers with an empty space below to fill in the corresponding 
symbol. Participants are given 90 seconds to fill in corresponding symbols under the 
number boxes. 
Other Covariates 
Self-reported history of diabetes or hypertension at baseline were included as 
covariates because of their known association with both BMI and cognitive performance 
(Gąsecki, Kwarciany, Nyka, & Markiewicz, 2013; Kirkman et al., 2012; Kuo et al., 
2005). Other covariates included age (in years), sex, race (White vs. African American), 
years of education, baseline MMSE score, intervention group, and study site. 
Analysis 
Differences in baseline characteristics by BMI categories were assessed by one-
way analyses of variance or χ2 tests when appropriate. Age and education were mean-
centered for all analyses (M=73.6 and 13.5, respectively). All cognitive outcomes were 
standardized (M=50, SD=10) before fitting latent growth curve models. A series of 
models were estimated to investigate the longitudinal relationship between cognitive 
performance and BMI across the baseline, 1-, 2-, 3-, 5-, and 10-year visits. First, 
unconditional latent growth curve models (LGCM) were initially fit to each cognitive 
outcome (i.e., memory, reasoning and processing speed) and BMI using Mplus 7 
(Muthén & Muthén, 2012). Next, a parallel process growth model was used to estimate 




cognitive outcomes and BMI (Figure 2) and included age, sex, race, years of education, 
history of diabetes or hypertension, baseline MMSE, intervention group, study site, and 
retest effects as covariates. Parallel process growth models are a type of latent growth 
curve model used to investigate change over time and explore predictors of these 
changes. Specifically, parallel process growth models allow the growth curves of BMI 
and cognition to be modeled simultaneously. The factor loadings on the growth rate 
factor are specified to reflect the time intervals between measurements and the growth 
trajectory shape. Setting the loadings as 0, 1.2, 2.2, 3.2, 5.2, and 10.2 reflects the linear 
trajectory across six time points at unequal intervals. The intercept and slope of BMI was 
allowed to correlate with the corresponding intercept and slope for each cognitive 
outcome. This allowed for the examination of both cross-sectional associations between 
BMI and cognitive outcomes, in addition to examining the extent to which changes in 
BMI were associated with changes in cognition over a 10-year period. Model fit was 
determined using the root mean square error of approximation (RMSEA), comparative 
fix index (CFI), and the standardized root mean square residual (SRMR). An RMSEA 
<0.05, a CFI > 0.96, and a SRMR <0.08 indicate excellent model fit (Wu, West, & 
Taylor, 2009). After the final model was selected, sensitivity analyses were conducted. 
For each of the four cognitive outcomes, multiple group models were run to test for 
invariance of associations by intervention group. There were no significant differences by 




Figure 2. Parallel process latent growth model of BMI and cognitive performance 
 
Legend. Parallel process latent growth curve model of BMI and cognitive performance. 
Latent variable intercepts and slopes are regressed on covariates that include age, sex, 
race, years of education, history of diabetes or hypertension, baseline MMSE score, 
intervention group, and study site. Residual error variances are shown by smaller dashed 
arrows going towards the observed (boxed) and latent (circled) dependent variables. 
Numbers on arrows going from latent growth parameters to observed time points indicate 
factor loadings. T = Assessment wave (1=Baseline; 2=Year 1; 3=Year 2; 4=Year 3; 
5=Year 5 6=Year 10). 
Results 
Exploratory analyses revealed all outcome measures were approximately 
normally distributed. Participant characteristics as a function of BMI categories are 
presented in Table 5. Persons who were classified as Class II obese (BMI ≥ 40kg/m2) at 
baseline were more likely to be younger, female, have fewer years of education, more 
self-reported health conditions, and lower scores on the MMSE. Participants classified as 
under- (BMI < 20kg/m2) or normal-weight (BMI 20-24.9kg/m2) were more likely to be 
older, female, and White with an average of 2 chronic health conditions. At baseline, the 
memory and reasoning composite scores did not significantly differ by BMI categories, 
while under- and normal-weight participants had significantly slower times on the speed 




analyzed baseline association between BMI and cognitive performance in the ACTIVE 
study.  
Prior to fitting a parallel process parallel process growth model, LGCM were fit 
for each cognitive outcome. The memory LGCM was an acceptable fit for the data, 
CFI=0.99, RMSEA=0.03, SRMR=0.02. The LGCMs also provided acceptable fit for the 
reasoning (CFI=0.98, RMSEA=0.04, SRMR=0.03) and speed (CFI=0.97, RMSEA=0.04, 
SRMR=0.05) composite scores and the DSST (CFI=0.99; RMSEA=0.03; SRMR=0.03) 
data. As a next step, unadjusted parallel process growth models were fit for each 
cognitive outcome (Table 6). Finally, a parallel process growth model adjusted for age, 
sex, race, years of education, history of diabetes or hypertension, intervention group, 
study site, and re-test effects was fit to each cognitive outcome (Table 7). 
For each cognitive outcome, standardized regression coefficients describing the 
association between covariates and intercepts and slopes are presented (Table 7) before 
describing the relationships between cognitive performance and BMI. 
Memory. At baseline, older age (β = -0.21), male sex (β = -0.08), White race (β = 
-0.15), greater educational attainment (β = -0.16), and higher MMSE scores (β = -0.07) 
were associated with lower BMI, whereas a history of diabetes (β = 0.21) or hypertension 
(β = 0.18) was associated with a higher BMI. Older age (β = -0.39), male sex (β = -0.14), 
and a history of diabetes or hypertension (β = -0.07; β = -0.05; respectively) were 
associated with lower memory composite scores, whereas individuals who indicated 
White race (β = 0.21), more years of education (β = 0.31), and higher MMSE scores (β = 
0.52) had higher memory composite scores. Age was associated with rate of change over 




decline on the memory composite (β = -0.30). Race was associated with a steeper annual 
rate of change on the memory composite score (β = -0.13). 
Reasoning. At baseline, older age (β = -0.21), male sex (β = -0.07), White race (β 
= -0.15), greater educational attainment (β = -0.13), and higher MMSE scores (β = -0.05) 
were associated with a lower BMI, while a history of diabetes or hypertension (β = 0.22; 
β = 0.18; respectively) were associated with a higher BMI. Older age (β = -0.32) and 
history of diabetes or hypertension (β = -0.06, β = -0.08; respectively) were associated 
with worse performance on the reasoning composite, whereas White race (β = 0.31), 
male sex (β = 0.06), greater educational attainment (β = 0.43) and higher MMSE scores 
(β = 0.52) were associated with better performance. Older age was associated with rate of 
change over time such that older individuals had steeper annual rates of decline in BMI 
and reasoning performance over time (β = -0.13; β = -0.23, respectively). Educational 
attainment was associated with rate of change over time such that individuals with greater 
educational attainment had faster rates of decline on the reasoning composite (β = -0.11). 
Speed. At baseline, older age (β = -0.19), male sex (β = -0.09), White race (β = -
0.16), greater educational attainment (β = -0.17) and higher MMSE scores (β = -0.09) 
were associated with lower BMI, while history of diabetes or hypertension (β = 0.21, β = 
0.18; respectively) were associated with higher BMI. Individuals at baseline who were 
older (β = 0.50) and had a history of diabetes or hypertension (β = 0.08; β = 0.05; 
respectively) had slower speed scores. Individuals at baseline who were male (β = -0.06), 
White (β = -0.10), had greater educational attainment (β = -0.20), and higher MMSE 
scores (β = -0.36) had faster speed scores. Only older age (β = -0.15) and history of 




DSST. At baseline, older age (β = -0.22), male sex (β = -0.07), White race (β = -
0.15), greater educational attainment (β = -0.15), and higher MMSE scores (β = -0.06) 
were associated with lower BMI, while diabetes (β = 0.21) and hypertension (β = 0.14) 
were associated with higher BMI. Individuals at baseline who were older (β = -0.30), 
male (β = -0.09), and reported a history of diabetes (β = -0.10) or hypertension (β = -
0.06) had lower scores on the DSST, while individuals who were White (β = 0.26), had 
greater educational attainment (β = 0.28) and higher MMSE scores (β = 0.40) had higher 
scores on the DSST. Age (β = -0.13) and history of hypertension (β = -0.10) were 
associated with rate of change in BMI over time, such that older individuals and those 
with a history of hypertension had faster rates of change in BMI over time. Age (β = -
0.25), race (β = -0.13), and history of diabetes (β = -0.11) were associated with rate over 
change over time in DSST scores, such that older individuals and those with a history of 
diabetes had steeper declines in DSST over time. 
Next, a parallel process GMM was fit to estimate the association between growth 
parameters of each cognitive outcome and BMI. Findings suggest that on average, 
participants were overweight (BMI 28.7 kg/m2) at baseline and lost about 0.1 kg/m2 
annually (roughly 2.2 pounds over 10 years). Better baseline memory (β=0.07, SE=0.04, 
p=.04), reasoning (β=0.08, SE= 0.03, p=.02), speed (β=-0.16, SE= 0.04, p=.007), and 
DSST (β = 0.09, SE=0.04, p=.01) performance was associated with attenuated declines in 
BMI (Table 7). Higher baseline BMI was associated with faster processing speed 
performance at baseline (β= -0.08, SE=0.02, p<.0001) and attenuated declines in 
reasoning ability (β=0.10, SE=0.02, p<.0001). Interestingly, changes in BMI were 




processing speed (r= -0.35, p<.0001), and DSST (r=0.25, p<.0001) over 10 years after 
adjusting for demographic and health characteristics suggesting that slower cognitive 
decline is associated with slower declines in BMI. 
Discussion 
The use of parallel process growth models in the current study simultaneously 
analyzed trajectories of BMI and cognitive performance to examine the dynamic 
relationship between these two processes. Current findings highlight the complex 
relationship between cognitive performance and BMI in older adults. Higher scores at 
baseline on the memory and reasoning composites were associated with steeper declines 
in BMI, while faster baseline processing speed scores were associated with slower rates 
of decline in BMI. Higher BMI at baseline was associated with better initial processing 
speed performance (Kuo et al., 2006) and accelerated improvement in reasoning ability 
which replicates prior cross-sectional analyses using ACTIVE data. Current findings 
raise the possibility that obesity produces differential effects on memory, reasoning, and 
processing speed and may suggest that, in the current sample of older adults, individuals 
with higher cognitive scores at baseline lost weight at a slower rate compared to those 
with lower cognitive scores.  
Interestingly, changes in BMI were associated with changes in memory, 
reasoning, and processing speed. Findings suggest that slower cognitive decline is 
associated with greater increase in BMI over time. Based on prior analyses (results not 
shown), attrition over the 10-year study period was related to baseline cognitive 
performance such that individuals with lower cognitive scores were more likely to drop 




link between changes in weight and cognitive performance is mixed. Results from 
community-dwelling Korean older adults aged 60-85 complement findings in the 
ACTIVE study (Han et al., 2009). Increased adiposity in men who were obese (as 
measured by BMI, waist circumference (WC), and waist-hip ratio (WHR)) at baseline 
was associated with a positive change in cognitive functioning. For women, both 
decreased adiposity over time when obese at the baseline (measured with WHR), or 
increased adiposity in women with normal adiposity at baseline (measured with WC), 
were both associated with cognitive declines. In contrast, results from a sample of 
middle-aged and older Australian women found no association between changes in 
weight and changes in cognitive performance (Lo et al., 2012). Null findings could be 
explained by modest sample size (n=334), lack of control for practice effects on the 
cognitive measures or the fact that participants were seen at only 2 occasions, roughly 7.5 
years apart. These conflicting results highlight the importance of both the age at which 
adiposity is measured as well as the measurement type.  
Recent studies indicate that weight change, not BMI per se, may be more closely 
linked to cognitive performance in older adults. Findings from the Women’s Health 
Initiative Study of Cognitive Aging (WHISCA) suggested that only weight loss was 
associated with impaired cognitive scores (i.e., verbal memory, fine motor speed, and 
global cognitive function; Driscoll et al., 2011) in contrast to results from current 
analyses in the ACTIVE cohort. Dementia is known to have a long prodromal phase in 
which appetite is severely decreased leading to significant weight loss and under nutrition 
(Albanese et al., 2013), explaining why cognitive performance may be associated with 




related to BMI (Buchman, Schneider, Wilson, Bienias, & Bennett, 2006) and could 
explain involuntary weight loss in preclinical dementia. This suggests that the timing of 
BMI measurement is very important and may determine the relationship between BMI 
and cognitive performance. Current findings raise the possibility that body weight (BMI) 
measured in the mid-70s (mean age of ACTIVE participants at baseline 73.6 years) may 
influence both concurrent and future cognitive performance up to 10 years later in a 
sample of older adults who were cognitively healthy and independently-functioning at 
baseline. 
Current analyses revealed that higher BMI at baseline was associated with 
attenuated declines in reasoning, which has been replicated in other samples of older 
adults (Luchsinger et al., 2013; Sturman et al., 2008). One of the single largest factors 
that determines whether an individual practices healthy behaviors is intelligence 
(Gottfredson, 2004). Individuals with higher cognitive abilities may have a reduced risk 
of obesity because they are more likely to engage in healthy behaviors (e.g., eat a 
healthier diet, exercise, and regular trips to the doctor). 
The current findings must be presented alongside some limitations. First, the 
ACTIVE trial recruited cognitively healthy and functionally independent older adults at 
baseline. Due to volunteer bias, the current findings may not generalize to a larger 
population of older adults. Second, the current study only included a single measure of 
body composition (BMI) measured in later life. Waist circumference and waist-to-hip 
ratio are more strongly associated with negative health outcomes compared to BMI 
(Dagenais et al., 2005; Lindqvist et al., 2006) and differential results by type of body 




adiposity parameters in midlife or intentionality of weight loss. Midlife obesity has been 
linked with an increased risk of cognitive decline and dementia (Anstey et al., 2011; Loef 
& Walach, 2013). Dieting has been impairments in reaction time, sustained attention, 
verbal memory, and working memory capacity (Green & Rogers, 1997;; Kemps, 
Tiggeman, & Marshall, 2005; Kemps & Tiggemann, 2005; Shaw & Tiggeman, 2004). 
Additional work is needed to clarify the mechanisms responsible for the association 






Chapter 4. Longitudinal Mediation of Grip Strength on Weight-Related Changes in 
Cognition 
Mobility disability is the most common form of disability in community samples 
of older adults, has dramatic effects on activities in everyday life (Ebrahim et al., 2000), 
and is associated with physical, sensory, and cognitive deficits (Anstey et al., 2005). 
Obesity may be strongly linked with mobility disability because added weight makes it 
more difficult to navigate the environment. In fact, results from the Health, Aging and 
Body Composition study suggest higher BMI was associated with increased risk of 
mobility limitations (Lee et al., 2005). Findings from the Longitudinal Study of Aging 
(LSOA), a prospective survey of 5,000 community-dwelling older adults aged 70 and 
older, suggest that the progression of incident disability began with difficulties in walking 
and was followed by difficulties in bathing, transferring, dressing, toileting, and feeding 
(Dunlop et al., 1997). 
The increasing prevalence of obesity in older adults has a profound impact on 
disability. During 1988-2004 the likelihood of functional impairment increased over 40% 
in obese older adults (Alley & Chang, 2007). Consequently, disability rates are predicted 
to dramatically increase (Sturm et al., 2004). Data from the National Health and Nutrition 
Examination Survey (NHANES III) highlight this trend; among obese individuals 37% 
reported disability in 1994, whereas in 2004, 42% reported disability and functional 
impairments (Alley & Chang, 2007). While obese populations have grown healthier since 
the 1960s (Gregg et al., 2005), the age of onset of obesity has decreased (Alley & Chang, 
2007). This would suggest that although obese populations are living longer, they are 




 A meta-analysis of obesity and mobility disability in older adults reported 
consistent findings linking high body mass index (BMI; especially those > 35 kg/m2) 
with an increased risk of mobility disability (Vincent et al., 2010). These results were 
extended to the disability domains of activities of daily living (ADLs) and instrumental 
activities of daily living (IADLs), in which obese (BMI ≥ 30 kg/m2) older adults aged 65 
and older had the highest risk of disability compared with normal weight older adults 
(Larrieu et al., 2004). Similar to the relationship between BMI and dementia risk, the 
relationship between BMI and physical disability is curvilinear. There is a beneficial 
effect associated with older adults being slightly overweight (i.e., BMI 25.0 - 29.9 kg/m2; 
Rejeski et al., 2010); however, once older adults cross the Class II obesity threshold 
(BMI ≥ 35 kg/m2), the risk of physical disability increases significantly (Al Snih et al., 
2007; Ferraro, Su, Gretebeck, Black, & Badlay, 2002; Mendes de Leon, Hansberry, 
Bienias, Morris, & Evans, 2006; Rejeski et al., 2010). 
Mobility impairments refer to the lack of muscle strength required to ambulate, 
lift heavy objects, or grasp items. Handgrip strength is associated with individual 
differences in cognitive performance in cross-sectional studies (Nourhashémi et al., 2002; 
Taekema et al., 2012). It has been hypothesized that grip strength and cognition are 
related due to central nervous system involvement. Measures of grip strength are 
sensitive to the aging process and have been used as a proxy for the integrity of the 
central nervous system (Christensen, MacKinnon, Korten, & Jorn, 2001; Salthouse, 
Hambrick, & McGuthry, 1998). Older adults in the Hispanic Established Population for 
the Epidemiological Study of the Elderly (H-EPESE) in the lowest handgrip strength 




highest quartile; whereas individuals in the highest grip strength quartile maintained a 
higher level of cognitive functioning (Alfaro-Acha et al., 2006). Importantly, these results 
suggest that physical declines may precede cognitive declines. 
There are multiple pathways through which obesity can increase the risk of 
disability in older adults. Direct effects include the increased risk of musculoskeletal 
conditions, like arthritis. In a nationally representative sample, the odds of arthritis and 
osteoarthritis were seven times higher for obese individuals compared to normal weight 
individuals. Furthermore, of those with arthritis or osteoarthritis, obese individuals 
reported more pain and stiffness, poorer function, greater disease severity, and lower 
health-related quality of life (Ackerman & Osborne, 2012). 
Indirect effects result from the increased risk of diabetes and cardiovascular 
diseases that are associated with obesity as well as disability. Although BMI may not be 
the best indicator of adiposity in older adults (see Haboubi et al., 1990; Vailas & Nitzke, 
1998), a recent study of multiple adiposity measures (i.e., BMI, waist and hip 
circumference, fat mass, fat-free fat mass, and percentage fat) found that for both men 
and women, BMI was the single best predictor of multiple types of disability (Wong et 
al., 2012). 
Progressive loss of muscle mass and an increase in fat mass occur in normal aging 
(Schultz et al., 2002) leading to lower quality muscle that is less capable of generating 
strength and power for mobility-related tasks (Marks, 2007). Poorer muscle quality and 
an increase in fat mass can significantly increase the risk of disability in older adults. A 
meta-analysis of middle-aged and older adults (Backholer et al., 2011) revealed a 




overweight or heavier, relative to normal weight individuals. In fact, when compared 
with normal weight older adults, older obese adults were more likely to report disabilities 
in multiple domains including ADLs, IADLs, and mobility even after adjustment for 
sociodemographic characteristics (Larrieu et al., 2004). 
The literature is replete with studies of either BMI and muscle strength and their 
association with cognitive performance, but few studies have examined the longitudinal 
mediation of grip strength on weight-related changes in cognition. The purpose of the 
current study is to examine the extent to which grip strength, a proxy for mobility 
limitations, mediates longitudinal BMI-related changes in cognition using the Advanced 
Cognitive Training for Independent and Vital Elderly (ACTIVE) data set. 
Methods 
The ACTIVE trial is a randomized, controlled-trial of behavioral training 
interventions (i.e., memory, reasoning, and processing speed) designed to improve 
cognitive abilities and functioning of independently-living older adults. Details on the 
screening, eligibility criteria, and recruitment have been previously reported in the 
literature (Ball et al., 2002; Jobe et al., 2001). Exclusion criteria were: 1) Mini-Mental 
State Exam (MMSE) score of ≤22; 2) functional dependence; 3) medical conditions with 
high risk of functional decline, including dementia diagnosis; 4) previous participation in 
cognitive training interventions; 5) vision, hearing, or communication impairments. 
ACTIVE recruited 2,832 participants in 1998, of whom 2,802 were randomized to 
one of four groups: 1) memory training (n=703); 2) reasoning training (n=699); 3) 
processing speed training (n=702); or 4) a no-contact control (n=698). At baseline 




(African American 26%). The sample was re-contacted for subsequent follow-up 
immediately following the intervention (post-test) and again 1-, 2-, 3-, 5-, and 10-years 
later. 
Measures 
Cognitive Function  
Trained assessors administered the test battery, which included a global cognitive 
measure (MMSE; Folstein, Folstein, & McHugh, 1975) and standardized 
neuropsychological tests to evaluate memory, reasoning, and processing speed. Each 
primary outcome was standardized to its baseline values. A composite measure of 
performance was computed for each of the three cognitive domains targeted by an 
ACTIVE intervention arm (i.e., memory, reasoning, processing speed), by equally 
weighting each measure within that domain, pooling total scores, and performing a Blom 
transformation (Blom, 1958) to normalize distributions. Following transformation, 
distributions of outcomes were normal. Test scores were then summed to form baseline 
cognitive composite scores that were standardized to the mean and standard deviation of 
the entire sample. If one or more tests of a composite measure were missing, the 
composite score was calculated as the average of the non-missing tests. 
Memory. A memory composite score was created using the Paragraph Recall test 
from the Rivermead Behavioral Memory Test (Wilson, Cockburn, & Baddeley, 1985) 
and modified versions of the Hopkins Verbal Learning Test (HVLT; Brandt, 1991) and 
the Rey Auditory Verbal Learning Test (AVLT; Rey, 1941). These measures include an 




used parallel, but not equivalent forms of the memory tests at each visit. When alternate 
forms are not of equivalent difficulty, analyses of intra-individual changes may be 
unintentionally biased (Gross et al., 2012). Alternate forms of the memory tests were 
placed on an equivalent metric using equipercentile equating procedures (Kolen & 
Brennan, 1995). A higher memory composite score indicated better memory function.  
Reasoning. For the reasoning composite three tests, Word Series (Gonda & 
Schaie, 1985), Letter Series (Thurstone & Thurstone, 1949), and Letter Sets (Erkstrom, 
French, Harman, & Dermen, 1976), were used. Word Series and Letter Series require 
participants to identify a pattern in a set of words or letters, and then select the next 
stimulus in the series from a list of possible answers. The Letter Set task requires 
participants to identify a common rule among four to five letter sets, marking the set that 
does not follow the rule. A higher reasoning composite score indicated better 
performance. 
Processing Speed. The processing speed composite score was derived from 
subtests of the Useful Field of Task (UFOV). The UFOV is a measure of information 
processing speed and selective and divided attention, and is related to IADLs and indices 
of mobility (Edwards et al., 2009). The test is administered on a touch-screen computer 
and consists of four increasingly complex subtests composed of multiple trials that vary 
in duration from 17 to 500ms. Lower scores on the UFOV indicated better performance. 
The Digit Symbol Substitution Test (DSST) is a subtest of the Wechsler Adult 
Intelligence Scale (WAIS-R; Wechsler, 1981) and is sensitive to virtually all 
neurocognitive impairments and depression (Dickinson, Ramsey, & Gold, 2007). A key 




numbers with an empty space below to fill in the corresponding symbol. Participants are 
given 90 seconds to fill in corresponding symbols under the number boxes.  
Physical Health 
Body Mass Index. Body weight status was classified based on body mass index 
(BMI), a measure of weight adjusted by height, and is thought to reflect overall adiposity.  
Handgrip Strength. Handgrip strength is a reliable proxy of overall strength and 
predicts physical disability and mobility limitations (Choquette et al., 2010; Rantanen et 
al., 1999; Sallinen et al., 2010; Shinkai et al., 2000). Grip strength was measured with the 
JAMAR® hydraulic hand dynamometer (Lafayette Instruments, Lafayette, Ind., USA). 
Two trials, measured in kilograms, are recorded for the dominant hand, defined as the 
hand used for writing. The highest value of the 2 trials was used in the analyses. 
Participants were in a seated position with the elbow flexed at 90˚ and were instructed to 
squeeze the handle as hard as possible for 3-5 seconds. Participants who reported recent 
worsening of pain or arthritis in their wrists, tendonitis, or hand/wrist surgery in the 
previous 3 months did not complete the grip strength measure. Grip strength was not 
measured at post-test or the first annual follow-up in the ACTIVE study. 
Other Covariates 
Women (Fried & Guralnik, 1997), African Americans (Mendes de Leon et al., 
2005), and older adults with less education (Mezler, Izmirlian, Leveille, & Guralnik, 
2001) have substantially higher rates of mobility disability. Mobility disability is also 
known to increase dramatically with age and is associated with chronic conditions like 




0=African American), years of education, baseline MMSE score, history of diabetes and 
hypertension, study site, and intervention group. 
Analysis 
Differences in baseline characteristics by sex-specific grip strength tertiles were 
assessed by one-way analyses of variance or χ2 tests when appropriate. Age and 
education were mean-centered for all analyses (M=73.6 and 13.5, respectively). All 
cognitive and handgrip strength measures were standardized (M=50, SD=10) before 
fitting latent growth curve models. 
A series of latent growth curve models (LGCM) were used to assess changes in 
handgrip strength and cognition over a 10-year period. Unconditional LGCM were 
initially fit to grip strength and each cognitive outcome using Mplus 7 (Muthén & 
Muthén, 2012). Next, a parallel process LGCM was used to model the association 
between the growth parameters of the cognitive outcomes with grip strength (the 
mediator). The growth trajectories for grip strength were non-linear which necessitated 
adding a quadratic function to the growth model. Finally, a model was used to test 
whether BMI at baseline was related to the latent growth factor of the mediator (path a; 
see Figure 3), and whether the growth factor of the mediator was related to the growth 
factor of the outcome, controlling for the BMI path (path b). Mediation is supported when 
BMI at baseline significantly changes the trajectory of the mediator (grip strength), 
which, in turn, affects the trajectory of the outcome (i.e., memory, reasoning, processing 
speed, or Digit Symbol Substitution Task). Bias-corrected bootstrapped confidence 




effect was considered statistically significant if the bias-corrected 95% CIs did not 
include zero. For bootstrapping, 1,000 replications were used. 
Figure 3. Mediating effect of grip strength on cognition 
 
Legend: (a) BMI effect on the mediator; (b) effect of mediator on the outcome variable 
(c) direct effect of BMI on the outcome variable 
 
 
For all models, missing data were handled by the maximum likelihood procedure 
in Mplus 7 (Muthén & Muthén, 2012) which uses all available data and assumes data are 
missing at random. After the final model was selected, sensitivity analyses were 
conducted. For each of the four cognitive outcomes, multiple group models were used to 
test for invariance of associations by intervention group. There were no significant 
differences by intervention arm; however, all models included intervention group as a 
covariate. Model fit was determined using the root mean square error of approximation 
(RMSEA), comparative fix index (CFI), and the standardized root mean square residual 
(SRMR). An RMSEA <0.05, a CFI > 0.96, and a SRMR <0.08 indicate excellent model 
fit (Wu, West, & Taylor, 2009). 
Results 
As a first step, LGCM were fit for each outcome. The LGCM provided acceptable 
fit for the memory (CFI=0.99, RMSEA=0.03, SRMR=0.02), reasoning (CFI=0.97, 




(CFI=0.95, RMSEA=0.04, SRMR=0.05) outcomes. For the mediating variable of 
interest, grip strength, LGCM provided excellent fit (CFI=0.99, RMSEA=0.02; 
SRMR=0.04). Next, parallel process LGCMs were used to evaluate how baseline BMI 
affects the growth of the three cognitive outcomes through changing the mediator (grip 
strength). All models provided good fit, and the RMSEA, CFI, and SRMR were in the 
acceptable ranges (Table 9). 
Participant characteristics as a function of sex-specific tertiles of grip strength are 
presented in Table 8. At baseline, the number of participants with a history of diabetes or 
hypertension did not differ by tertiles of sex-specific grip strength. Individuals with 
higher grip strength values were more likely to be younger (p<.0001). For men, there 
were no significant differences in race by tertiles of handgrip strength, but this was not 
the case for women. At baseline, White women were more likely to have lower grip 
strength values compared to African American women (p<.0001). This may be explained 
by the larger proportion of White women with self-reported history of osteoporosis at 
baseline with lower values on grip strength (p<.0001). Higher grip strength values were 
associated with a higher baseline BMI in both men and women (p<.0001, p=.02; 
respectively). Individuals with higher grip strength values at baseline were also more 
likely to have better scores on the memory, reasoning, and speed composites as well as 
the Digit Symbol task. However, the magnitude of the effect was larger for men. At 
baseline, men in the first grip-strength tertile were more likely to have less education 





Older individuals were more likely to have both lower grip strength (β=-0.23; 
p<.0001) and lower cognitive scores (p<.0001) at baseline as well as accelerated declines 
in grip strength (β≈-0.18; p<.0001; Table 9), memory, (β=-0.38; p<.0001), reasoning 
(β=-0.25, p<.0001), and speed (β=0.25, p<.0001) scores over time. Compared with 
women, men were more likely to have better grip strength at baseline (β=0.70; p<.0001) 
and were more likely to maintain their initial values of grip strength over time as 
evidenced by attenuated declines over follow-up (β=0.37; p<.0001). Race was associated 
with baseline cognitive performance and grip strength such that compared with African 
Americans, Whites had better memory (β=0.21; p<.0001), reasoning (β=0.26; p<.0001), 
speed (β=-0.12; p<.0001), and DSST (β=0.18; p<.0001) performance. However, Whites 
on average, had worse grip strength at baseline compared with African Americans (β=-
0.20; p<.0001), which may be explained by the higher proportion of White women with a 
history of osteoporosis. 
Individuals with greater educational attainment achieved higher scores on the 
memory (β=0.20; p<.0001), reasoning (β=0.31; p<.0001), and speed (β=-0.09; p<.0001) 
at baseline. Greater educational attainment was associated with accelerated declines in 
reasoning (β=-0.10; p=.03). At baseline, higher MMSE scores were associated with better 
grip strength (β=0.03; p=.05) as well as better performance on all cognitive measures 
(p<.01). Higher baseline MMSE scores were associated with attenuated declines in speed 
(β=-0.14; p<.01). Self-reported diagnosis of diabetes was associated with lower grip 
strength at baseline (β=-0.07; p<.0001), poorer performance at baseline on memory (β=-
0.04; p=.03) and speed (β=0.08; p<.0001) measures as well as accelerated declines in 




baseline grip strength or cognitive performance nor associated with changes in these 
variables over time.  
Table 10 shows the results of the mediated effect of BMI on cognition via grip 
strength. First, for all three outcomes, a higher BMI was significantly associated both 
with better initial values (i.e., intercept; β=0.08; p<.0001) of grip strength and accelerated 
declines on grip strength over time (β=-0.05; p<.0001). Second, better grip strength at 
baseline was associated with slower declines in cognition over time for all cognitive 
outcomes (memory β=0.21; reasoning β=0.36; speed β=-0.21; and Digit Symbol 
β=0.21). Higher BMI at baseline was significantly associated with better reasoning 
performance at baseline (β=0.04; 95% CI 0.01, 0.07; p=.02) and marginally associated 
with better speed at baseline (β=-0.04; 95% CI -0.07, 0.002; p=.06). Although there were 
no direct effects of BMI on cognitive performance, BMI did mediate changes in cognitive 
performance through its influence on initial levels of grip strength (i.e., intercept) as well 
as changes in grip strength over time. The indirect effect of BMI on changes in cognition 
via the grip strength slope was only significant in the memory (β=-0.01; 95% CI -0.02, -
0.004) and reasoning groups (β=-0.04; 95% CI -0.02, -0.002); marginal significance was 
achieved in the speed group. BMI also appears to mediate changes in cognition through 
its influence on initial values of grip strength. Indirect effects of BMI on changes in 
cognition via the grip strength intercept were significant for the memory (β=0.02; 95% CI 
0.004, 0.03; p=.02), reasoning (β=0.03; 95% CI 0.01, 0.05; p=.002), and speed (β=-0.02; 
95% CI -0.03, -0.002; p=.02) outcomes. 
Figures 4 – 7 illustrate the mediation model, showing the parallel process model 




shown in bold. The statistically significant paths for the mediating effects are shown with 
dashed red arrows. For all cognitive outcomes, the initial values of the mediator (grip 
strength) were significantly and negatively associated with its growth factor (β=-0.59). 
This indicates that individuals with higher baseline values of grip strength showed 
accelerated declines in grip strength over time. Better grip strength at baseline was 
associated with better baseline performance on the memory (β=0.08, p=.002), reasoning, 
(β=0.09, p<.0001), and speed composites (β=-0.19, p<.0001). At baseline, individuals 
with higher reasoning (β=0.09, 95% CI 0.01, 0.17, p=.04), and DSST (β=0.17, 95% CI 
0.03, 0.30, p=.03) scores showed less decline on grip strength over time. 
BMI was significantly positively associated with initial values of grip strength 
(β=0.08, all outcomes) and reasoning scores (β=0.04, SE=0.01, p=.01), and marginally 
associated with speed (β=-0.04, SE=0.02, p=.06), suggesting that a higher BMI was 
associated with better grip strength and reasoning performance as well as faster speed 
scores. Furthermore, BMI was significantly negatively associated with the grip strength 
slope (path a; β=-0.05, SE=0.01, p<.0001), indicating a higher BMI accelerated declines 
in grip strength. Higher BMI at baseline was also associated with attenuated declines in 
memory (β=0.30, SE=0.06, p<.0001) and reasoning (β=0.31, SE=0.01; p<.0001). For the 
memory (β=0.24; 95% CI 0.12, 0.36; p<.0001) and reasoning (β=0.18; 95% CI 0.06, 
0.15; p=.003) outcomes, slower declines in grip strength were significantly associated 
with slower declines in cognition; (Figure 3, path b). Marginal significance was found for 
the speed outcome (β=-0.14; 95% CI -0.29, 0.01; p=.06). Initial levels of grip strength 
were significantly associated with changes in memory (β=0.21, 95% CI 0.07, 0.35, 




-0.05, p=.008), and DSST (β=0.21; 95% CI 0.01, 0.42; p=.04) such that better handgrip 
strength at baseline was associated with attenuated declines in cognition. 
Discussion 
To our knowledge no study has examined the longitudinal mediating effect of grip 
strength on cognitive performance in older adults. The current proposal examined 
whether BMI at baseline affected grip strength and whether the change in grip strength 
affected measures of cognitive performance over time using mediation analyses. Both 
higher BMI and better grip strength at baseline were associated with accelerated declines 
in grip strength over time in all groups. The association between BMI and cognition is 
often muddied by the inclusion of individuals in a preclinical phase of dementia because 
individuals often lose weight prior to dementia diagnosis and in the early stages of 
dementia (Stewart et al., 2005; White, Pieper, & Schmader, 1999). Gao et al. (2011) 
reported that six years prior to dementia diagnosis, individuals with incident dementia 
had significantly lower BMI compared to those with normal cognition. Results from the 
Chicago Health and Aging Project highlight the importance of taking into account 
dementia diagnosis status of those in a preclinical phase of dementia. When these persons 
were included, higher BMI was protective against cognitive decline (Sturman et al., 
2008).  
In the memory and reasoning analyses, the direct effect of grip strength slope was 
significantly and positively associated with the changes in cognition. Indirect effects from 
BMI to the memory and reasoning slope via the grip strength slope were also significant 
but in the opposite direction, suggesting that a higher BMI accelerates declines in grip 




significant trend (p=.08) in speed composite scores also suggests that BMI had an 
indirect effect on changes in speed over time through its effects on changes in grip 
strength. 
One of the more provocative findings from the current analyses revealed that 
initial levels of grip strength were associated with changes in cognition. Better grip 
strength at baseline was associated with slower declines in memory (β=0.21; SE=0.08; 
p=.003), reasoning (β=0.37; SE=0.02; p<.0001), speed (β=-0.21; SE=0.06; p=.01) and 
DSST (β=0.26; SE=0.06; p=.03). Several studies have found no association between 
baseline levels of grip strength and changes in specific cognitive domains (e.g., 
Christensen et al., 2001; Taekema et al., 2012), whereas others report an association 
between grip strength and accelerated declines in global cognitive performance (Alfaro-
Acha et al., 2006; Clouston et al., 2013; Taekema, Gussekloo, Maier, Westendorp, & de 
Craen, 2010). Differences in the sampling framework may explain why previous studies 
did not detect an association between initial levels of grip strength and changes in 
cognition. Unlike the ACTIVE dataset used in the current analyses, which recruited 
independently living older adults aged 65 and older at baseline (mean age at baseline was 
74 years) with no cognitive or functional impairments, the two previous studies had no 
exclusion criteria in terms of health or functioning and instead recruited individuals from 
a general geographic region and/or those who met age requirements. These conflicting 
results highlight the importance of measurement timing when exploring the complex 
relationship between functional and cognitive performance. 
The current findings suggest that better memory, reasoning, and processing speed 




replicated in other samples of older adults (Taekema et al., 2012). Others find executive 
dysfunction is a better predictor of functional decline than age, educational attainment, 
and general health status (Cahn-Weiner, Malloy, Boyle, Marran, & Salloway, 2000). 
Executive functioning has also been associated with lower extremity function in several 
studies of older adults such that individuals with poorer performance on measures of 
executive function were more likely to have poorer performance on measures of lower 
extremity function (Ble et al., 2005). A study of twin pairs identified genetic factors 
common to hand grip strength, processing speed, and working memory (Ogata, Kato, 
Honda, & Hayakawa, 2014). Previous findings suggest the mechanism driving the 
association between muscle strength (i.e., grip strength) and cognitive functioning has a 
neurobiological basis which affects both functional and cognitive decline (Buchman et 
al., 2007; Raji et al., 2005; Taekema et al., 2012).  
Interestingly, in the current analyses grip strength at baseline was associated with 
baseline memory, reasoning, and speed performance. The reasoning composite score in 
ACTIVE most closely aligns with executive function in that the three tests used to create 
the composite score require strategy formation, behavioral spontaneity, and retrieval 
ability from long-term memory. Although there was no direct effect of the grip strength 
slope on changes in reasoning performance, there was a direct effect from initial values 
of grip strength (intercept) on changes in reasoning performance. Furthermore, there were 
significant effects from BMI to changes in reasoning performance via the grip strength 
intercept. It is possible that multiple indirect effects with opposing signs can negate the 




The current analyses used a well-characterized large sample of older adults 
followed over a 10-year period. Strengths of the current study include a large, ethnically 
and geographically diverse sample, single blind multi-site, randomized controlled design, 
10 years of follow-up period, multiple measures of cognition and functioning. Each 
cognitive ability targeted by an intervention (i.e., memory, reasoning, and processing 
speed) was measured with multiple tests that are known to be sensitive to age-related 
changes in cognitive abilities. Advanced mediation analysis methods were also used to 
explore the effect of mediated grip strength on cognition. 
When interpreting the current findings, several limitations must be mentioned. 
First, only one objective measure of physical performance was available in the ACTIVE 
study. Findings in the literature suggest that measures of physical functioning differ in 
their sensitivity to cognitive change (Clouston et al., 2013); additional measures of 
physical performance (e.g., chair stands, gait speed) may have revealed different patterns 
between BMI, physical functioning, and cognitive performance. There is strong evidence, 
however, to suggest that grip strength is a valid and reliable marker of physical 
performance in community-dwelling older adults (see Mijnarends et al., 2013; Stevens et 
al., 2012), predicts physical disability and mobility limitations (Choquette et al., 2010; 
Rantanen et al., 1999; Sallinen et al., 2010; Shinkai et al., 2000), and is more feasible to 
administer in clinical and large-scale epidemiological studies. Furthermore, factor 
analyses comparing handgrip strength and knee extension strength suggest that the two 
measures reflect a common construct (Bohannon, 2012). Second, although BMI was not 




cognitive performance and grip strength such that individuals with better cognitive 
performance or grip strength were more likely to be observed at the 10-year follow-up.  
The current analysis did not examine the order in which physical and cognitive 
declines occurred. One study found that midlife changes in fluid cognition predicted 
levels of physical performance 10 years after the onset of cognitive decline (Buracchio, 
Dodge, Howieson, Wasserman, & Kave, 2010), whereas Kuh and colleagues (2009) 
found that gait speed declined more than a decade before the onset of cognitive 
impairment. This suggests that the complex relationships between physical performance 
and cognition are differentially susceptible to change and may depend on an individual’s 
age. Future analyses should determine the order in which declines occur as well as 
identify patterns and rates of change in cognitive and functional decline. 
Results from the current study highlight the complex relationship between BMI, 
physical performance, and cognition in older adults. Although higher BMI at baseline is 
associated with better grip strength at baseline, it is also associated with accelerated 
declines in grip strength over10 years. These accelerated declines in grip strength 
negatively affect memory and reasoning performance. Better grip strength and cognitive 
performance at baseline are also associated with slower declines in cognition over a 10- 




Chapter 5. Discussion and Public Health Implications 
The current study examined the dynamic relationship between body weight 
(defined by BMI), physical performance (defined using handgrip strength), and cognition 
in a sample of older adults participants in the ACTIVE trial over a 10-year period. Excess 
weight affects virtually every aspect of an individual’s health and is linked with a variety 
of negative health outcomes including diabetes, heart disease, impaired respiratory and 
cognitive function, arthritis, and an increased risk of death. Body weight is one potential 
modifiable risk factor for both cognitive and functional impairments but the relationship 
between body weight and cognitive and functional abilities is complex and inconclusive. 
Findings from the current proposal highlight the complex relationship between 
physical performance and cognitive performance in older adults. Results from the current 
analyses suggest that higher BMI at baseline was associated with both cognitive and 
functional performance. Results from Aim 1 suggest that better performance on memory, 
reasoning, speed, and Digit Symbol tasks was associated with attenuated declines in BMI 
over a 10-year period. Furthermore, changes in cognition were associated with changes in 
BMI, suggesting that slower cognitive declines were associated with a greater increase in 
BMI.  
Aim 2 explored the mediated effect of grip-strength on weight-related changes in 
BMI. Findings revealed that a higher BMI at baseline was associated with better handgrip 
strength at baseline and accelerated declines on grip strength over time; whereas higher 
grip strength at baseline was associated with slower declines in cognition over time. 
Slower declines in grip strength were associated with slower declines in memory and 




indirect effect of BMI on cognition through changes in grip strength in the memory and 
reasoning outcomes, such that, a higher BMI was associated with accelerated declines in 
grip strength, which in turn were associated with accelerated declines in cognition. 
Results in the speed group were marginally significant (p=.08). These findings are 
provocative given the large body of research in older adults suggesting that excess weight 
is protective against cognitive declines. 
Strengths 
This proposal has several strengths and limitations. The ACTIVE study allows for 
the observation of cognitively healthy older adults without severe functional limitations 
at baseline as they transitioned into an age with the highest risk of cognitive impairment. 
In addition, the randomized longitudinal design allowed for changes in obesity, physical 
functioning, and cognitive functioning to be explored while ruling out potential baseline 
differences among individuals. Each targeted domain of cognition (i.e., memory, 
reasoning, and processing speed) was measured using multiple, validated cognitive tests. 
Stringent protocols were used to ensure testing environments were equivalent across the 
six sites, in addition to careful quality control measures. Furthermore, recruitment 
strategies ensured that a diverse sample of older adults was included in the ACTIVE 
study. Recruitment occurred in six geographically distinct regions in the United States 






Because this is a longitudinal study of older adults at least 65 years of age at 
baseline (M=74.5 years) with 10 years of follow-up, attrition was an issue. At the 10th 
annual follow-up, only 43.5% of the original sample (1220/2802) were assessed. Of the 
1,578 participants who were deactivated or lost to follow-up, death was the primary 
reason for non-participation (Table 3). Although rates of attrition appear large, the rates 
are comparable to other longitudinal studies of older adults (Chatfield, Brayne, & 
Matthews, 2005). 
Table 3. Reasons for deactivation across 10 years of follow-up 
Reason for deactivation N % 
Death 634 40.2 
Subject decision 555 35.2 
Site decision 276 17.5 
Family refused access 52 3.3 
Lost to follow-up 61 3.9 
 
Participants who at baseline, were younger, female, married, had fewer physical 
and mental health problems, and better grip strength were more likely to participate in the 
10-year follow-up (Table 4). Individuals with better cognitive performance were also 
more likely to be retained at the 10th annual follow-up. Participation in the 10-year 
follow-up was not associated with baseline BMI. 







Age, mean (SD) 75.0 (6.2) 71.8 (4.9) <.0001 
Sex, n (%)   <.0001 
 Male 430 (27) 246 (20)  
 Female 1152 (73) 974 (80)  




 White 1130 (71) 924 (76)  
 African American 440 (29) 288 (24)  
Education, n (%)   .05 
 No college 1166 (74) 857 (70)  
 College (≥ 16 years) 416 (26) 361 (30)  
Marital status, n (%)   <.0001 
 Not married 1062 (67) 731 (60)  
 Married 519 (33) 488 (40)  
Depressive symptoms, mean (SD) 5.8 (5.4) 4.5 (4.7) <.0001 
SF-36 Physical Functioning, mean (SD) 64.2 (24.8) 74.7 (21.8) <.0001 
Health conditions, n (%) 2.4 (1.5) 2.0 (1.4) <.0001 
Grip strength, mean (SD) 24.69 (8.3) 25.66 (8.6) <.01 
Body mass index, n (%)   .11 
 Normal weight (BMI 18.5-24.9) 430 (28) 292 (24)  
 Overweight (BMI 25-29.9) 612 (39) 486 (40)  
 Class I obesity (BMI 30-34.9) 308 (19) 275 (22)  
 Class II obesity (≥BMI 35) 198 (12) 155 (12)  
Diabetes, n (%)   <.001 
 Yes 234 (15) 124 (10)  
 No 1346 (85) 1095 (90)  
Myocardial infarction, n (%)   <.0001 
 Yes  223 (14) 86 (7)  
 No 1348 (86) 1129 (93)  
Hypertension, n (%)   <.001 
 Yes 854 (54) 574 (47)  
 No 717 (46) 639 (53)  
High cholesterol, n (%)   .17 
 Yes 675 (43) 551 (46)  
 No 879 (57) 645 (54)  
Stroke, n (%)   .07 
 Yes 122 (8) 73 (6)  
 No 1448 (92) 1139 (94)  
Cognitive performance, mean (SD)    
 Mini-Mental State Exam score 27.0 (2.0) 27.7 (1.9) <.0001 
 Memory composite -0.6 (2.4) 0.9 (2.4) <.0001 
 Reasoning composite -0.6 (2.5) 0.8 (2.6) <.0001 
 Processing speed composite 0.5 (2.4) -0.7 (2.4) <.0001 
 Everyday function composite 0.2 (2.1) -0.3 (1.9) <.0001 
 
A second limitation is the nature of the ACTIVE sample. The cohort is volunteer-
based and at the time of recruitment, was comprised of a relatively healthy sample of 




Because of this, ACTIVE participants likely represent a more resilient group of older 
adults compared to the general population. In fact, this is evident in the lack of functional 
declines seen in the control group at the 24-month follow-up (Wolinsky et al., 2006). 
Generalizability may therefore be limited. Other primary limitations include self-report 
measures of medical disorders and a single measure of adiposity. 
Public Health Significance 
Globally, a new case of dementia is diagnosed every seven seconds (Ferri et al., 
2005) and represents a significant public health challenge. Modifiable factors associated 
with cognitive functioning represent a promising area in public health. Analyses in the 
current proposal explored how obesity and physical functioning affect cognition in older 
adults. Findings clarify the extent to which weight in older adults is associated with 
changes in functional and cognitive performance. From a public health perspective, the 
question remains how to best identify older adults at risk for future cognitive and 
functional declines.  
The most recent meta-analysis of midlife obesity and dementia calculated the 
population attributable risk (PAR), defined as the percentage of individuals suffering 
from dementia attributable to the risk factor of midlife obesity, using a sample of over 
50,000 individuals (Loef & Walach, 2013). Unlike results reported by Anstey and 
colleagues (2011), Loef and Walach (2013) found no association between underweight 
BMI and AD risk. The adjusted PARs were calculated for both men and women in 2010, 
2030, and 2050. Between 2010 and 2030, an additional 7.8% of dementia cases in men 
and 5.9% of dementia cases in women would be attributable to midlife obesity; whereas 




dementia cases in women would be attributable to midlife obesity (Loef & Walach, 
2013). Along with the currently increasing rates of obesity in midlife, Loef and Walach’s 
(2013) findings suggest that the effects of obesity on dementia risk will be felt for many 
decades to come.  
The protective mechanisms by which some obese individuals avoid the 
detrimental consequences of obesity are not well understood. It is still unclear if obesity 
per se or rather the increased risk of chronic health conditions (e.g., Type II diabetes, 
coronary heart disease, or hypertension) is associated with negative health outcomes. One 
possible explanation for the differential effects of obesity may be related to fat 
distribution. Several studies have shown that increased visceral and abdominal fat are 
associated with negative health outcomes, independent of overall adiposity (Fox et al., 
2007; Janssen, Katzmarzyk, & Ross, 2004; Koster et al., 2010). 
The current analyses used body mass index (BMI) as a measure of adiposity in 
older adults. However, some findings suggest that waist circumference (WC) and waist-
to-hip ratio (WHR) have a stronger relationship with cognitive performance and dementia 
risk when compared with BMI. WC and WHR measure central obesity and reflect the 
abdominal distribution of body fat whereas BMI is a measure of overall adiposity. 
Central obesity is a stronger risk factor for cardiovascular disease and mortality compared 
with BMI (Whitmer et al., 2008). Visceral, or abdominal, fat is more metabolically active 
than subcutaneous fat and has a stronger link to insulin resistance (Elias, Goodell, & 
Waldstein, 2012). 
As age increases, the association between cardiovascular risk factors (i.e., 




This diminished risk may be attributable to attrition due to morbidity and mortality of 
individuals with poor health in midlife who are also likely to perform worse on tests of 
cognitive functioning compared to those with better health (Elias, Goodell, & Waldstein, 
2012). Future research is still needed to elucidate the mechanisms by which obesity 





Ackerman, I. N., & Osborne, R. H. (2012). Obesity and increased burden of hip and knee 
joint disease in Australia: Results from a national survey. BMC Musculoskeletal 
Disorders, 13, 254-267. 
Al Snih, S., Ottenbacher, K. J., Markides, K. S., Kuo, Y. F., Eschbach, K., & Goodwin, J. 
S. (2007). The effect of obesity on disability vs mortality in older Americans. 
Archives of Internal Medicine, 167, 774-780. 
Al Snih, S., Markides, K. S., Ottenbacher, K. J., & Raji, M. A. (2004). Hand grip strength 
and incident ADL disability in elderly Mexican Americans over a seven-year 
period. Aging Clinical and Experimental Research, 16, 481-486. 
Albanese, E., Hardy, A., Wills, A., Kuh, D., Guralnik, J., & Richards, M. (2012). No 
association between gain in body mass index across the life course and midlife 
cognitive function and reserve – The 1946 British cohort study. Alzheimer’s & 
Dementia, 8, 470-482. 
Albert, M. S. (2011). Changes in cognition. Neurobiology of Aging, 32, Supplement 1(0), 
S58-S63. 
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., … & 
Phelps, C. H. (2011). The diagnosis of mild cognitive impairment due to 
Alzheimer’s disease: Recommendations from the National Institute on Aging-
Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s 




Albert, M. S., Jones, K., Savage, C. R., Berkman, L., Seeman, T., Blazer, D., & Rowe, R. 
W. (1995). Predictors of cognitive change in older persons: MacArthur Studies of 
Successful Aging. Psychology & Aging, 10(4), 578-589. 
Alfaro-Acha, A., Al Snih, S., Raji, M. A., Kuo, Y. F., Markides, K. S., & Oteenbacher, 
K. J. (2006). Handgrip strength and cognitive decline in older Mexican 
Americans. Journal of Gerontology Series A: Biological and Medical Sciences, 
61, 859-865. 
Alley, D. E., & Chang, V. W. (2007). The changing relationship of obesity and disability, 
1988-2004. JAMA, 298, 2020-2027. 
Angevaren, M., Aufdemkampe, G., Verhaar, H. J., Aleman, A., & Vanhees, L. (2008). 
Physical activity and enhanced fitness to improve cognitive function in older 
people without known cognitive impairment. Cochrane Database of Systematic 
Reviews (Online), (3)(3), CD005381. doi:10.1002/14651858. CD005381.pub3 
Anstey, K. J., Cherbuin, N., Budge, M., & Young, J. (2011). Body mass index in midlife 
and late-life as a risk factor for dementia: a meta-analysis of prospective studies. 
Obesity Reviews, 12, e426-e437. 
Anstey, K. J., Wood, J. M., Lord, S. R., & Walker, J. G. (2005). Cognitive, sensory, and 
physical factors enabling driving safety in older adults. Clinical Psychology 
Review, 25, 45-65. 
Ariza, M., Garolera, M., Jurado, M. A., Garcia-Garcia, I., Hernan I, Sánchez-Garre, C., 
… & Narberhaus, A. (2012) Dopamine genes (DRD2/ANKK1-TaqA1 and 
DRD4-7R) and executive function: Their interaction with obesity. PLoS ONE 




Atti, A. R., Palmer, K., Volpato, S., Winbald, B., De Ronchi, D., & Fratiglioni, L. (2008). 
Late-life body mass index and dementia incidence: Nine-year follow-up from the 
Kungsholmen Project. Journal of the American Geriatric Society, 56, 111-116. 
Avlund, K. (1997). Methodological challenges in measurements of functional ability in 
gerontological research. A review. Ageing Clinical and Experimental Research, 9, 
164-174. 
Backholer, K., Wong, E., Freak-Poli, R., Walls, H. L., & Peeters, A. (2011). Increasing 
body weight and risk of limitations in activities of daily living: a systematic 
review and meta-analysis. Obesity Reviews, 13, 456-468. 
Bagger, Y. Z., Tankó, L. B., Alexandersen, P., Qin, G., & Christiansen, C. (2004). The 
implications of body fat mass and fat distribution for cognitive function in elderly 
women. Obesity Research, 12, 1519-1526. 
Ball, K., Berch, D. B., Helmers, K. F., Jobe, J. B., Leveck, M. D., Marsiske, M., … & 
Willis, S. L. (2002). Effects of cognitive training interventions with older adults: a 
randomized controlled trial. JAMA, 288, 2271–2281. 
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011). 
Alzheimer’s disease. Lancet, 377, 1019-1031. 
Balakrishnan, K., Verdile, G., Mehta, P. D., Beilby, J., Nolan, D., Galvao, D. A., … & 
Martins, R. N. (2005). Plasma Aβ42 correlates positively with increased body fat 
in individuals. Journal of Alzheimer’s Disease, 8, 269-282. 
Banks, W. A. (2008). The blood-brain barrier as a cause of obesity. Current 




Banks, W. A., Coon, A. B., Robinson, S. M., Moinuddin, A., Schultz, J. M., Nakaoke, R., 
& Morely, J. E. (2004). Triglycerides induce leptin resistance at the blood-brain 
barrier. Diabetes, 53, 1253–1260. 
Barberger-Gateau, P., Rainville, C., Letenneur, L., & Dartigues, J. F. (2000). A 
hierarchical model of domain of disablement in the elderly: a longitudinal 
approach. Disability & Rehabilitation, 22, 308-317. 
Barberger-Gateau, P., Fabrigoule, C., Helmer, C., Rouch, I., & Dartigues, D. F. (1993). 
Functional impairment in instrumental activities of daily living: an early clinical 
sign of dementia? Journal of the American Geriatric Society, 47, 456-462. 
Barnes, D. E., Alexopoulos, G. S., Lopez, O. L., Williamson, J. D., & Yaffe, K. (2006). 
Depressive symptoms, vascular disease, and mild cognitive impairment: Findings 
from the Cardiovascular Health Study. Archives of General Psychiatry, 63(3), 
273-280. 
Barnes, D. E., & Yaffe, K. (2011). The projected effect of risk factor reduction on 
Alzheimer’s disease prevalence. The Lancet Neurology, 10(9), 819-828. 
Barness, L. A., Opitz, J. M., & Gilbert-Barness, E. (2007). Obesity: Genetic, molecular, 
and environmental aspects. American Medical Journal of Medical Genetics Part 
A, 143A, 3016-3034. 
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. 
E. (2004). Sarcopenic obesity predicts instrumental activities of daily living 
disability in the elderly. Obesity Research, 12, 1995-2004. 
Beauchet, O. (2006). Testosterone and cognitive function: Current clinical evidence of a 




Beavers, K. M., Miller, M. E., Rejeski, W. J., Nicklas, B. J., & Krichesvsky, S. B. (2013). 
Fat mass loss predicts gain in physical function with intentional weight loss in 
older adults. Journal of Gerontology Medical Sciences, 68, 80-86. 
Bebbington, P. E., Dunn, G., Jenkins, R., Lewis, G., Brugha, T., Farrell, M., & Meltzer, 
H. (2003). The influence of age and sex on the prevalence of depressive 
conditions: Report from the National Survey of Psychiatric Morbidity. 
Psychological Medicine, 28, 9-19. 
Bekinschtein, P., Cammarota, M., Katche, C., Slipczuk, L., Rossato, J. I., Goldin, A., 
Izquierdo, I., & Medina, J. H. (2008). BDNF is essential to promote persistence of 
long-term memory storage. Proceedings for the National Academy of Sciences, 
105(7), 2711-2716. doi:10.1073/pnas. 0711863105.  
Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Mendes de Leon, C. F., 
Arnold, S. E., Barnes, L. L., & Bienias, J. L. (2003). Education modifies the 
relation of AD pathology to level of cognitive function in older persons. 
Neurology, 60(12), 1909-1915. 
Berlau, D. J., Corrada, M. M., Peltz, C. B., & Kawas, C. H. (2012). Disability in the 
oldest-old: Incidence and risk factors in the 90+ study. American Journal of 
Geriatric Psychiatry, 20, 159-168. 
Beydoun, M. A., Beydoun, H. A., & Wang, Y. (2008). Obesity and central obesity as risk 
factors for incident dementia and its subtypes: a systematic review and meta-
analysis. Obesity Reviews, 9, 204-218.  
Birren, J. E., Woods, A. M., & Williams, M. V. (1980). Behavioral slowing with age: 




the 1980s: Psychological issues (pp. 293-308). Washington: American 
Psychological Association. 
Blankevoort, C. G., van Heuvelen, M. J. G., Boersma, F., Luning, H., de Jong, J., & 
Scherder, E. J. A. (2010). Review of effects of physical activity on strength, 
balance, mobility and ADL performance in elderly subjects with dementia. 
Dementia and Geriatric Cognitive Disorders, 30(5), 392-402.  
Ble, A., Volpato, S., Zuliani, G., Guralnik, J. M., Bandinelli, S., Lauretani, F., & … 
Ferrucci, L. (2005). Executive function correlates with walking speed in older 
persons: The InCHIANTI study. Journal of the American Geriatrics Society, 53, 
410-415. 
Blom, G. (1958). Statistical Estimates and Transformed Beta Variables. New York: John 
Wiley & Sons.  
Bohannon, R. W. (2012). Are hand-grip and knee extension strength reflective of a 
common construct? Perceptual and Motor Skills, 114, 514-518. 
Bouchard, D. R., Dionne, I. J., & Brochu, M. (2009). Sarcopenic/obesity and physical 
capacity in older men and women: Data from the Nutrition as a Determinant of 
Successful Aging (NuAge)-the Quebec longitudinal study. Obesity (Silver 
Spring), 17, 2082-2088. 
Bourdel-Marchasson, I., Lapre, E., Laksir, H., & Puget, E. (2010). Insulin resistance, 
diabetes and cognitive function: Consequences for preventative strategies. 
Diabetes and Metabolism, 36, 173-181. 
Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer related changes. 




Brands, A. M. A., Kessels, R. P. C., deHaan, R. H. F., Kappelle, L. J., & Biessels, G. J. 
(2004). Cerebral dysfunction in type 1 diabetes: Effects of insulin, vascular risk 
factors and blood-glucose levels. European Journal of Pharmacology, 490, 159-
168. 
Brandt, J. (1991). The Hopkins Verbal Learning Test: Development of a new memory 
test with six equivalent forms. Clinical Neuropsychologist, 5, 125-142.  
Brandt, J., Aretouli, E., Neijstrom, E., Samek, J., Manning, K., Albert, M. S., & Bandeen-
Roche, K. (2009). Selectivity of executive function deficits in mild cognitive 
impairment. Neuropsychology, 23(5), 607-618. 
Brookmeyer, R., & Gray, S. (2000). Methods for projecting the incidence and prevalence 
of chronic diseases in aging populations: Application to Alzheimer’s diseases. 
Statistics in Medicine, 19(11-12), 1481-1493. 
Buchman, A. S., Wilson, R. S., Boyle, P. A., Bienias, J. L., & Bennett, D. A. (2007). Grip 
strength and the risk of incident Alzheimer’s disease. Neuroepidemiology, 29, 66-
73. 
Buchman, A. S., Schneider, J. A., Wilson, R. S., Bienias, J. L., & Bennett, D. A. (2006). 
Body mass index in older persons is associated with Alzheimer disease pathology. 
Neurology, 67, 1949–1954. 
Buchman, A., Wilson, R., Bienias, J., Shah, R., Evans, D., & Bennett, D. (2005). Change 





Buracchio, T., Dodge, H. H., Howieson, D., Wasserman, D., & Kave, J. (2010). The 
trajectory of gait speed predicting mild cognitive impairment. Archives of 
Neurology, 67, 980-986.  
Cabeza, C., & Nyberg, L. (2000). Imaging Cognition II: an empirical review of 275 PET 
and fMRI studies. Journal of Cognitive Neuroscience, 12(1), 1-47. 
Cahn-Weiner, D. A., Malloy, P. F., Boyle, P. A., Marran, M., & Salloway, S. (2000). 
Prediction of functional status from neuropsychological tests in community- 
dwelling elderly individuals. Clinical Neuropsychology, 14, 187–195. 
Carmelli, D., Swan, G. E., DeCarli, C., & Reed, T. (2002). Quantitative genetic modeling 
of regional brain volumes and cognitive performance in older male twins. 
Biological Psychology, 61(1-2), 139-155. 
Carson, A. P., Howard, G., Burke, G. L., Shea, S., Levitan, E. B., & Munter, P. (2011). 
Ethnic differences in hypertension incidence among middle-age and older adults. 
The multi-ethnic study of atherosclerosis. Hypertension, 57, 1101-1107. 
Cauley, J. A. (2011). Defining ethnic and racial differences in osteoporosis and fragility 
fractures. Clinical Orthopaedics and Related Research, 469, 1891-1899. 
Centers for Disease Control and Prevention. (2005). National diabetes fact sheet: General 
information and national estimates on diabetes in the United States, 2005. Atlanta, 
GA: U.S. Department of Health and Human Services, Centers for Disease Control 
and Prevention.  
Centers for Medicare and Medicaid Services. (2012). Chronic conditions among 
Medicare beneficiaries, chartbook, 2012 edition. Baltimore, MD: U.S. 




Chatfield, M. D., Brayne, C. E., & Matthews, F. E. (2005). A systematic literature review 
of attrition between waves in longitudinal studies in the elderly shows a consistent 
pattern of dropout between differing studies. Journal of Clinical Epidemiology, 
58, 13-19. 
Chen, L., Nelson, D. R., Zhao, Y., Cui, Z., & Johnston, J. A. (2013). Relationship 
between muscle mass and muscle strength, and the impact of comorbidities: a 
population-based, cross-sectional study of older adults in the United States. BMC 
Geriatrics, 16, 74. 
Cheng, G., Huang, C., Deng, H., & Wang, H. (2012). Diabetes as a risk factor for 
dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. 
Journal of Internal Medicine, 42, 481-484. 
Cherubini, A., Lowenthal, D. T., Paran, E., Mecocci, P., Williams, L. S., & Senin, U. 
(2010). Hypertension and cognitive function in the elderly. Disease a Month, 56, 
106-147. 
Chodosh, J., Miller-Martinez, D., Aneshensel, C. S., Wight, R. G., & Karlamangla, A. S. 
(2010). Depressive symptoms, chronic diseases, and physical disabilities as 
predictors of cognitive functioning trajectories in older Americans. Journal of the 
American Geriatric Society, 58, 2350-2357. 
Choquette, S., Bouchard, D. R., Doyon, C. Y., Sénéchal, M., Brouchu, M., & Dionne, I. 
J. (2010). Relative strength as a determinant of mobility in elders 67-84 years of 
age. A NUAGE study: Nutrition as a determinant of successful aging. The 




Christensen, H. (2001). What cognitive changes can be expected with normal aging? 
Australian and New Zealand Journal of Psychiatry, 6, 768-775. 
Christensen, H., MacKinnon, A. J., Korten, A., & Jorn, A. K. (2001). The “common 
cause hypothesis” of cognitive aging: Evidence not only for a common factor but 
also specific associations of age with vision and grip strength in a cross-sectional 
analysis. Psychology and Aging, 16, 588-599. 
Clark, D. O., Mungai, S. M., Stump, T. E., & Wolinsky, F. D. (1997). Prevalence and 
impact of risk factors for lower body difficulty among Mexican Americans, 
African Americans, and Whites. Journal of Gerontology: Medical Sciences, 52, 
97-105. 
Colcombe, S., & Kramer, A. F. (2003). Fitness effects on the cognitive function of older 
adults: a meta-analytic study. Psychological Science, 14, 125-130.  
Clouston, S. A. P., Brewster, P., Kuh, D., Richards, M., Cooper, R., Hardy, R., Rubin, M. 
S., & Hofer, S. M. (2013). The dynamic relationship between physical function 
and cognition in longitudinal aging cohort. Epidemiologic Reviews, 35, 33-50. 
Corley, J., Gow, A. J., Starr, J. M., & Deary, I. J. (2010). Is body mass index in old age 
related to cognitive abilities? The Lothian birth cohort 1936 study. Psychology 
and Aging, 25, 867-875. 
Cosentino, S., Scarmeas, N., Helzner, E., Glymour, M. M., Brandt, J., Albert, M., 
Blacker, D., & Stern, Y. (2008). APOE epsilon 4 allele predicts faster cognitive 
decline in mild Alzheimer disease. Neurology, 70(19 Pt 2), 1842-1849.  
Craik, F. I. M. (2008). Memory changes in normal and pathological aging. Canadian 




Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederhold, T., Landi, F., … 
& Zamboni, M. (2010). Sarcopenia: European consensus on definition and 
diagnosis: Report of the European working group on sarcopenia in older people. 
Age and Ageing, 4, 412–423. 
Cserjesi, R., Molnar, D., Luminet, O., & Lenard, L. (2007). Is there any relationship 
between obesity and mental flexibility in children? Appetite, 49, 675–678. 
Dagenais, G. R., Yi, Q., Mann, J. F., Bosch, J., Pogue, J., & Yusuf, S. (2005). Prognostic 
impact of body weight and abdominal obesity in women and men with 
cardiovascular disease. American Heart Journal, 149, 54–60. 
Davis, J. W., Ross, P. D., Preston, S. D., Nevitt, M. C., & Wasnich, R. D. (1998). 
Strength, physical activity, and body mass index: Relationship to performance-
based measures and activities of daily living among Japanese women in Hawaii. 
Journal of the American Geriatrics Society, 46, 274- 279. 
Dickinson, D., Ramsey, M. E., & Gold, J. M. (2007). Overlooking the obvious: a meta-
analytic comparison of digit symbol coding tasks and other cognitive measures in 
schizophrenia. Archives of General Psychiatry, 64, 532-542. 
Dietschy, J. M., & Turley, S. D. (2001). Cholesterol metabolism in the brain. Current 
Opinion in Lipidology, 12, 105-112. 
Driscoll, I., Davatzikos, C., An, Y., Wu, X., Shen, D., Kraut, M., & Resnick, S. M. 
(2009). Longitudinal pattern of regional brain volume change differentiates 




Dunlop, D. D., Hughes, S. L., & Manheim, L. M. (1997). Disability in activities of daily 
living: Patterns of change and a hierarchy of disability. American Journal of 
Public Health, 87, 378-383. 
Duron, E. & Hanon, O. (2008). Vascular risk factors, cognitive decline, and dementia. 
Vascular Health and Risk Management, 4, 363-381. 
Ebrahim, S., Wannamethee, S. G., Whincup, P., Walker, M., & Shaper, A. G. (2000). 
Locomotor disability in a cohort of British men: the impact of lifestyles and 
disease. International Journal of Epidemiology, 29, 478-486. 
Edwards, J. D., Myers, C., Ross, L. A., Roenker, D. L., Cissell, G. M., McLaughlin, A. 
M., & Ball, K. K. (2009). The longitudinal impact of cognitive speed of 
processing training on driving mobility. The Gerontologist, 49(4), 485-494.  
Elias, M. F., Goodell, A. L., & Waldenstein, S. R. (2012). Obesity, cognitive functioning 
and dementia: Back to the future. Journal of Alzheimer’s Disease, 30, S113-S125. 
Elias, M. F., Elias, P. K., Sullivan, L. M., Wolf, P. A., & D’Agostino, R. B. (2005). 
Obesity, diabetes and cognitive deficit: the Framingham Heart Study. 
Neurobiology of Aging, 26S, S11-S16. 
Elias, M. F., Elias, P. K., Sullivan, L. M., Wolf, P. A., & D’Agostino, R. B. (2003). 
Lower cognitive function in the presence of obesity and hypertension: the 
Framingham Heart Study. International Journal of Obesity, 27, 260-268. 
Elmquist, J. K., & Flier, J. S. (2004). The fat-brain axis enters a new dimension. Science, 
304(5667), 63-64. 
Erkstrom, R. B., French, J. W., Harman, H. H., & Dermen, D. (1976). Manual for kit of 




Evans, D. A., Bennett, D. A., Wilson, R. S., Bienias, J. L., Morris, M. C., Scherr, P. A., 
… & Schneider, J. (2003). Incidence of Alzheimer disease in a biracial urban 
community: Relation to apolipoprotein e allele status. Archives of Neurology, 60, 
185-189. 
Evans, R. M., Emsley, C. L., Gao, S., Sahota, A., Hall, K. S., Farlow, M. R., & Hendrie, 
H. (2000). Serum cholesterol, APOE genotype, and the risk of Alzheimer’s 
disease: a population-based study of African Americans. Neurology, 54, 240-242. 
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in 
Adults: Executive summary of the third report of the National Cholesterol 
Education Program (NCEP). JAMA, 285, 2486-2497. 
Federal Interagency Forum on Aging-Related Statistics. (2012). Older Americans 2012: 
Key Indicators of Well-being. Retrieved from 
http://www.agingstats.gov/Main_Site/Data/2012_ Document/About.aspx 
Ferraro, K. F., Su, Y. P., Gretebeck, R. J., Black, D. R., & Badylak, S. F. (2002). Body 
mass index and disability in adulthood: a 20-year panel study. American Journal 
of Public Health, 92, 834-840. 
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., … & 
Saczufca, M. (2005). Global prevalence of dementia: a Delphi consensus study. 
Lancet, 366, 2112-2117. 
Finkelstein, E. A., Fiebelkorn, I. C., & Wang, G. (2003). National medical spending 
attributable to overweight and obesity: How much, and who’s paying? Health 




Flegal, K. M. (2005). Epidemiologic aspects of overweight and obesity in the United 
States. Physiology and Behavior, 86, 599-602.  
Flegal, K. M., Carroll, M. D., Kuczmarski, R. J., & Johnson, C. L. (1998). Overweight 
and obesity in the United States: Prevalence and trends 1960-1994. International 
Journal of Obesity, 22, 39-47. 
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state: a practical 
method for grading the cognitive state of patients for the clinician. Journal of 
Psychiatric Research, 12(3), 189-198.  
Fontebonne, A., Berr, C., Ducimetiere, P., & Alperovitch, A. (2001). Changes in 
cognitive abilities over a 4-year period are unfavorably affected in elderly 
diabetes subjects: Results of the Epidemiology of Vascular Aging Study. Diabetes 
Care, 24, 366-370. 
Fox, C. S., Massaro, J. M., Hoffman, U., Pou, K. M., Maurovich-Horvat, P., Liu, C. Y., 
… & O’Donnell, C. J. (2007). Abdominal visceral and subcutaneous adipose 
tissue compartments: Association with metabolic risk factors in the Framingham 
Heart Study. Circulation, 116, 39-48. 
Fratiglioni, L., & Wang, H. X. (2007). Brain reserve hypothesis in dementia. Journal of 
Alzheimer’s Disease, 12, 11-22. 
Fried, L. P. (1996). Older women: Health status, knowledge, and behavior. In M. Falik & 
K. Scott Collins (Eds). Women's health: Commonwealth fund survey (pp. 175-




Fried, L. P., & Guralnik, J. M. (1997). Disability in older adults: Evidence regarding 
significance, etiology, and risk. Journal of the American Geriatrics Society, 45, 
92-100. 
Friedman, J. M., Elasy, T., & Jensen, G. L. (2001). The relationship between body mass 
index and self-reported functional limitation among older adults: a gender 
difference. Journal of the American Geriatric Society, 49, 398–403. 
Fulop, T., Larbi, A., Witkowski, J. M., McElhaney, J., Loeb, M., Mitnitski, A., & 
Pawelec, G. (2010). Aging, frailty and age-related diseases. Biogerontology, 11, 
547-563.  
Gao, S., Nguyen, J. T., Hendrie, H. C., Unverzagt, F. W., Hake, A., Smith-Gamble, V., & 
Hall, K. (2011). Accelerated weight loss and incident dementia in an elderly 
African-American cohort. Journal of the American Geriatric Society, 59, 18-25. 
García-Casares, N., Berthier, M. L., Jorge, R. E., Gonzales-Algere, P., Gutiérrez Cardo, 
A., Rioja Villodres, K., … & González-Santos, P. (2014). Structural and 
functional brain changes in middle-aged type 2 diabetic patients: a cross-sectional 
study. Journal of Alzheimer’s Disease, 40, 375-380. 
Gąsecki, D., Kwarciany, M., Nyka, W., & Markiewicz, K. (2013). Hypertension, brain 
damage and cognitive decline. Current Hypertension Reports, 15, 547-558. 
Gazdzinski, S., Kornak, J., Weiner, M. W., & Meyerhoff, D. J. (2008). Body mass index 
and magnetic resonance markers of brain integrity in adults. Annuals of 
Neurology, 63, 652-657. 
Gazdzinski, S., Millin, R., Kaiser, L. G., Durazzo, T. C., Mueller, S. G., Weiner, M. W., 




normal elderly: a proton magnetic resonance spectroscopy study. Obesity (Silver 
Spring), 18, 743-748. 
Giampaoli, S., Ferrucci, L., Cecchi, F., Lo Noce, C., Poce, A., Dima, F., Santaquilani, A., 
Vescio, M. F., & Menotti, A. (1999). Hand-grip strength predicts incident 
disability in non-disabled older men. Age and Ageing, 28, 283-288. 
Gill, T. M., Murphy, T. E., Barry, L. C., & Allore, H. G. (2009). Risk factors for 
disability subtypes in older persons. Journal of the American Geriatrics Society, 
57, 1850-1855.  
Gill, T. M., Baker, D. I., Gottschalk, M., Peduzzi, P. N., Allore, H., & Byers, A. (2002). 
A program to prevent functional decline in physically frail, elderly persons who 
live at home. The New England Journal of Medicine, 347, 1068-1074. 
Gill, T. M., Williams, C. S., Richardson, E. D., Berkman, L. F., & Tinetti, M. E. (1997). 
A predictive model for ADL dependence in community-living older adults based 
on a reduced set of cognitive status items. Journal of the American Geriatrics 
Society, 45, 441-445. 
Gold, C. H., Malmberg, B., McClearn, G. E., Pedersen, N. L., & Berg, S. (2002). Gender 
and health: a study of older unlike-sex twins. Journal of Gerontology 
Psychological and Social Sciences, 57(3), S168-S176. 
Gonda, J., & Schaie, K. W. (1985). Schaie-Thurstone Mental Abilities Test: Word Series 
Test. Palo Alto, CA: Consulting Psychologists Press. 
Gottfredson, L. S. (2004). Intelligence: is it the epidemiologists’ elusive “fundamental 
cause” of social class inequalities in health? Journal of Personality and Social 




Green, M. W., Elliman, N. & Rogers, P. J. (1997). Impaired cognitive processing in 
dieters: Failure of attentional focus or resource capacity limitation? British 
Journal of Health Psychology, 2, 259–267. 
Gregg, E. W., Cheng, Y. J., Cadwell, B. L., Imperatore, G., Williams, D. E., Flegal, K. 
M., Narayan, K. M. V., & Williamson, D. F. (2005). Secular trends in 
cardiovascular disease risk factors according to body mass index. JAMA, 292, 
1868-1874. 
Gregor, M. F., & Hotamisligil, G. S. (2011). Inflammatory mechanisms in obesity. 
Annual Reviews in Immunology, 29, 415-445. 
Gross, A. L., Inouye, S. K., Rebok, G. W., Brandt, J., Crane, P. K., Parisi, J. M., … & 
Jones, R. N. (2012). Parallel but not equivalent: Challenges and solutions for 
repeated assessment of cognition over time. Journal of Clinical and Experimental 
Neuropsychology, 37, 758-772. 
Gunstad, J., Spitznagel, M. B., Paul, R. G., Cohen, R. A., Kohen, M., Luyster, F. S., … & 
Gordon, E. (2008). Body mass index and neuropsychological function in healthy 
children and adolescents. Appetite, 50, 246-251. 
Gunstad, J., Paul, R. H., Cohen, R. A., Tate, D. F., & Gordon, E. (2006). Obesity is 
associated with memory deficits in young and middle-aged adults. Eating and 
Weight Disorders, 11, 15-19. 
Gurland, B. J., Wilder, D. E., Lantigua, R., Stern, Y., Chen, J., Killeffer, E. H. P., & 
Mayeux, R. (1999). Rates of dementia in three ethnoracial groups. International 




Guralnik, J. M., Simonsick, E., M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D., 
G., Scherr, P. A., & Wallace, R. B. (1994). A short physical performance battery 
assessing lower extremity function: Association with self-reported disability and 
prediction of mortality and nursing home admissions. Journal of Gerontology 
Series B: Medical Sciences, 49, M85-M94. 
Guralnik, J. M., LaCroix, A. Z., Abbott, R. D., Berkman, L. F., Satterfield, S., Evans, D. 
A., & Wallace, R. B. (1993). Maintaining mobility in later life. Demographic 
characteristics and chronic conditions. American Journal of Epidemiology, 
137(8), 845-857. 
Guralnik, J. M., LaCroix, A. Z., Everett, D. F., & Kovar, M. G. (1989). Aging in the 
eighties: the prevalence of comorbidity and its association with disability. 
Advance Data from Vital and Health Statistics; No. 170, Hyattsville, MD: 
National Center for Health Statistics. 
Gustafson, D. (2006). Adiposity indices and dementia. Lancet Neurology, 5, 713-720. 
Gustafson, D. (2008). A life course of adiposity and dementia. European Journal of 
Pharmacology, 585, 163-175.  
Guxens, M., Mendez, M. A., Julves, J., Plana, E., Forns, J., Basagaña, X., Torrent, M., & 
Sunyer, J. (2009). Cognitive function and overweight in preschool children. 
American Journal of Epidemiology, 170, 438-446. 
Haboubi, N.Y., Hudon, P. R., & Pathy, M. S. (1990). Measurement of height in the 




Hammond, J. M. (1995). Multiple jeopardy or multiple resources? The intersection of 
age, race, living arrangements, and education level and the health of older women. 
Journal of Women and Aging, 7, 5-24. 
Haan, M. N. (2006). Therapy insight: Type 2 diabetes mellitus and the risk of late-onset 
Alzheimer’s disease. Nature Clinical Practice Neurology, 2, 159-166.  
Hajjar, I., Quach, L., Yang, F., Chaves, P. H., Newman, A. B., Mukamal, K., … & 
Lipsitz, L. A. (2011). Hypertension, white matter hyperintensities, and concurrent 
impairments in mobility, cognition, and mood: the Cardiovascular Health Study. 
Circulation, 128, 858-865. 
Hall, K., Murrell, J., Ogunniyi, A., Deeg, M., Baiyewu, O., Gao, S., … & Hendrie, H. 
(2006). Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic 
study of Nigerian Yoruba. Neurology, 66, 223-227. 
Han, C., Jo, S. A., Seo, J. A., Kim, B. G., Kim, N. H., Jo, I., Park, M. H., & Park, K. W. 
(2009). Adiposity parameters and cognitive function in the elderly: Application of 
“Jolly Fat” hypothesis to cognition. Archives of Gerontology and Geriatrics, 49, 
e133-e138. 
Harvey, J., Solovyova, N., & Irving, A. (2006). Leptin and its role in hippocampal 
synaptic plasticity. Progress in Lipid Research, 45, 369-378. 
Hassenstab, J. J., Sweat, V., Bruehl, H., & Convit, A. (2010). Metabolic syndrome is 
associated with learning and recall impairment in middle age. Dementia and 
Geriatric Cognitive Disorders, 29, 356-362. 
Hassing, L. B., Dahl, A. K., Pedersen, N. L., & Johansson, B. (2010). Overweight in 




with longitudinal assessments. Dementia and Geriatric Cognitive Disorders, 29, 
543-552.  
Heiat, A., Vaccarino, V., & Krumholz, H. M. (2001). An evidence-based assessment of 
federal guidelines for overweight and obesity as they apply to elderly persons. 
Archives of Internal Medicine, 161, 1194-1203. 
Hendrie, H. C., Purnell, C., Wicklund, A. H., & Weintraub, S. (2010). Defining and 
assessing cognitive and emotional health in later life. In C. A. Depp & D. V. Jeste 
(Eds). Successful cognitive and emotional aging (pp.17-36). Washington DC: 
American Psychological Association. 
Hendrie, H. C., Albert, M. S., Butters, M. D., Gao, S., Knopman, D. S., Launer, L. J., & 
Yaffe, K. (2005). The NIH cognitive and emotional health project report of the 
critical evaluation study committee. Retrieved from 
http://trans.nih.gov/ceph/CriticalEvaluationStudyReport.pdf  
Ho, A. J., Raji, C. A., Becker, J. Y., Lopez, O. L., Kuller, L. H., Hua, X., … & Weiner, 
M. W. (2010). Obesity is linked with lower brain volume in 700 AD and MCI 
patients. Neurobiology of Aging, 21, 1326-1339. 
Hochberg, M. C. (2007). Racial differences in bone strength. Transactions of the 
American Clinical and Climatological Association, 118, 305-315. 
Hughes, T. F., & Ganguli, M. (2009). Modifiable midlife risk factors for late-life 
cognitive impairment and dementia. Current Psychiatry Reviews, 5, 73-92. 
Hurd, M. D., Martorell, P., Delavande, A., Mullen, K. J., & Langa, K. M. (2013). 
Monetary costs of dementia in the United States. New England Journal of 




Ishizaki, T., Watanabe, S., Suzuki, T., Shibata, H., & Haga, H. (2000). Predictors for 
functional decline among nondisabled older Japanese living in a community 
during a 3-year follow-up. Journal of the American Geriatric Society, 48, 1424-
1429. 
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., 
Petersen, R. C., & Trojanowski, J. Q. (2010). Hypothetical model of dynamic 
biomarkers of the Alzheimer’s pathological cascade. Lancet Neurology, 9, 119-
139.  
Janssen, I., Katzmarzyk, P. T., & Ross, R. (2004). Waist circumference and not body 
mass index explains obesity-related health risk. American Journal of Clinical 
Nutrition, 79, 379-384. 
Jensen, G. L., & Friedman, J. M. (2002). Obesity is associated with functional decline in 
community-dwelling rural older persons. American Journal of Geriatric Society, 
50, 918-923.  
Jeong, S. K., Sam, H. S., Son, M. H., Son, E. J. & Cho, K. H. (2005). Interactive effect of 
obesity indexes on cognition. Dementia and Geriatric Cognitive Disorders, 19, 
91-96. 
Jobe, J. B., Smith, D. M., Ball, K., Tennstedt, S. L., Marsiske, M., Willis, S. L., … & 
Kleinman, K. (2001). ACTIVE: a cognitive intervention trial to promote 
independence in older adults. Controlled Clinical Trials, 22, 453–479. 
Johnson, J. K., Lui, L. Y., & Yaffe, K. (2007). Executive function, more than global 
cognition predictions functional decline and mortality in elderly women. Journals 




Kelley-Moore, J. A., & Ferraro, K. F. (2004). The Black/White disability gap: Persistent 
inequality in later life? Journal of Gerontology, 59, S34-S43. 
Kemps, E., Tiggemann, M., & Marshall, K. (2005). Relationship between dieting to lose 
weight and the functioning of the central executive. Appetite, 45, 287–294. 
Kemps, E. & Tiggemann, M. (2005). Working memory performance and preoccupying 
thoughts in female dieters: Evidence for a selective central executive impairment. 
British Journal of Health Psychology, 44, 357–366. 
Kensinger, E. A. (2009). Cognition in aging and age-related disease. In L. R. Squire 
(Ed.), Encyclopedia of Neuroscience (pp.1055-1061). New York, NY: Elsevier 
Ltd. 
Khoshdel, A. R., Carney, S. L., & Gillies, A. (2012). Circulatory syndrome: an evolution 
of the metabolic syndrome concepts. Current Cardiology Reviews, 8, 68-76.  
Kimm, H., Lee, P. H., Shin, Y. J., Park, K. S., Jo, J., Lee, Y., Kang, H. C., & Lee, S. H. 
(2011). Mid-life and late-life vascular risk factors and dementia in Korean men 
and women. Archives of Gerontology and Geriatrics, 52, e117-e122. 
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., … & 
Swift, C. S. (2012). Diabetes in older adults: a consensus report. Journal of the 
American Geriatrics Society, 35, 2650-2664. 
Kivipelto, M., Helkala, E. L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, 
K., … & Nissinen, A. (2001a). Midlife vascular risk factors and Alzheimer’s 




Kivipelto, M., Helkala, E. L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, 
K., … & Nissinen, A. (2001b). Midlife vascular risk factors and late-life mild 
cognitive impairment: a population-based study. Neurology, 56, 1683-1689. 
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kareholt, I., Winbald, B., … & 
Nissinen, A. (2005). Obesity and vascular risk factors at midlife and the risk of 
dementia and Alzheimer disease. Archives of Neurology, 62, 1556-1560.  
Kohler, S., van Boxtel, M., Jolles, J., & Verhey, F. (2011). Depressive symptoms and risk 
for dementia: a 9-year follow-up of the Maastricht Aging Study. American 
Journal of Geriatric Psychiatry, 19(10), 902-905. 
Kolen, M., & Brennan, R. (1995). Test Equating Methods and Practices. New York: 
Springer. 
Koster, A., Stenholm, S., Alley, D. E., Kim, L. J., Simonsick, E. M., Kanaya, A. M., … 
& Harris, T. B. (2010). Body fast distribution and inflammation among obese 
older adults with and without metabolic syndrome. Obesity (Silver Spring), 18, 
2354-2361. 
Kozauer, N. A., Mielke, M. M., Chan, G. K., Rebok, G. W., & Lykestsos, C. G. (2008). 
Apolipoprotein E genotype and lifetime cognitive decline. International 
Psychogeriatrics, 20, 109-123. 
Kramarova, T. V., Wright, K. D., & Pongratz, I. (2009). The role of estrogen receptors in 
obesity. Drug Discovery Today: Disease Mechanisms, 6, e49-e54. 
Kramer, A. F., Erickson, K. I., & Colcombe, S. J. (2006). Exercise, cognition, and the 
aging brain. Journal of Applied Physiology: Respiratory, Environmental and 




Krombholz, H. (2013). Motor and cognitive performance of overweight preschool 
children. Perceptual Motor Skills, 116, 40-57. 
Kuczmarski, M. F., Kuczmarski, R. J., & Najjar, M. (2001). Effects of age on validity of 
self-reported height, weight, and body mass index: Findings from the third 
National Health and Nutrition Examination Survey, 1988-1994. Journal of the 
American Dietary Association, 101, 28-34. 
Kuh, D., Cooper, R., Hardy, R., Guralnik, J., & Richards, M. (2009). Lifetime cognitive 
performance is associated with midlife physical performance in a prospective 
national birth cohort study. Psychosomatic Medicine, 71, 38-48. 
Kukull, W. A., & Ganguli, M. (2000). Epidemiology of dementia: Concepts and 
overview. Clinical Neurology, 18, 923-950. 
Kuo, H. K., Jones, R. N., Milberg, W. P., Tennstedt, S., Talbot, L., Morris, J. N., & 
Lipsitz, L. A. (2006). Cognitive function in normal-weight, overweight, and obese 
older adults: an analysis of the Advanced Cognitive Training for Independent and 
Vital Elderly cohort. American Journal of Geriatric Society, 54, 97-103. 
Kuo, H. K., Jones, R. N., Milberg, W. P., Tennstedt, S., Talbot, L., Morris, J. N., & 
Lipsitz, L. A. (2005). Effects of blood pressure and diabetes mellitus on cognitive 
and physical function in older adults: a longitudinal analysis of the Advanced 
Cognitive Training for Independent and Vital Elderly cohort. American Journal of 
Geriatric Society, 53, 1154-1161. 
Kuusisto, J., Koivisto, K., Mykkanen, L., Helkala, E. L.,Vanhanen, M., Hanninen, T., … 




syndrome and Alzheimer’s disease independent of apolipoprotein E4 phenotype: 
Cross sectional population based study. British Medical Journal, 315, 1045-1049. 
Larrieu, S., Pérès, K., Letenneur, L., Berr, C., Dartigues, J. F., Richie, K., … & 
Barberger-Gateau, P. (2004). Relationship between body mass index and different 
domains of disability in older persons: the 3C study. International Journal of 
Obesity, 28, 1555-1560. 
Larson, E. B., Wang, L., Bowen, J. D., McCormick, W. C., Teri, L., … & Kukull, W. 
(2006). Exercise is associated with reduced risk for incident dementia among 
persons 65 years of age and older. Annals of Internal Medicine, 144, 73-81. 
Launer, L. J., Hughes, T., Yu, B., Masaki, K., Petrovitch, H., Ross, G. W., & White, L. R. 
(2010). Lowering midlife levels of systolic blood pressure as a public health 
strategy to reduce late-life dementia. Hypertension, 55, 1352-1359. 
Lawton, M. P., & Brody, E. M. (1969). Assessment of older people: Self-maintaining and 
instrumental activities of daily living. The Gerontologist, 9, 179-186. 
Lee, J. S., Kritcheevksy, S. B., Tylavsky, F., Harris, T., Simonsick, E. M., Rubin, S. M., 
& Newman, A. B. (2005). Weight change, weight change intention, and the 
incidence of mobility limitation in well-functioning community-dwelling older 
adults. Journal of Gerontology: Medical Sciences, 60A, 1007-1012. 
Lee, Y. H., Martin, J. M., Maple, R. L., Tharp, W. G., & Pratley, R. E. (2009). Plasma 
Amyloid-β peptide levels correlate with adipocyte amyloid precursor protein gene 
expression in obese individuals. Neuroendocrinology, 90, 383-390. 
Li, J. J., & Chen, J. L. (2005). Inflammation may be a bridge connecting hypertension 




Li, J., Wang, Y. J., Zhang, M., Xu, Z. Q., Gao, C. Y., Fang, C. Q., … & Zhou, H. D. 
(2011). Vascular risk factors promote conversion from mild cognitive impairment 
to Alzheimer disease. Neurology, 76, 1485-1491. 
Li, K. Z. H., Lindenberger, U., Freund, A. M., & Baltes, P. B. (2001). Walking while 
memorizing: Age-related differences in compensatory behavior. Psychological 
Science, 12, 230-237. 
Li, Y., Dai, Q., Jackson, J. C., & Zhang, J. (2008). Overweight is associated with 
decreased cognitive functioning among school-age children and adolescents. 
Obesity, 16, 1809–1815. 
Lin, S. F., Beck, A. N., Finch, B. K., Hummer, R. A., & Master, R. K. (2012). Trends in 
US older adults disability: Exploring age, period, and cohort effects. American 
Journal of Public Health, 102, 2157-2163. 
Lindenberger, U., Marsiske, M., & Baltes, P. B. (2000). Memorizing while walking: 
Increase in dual-task costs from young adulthood to old age. Psychology and 
Aging, 15, 417-436. 
Lindqvist, P., Andersson, K., Sundh, V., Lissner, L., Bjorkelund, C., & Bengtsson, C. 
(2006). Concurrent and separate effects of body mass index and waist-to-hip ratio 
on 24-year mortality in the Population Study of Women in Gothenburg: Evidence 
of age-dependency. European Journal of Epidemiology, 21, 789–794. 
Lo, A. H. Y., Pachana, N. A., Byren, G. J., Sachdev, P. S., & Woodman, R. J. (2012). 
Relationship between changes in body weight and cognitive function in middle-




Loef, M., & Walach, H. (2013). Midlife obesity and dementia: Meta-analysis and 
adjusted forecast of dementia prevalence in the United States and China. Obesity, 
21, E51-E55. 
Lokken, K. L., Boeka, A. G., Austin, H. M., Gunstad, J., Harmon, C. M. (2009). 
Evidence of executive dysfunction in extremely obese adolescents: a pilot study. 
Surgery for Obesity and Related Disorders, 5, 547–552. 
Loscalzo, J., Fauci, A. S., Braunwald, E., Dennis, L. K., Hauser, S. L., & Longo, D. L. 
(2008). Harrison’s principles of internal medicine (17th ed.). New York, NY: 
McGraw-Hill. 
Luchsinger, J. A., Biggs, M., Kizer, J. R., Barzilay, J., Fitzpatrick, A., Newman, A., 
Longstreth, W., … & Kuller, L. (2013). Adiposity and cognitive decline in the 
Cardiovascular Health Study. Neuroepidemiology, 40, 274-281. 
MacMahon, S., Peto, R., Cutler, J., Collins, R., Sorlie, P., Neaton, J., … & Dyer, A. 
(1990). Blood pressure, stroke, and coronary heart disease: Part I-prolonged 
differences in blood pressure: Prospective observational studies correlated for the 
regression dilution bias. Lancet, 335, 765-774. 
MacKinnon, D. P., Krull, J. L., & Lockwood, C. L. (2000). Equivalence of the mediation, 
confounding, and suppression effect. Prevention Science, 1, 173-181. 
Mahoney, J. R., Verghese, J., Goldin, Y., Lipton, R., & Holtzer, R. (2010). Alerting, 
orienting, and executive attention in older adults. Journal of the International 
Neuropsychological Society, 16, 877–89. 
Marks, R. (2007). Obesity profiles with knee osteoarthritis: Correlations with pain, 




McGuire, L. C., Ford, E. S., & Ajani, U. A. (2006). Cognitive functioning as a predictor 
of functional disability in later life. American Journal of Geriatric Psychiatry, 14, 
36-42. 
Mendes de Leon, C. F., Barnes, L. L., Bienias, J. L., Skarupski, K. A., & Evans, D. A. 
(2005). Racial disparities in disability: Recent evidence from self-reported and 
performance-based disability measures in a population-based study of older 
adults. Journal of Gerontology, 60, S263-S271. 
Mendes de Leon, C. F., Hansberry, M. R., Bienias, J. L., Morris, M. C., & Evans, D. A. 
(2006). Relative weight and mobility: a longitudinal study in a biracial population 
of older adults. Annals of Epidemiology, 16, 766-770. 
Merched, A., Xia, Y., Visvikis, S., Serot, J. M., & Siest, G. (2000). Decreased high-
density lipoprotein cholesterol and serum apolipoprotein AI concentrations are 
highly correlated with the severity of Alzheimer’s disease. Neurobiology of Aging 
21, 27-30. 
Merton, R. K. (1968). The Matthew effect in science: the reward and communication 
system of science. Science, 159, 56–63. 
Mezler, D., Izmirlian, G., Leveille, S. G., & Gurlnik, J. M. (2001). Educational 
differences in prevalence of mobility disability in old age: the dynamics of 
incidence, mortality, and recovery. Journals of Gerontology Series B: Social 
Sciences, 56B, S294-S301. 
Mielke, M. M., Zandi, P. P., Shao, H., Waern, M., Ostling, S., Guo, X., Bjorkelund, C., 




between cholesterol and dementia from midlife to late life. Neurology, 75, 1888-
1895. 
Mielke, M. M., Zandi, P. P., Sjogren, M., Gustafson, D., Ostling, S., Steen, B., & Skoog, 
I. (2005). High total cholesterol levels in late life associated with a reduced risk of 
dementia. Neurology, 64, 1689-1695. 
Miller, S. L., & Wolfe, R. R. (2008). The danger of weight loss in the elderly. Journal of 
Nutrition, Health, and Aging, 12, 487-491. 
Mijnarends, D. M., Meijers, J. M. M., Halfens, R. J. G., ter Borg, S., Luiking, Y. C., … & 
Schols Prof, J. M. G. (2013). Validity and reliability of tools to measure muscle 
mass, strength, and physical performance in community-dwelling older people: a 
systematic review. Journal of the American Medical Directors Association, 14, 
170-178. 
Mokdad, A. H., Marks, J. S., Stroup, D. F., & Gerberding, J. L. (2004). Actual causes of 
death in the United States, 2000. JAMA, 291, 1238-1245. 
Mond, J. M., Stich, H., Hay, P. J., Kraemer, A., & Baune, B. T. (2007). Associations 
between obesity and developmental functioning in pre-school children: a 
population-based study. International Journal of Obesity, 31, 1068–1073. 
Morris, J. K., Vidoni, E. D., Perea, R. D., Rada, R., Johnson, D. K., Lyons, K., Pahwa, 
R., Burns, J. M., & Honea, R. A. (2014). Insulin resistance and gray matter 
volume in neurodegenerative disease. Neuroscience, http://dx.doi.org/10.1016/j. 
neuroscience.2014.04.006 
Muthén, L. K., & Muthén, B. O. (1998-2012). Mplus User’s Guide (7th ed.). Los 




Nagi, S. Z. (1965). Some conceptual issues in disability and rehabilitation. In M. B. 
Sussman (Ed.), Sociology & rehabilitations (pp.100-113). Washington, DC: 
American Sociological Association. 
National Heart Lung and Blood Institute, National Institutes of Health. Expert Panel on 
the Identification Evaluation and Treatment of Overweight and Obesity in Adults. 
(1998). Clinical guidelines on the identification, evaluation, and treatment of 
overweight and obesity in adults-the evidence report (NIH Publication No. 98-
4083). Retrieved from http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf 
National Heart Lung and Blood Institute, National Institutes of Health (2008). Obesity 
Education Initiative: The Evidence Report. Bethesda, MD. 
Neovius, K., Rasmussen, F., Sunstrom, J., & Neovius, M. (2010). Forecast of premature 
mortality as a result of trends in obesity and smoking: Nationwide cohort 
simulation study. European Journal of Epidemiology, 25, 703-709. 
Ng, T. P., Leong, T., Chiam, P. C., & Kua, E. H. (2010). Ethnic variations in dementia: 
the contributions of cardiovascular, psychosocial and neuropsychological factors. 
Dementia and Geriatric Cognitive Disorders, 29, 131-138. 
Notkola, I. L., Sulkava, R., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., 
Tuomilehto, J., & Nissinen, A. (1998). Serum total cholesterol, apolipoprotein E 
epsilon 4 allele, and Alzheimer’s disease. Neuroepidemiology, 17, 14-20.  
Nourhashémi, F., Andrieu, S., Gillette-Guyonnet, S., Reynish, E., Albarède, J. 
L., Grandjean, H., & Vellas, B. (2002). Is there a relationship between fat-free 
soft tissue mass and low cognitive function? Results from a study of 7,105 




Ogata, S., Kato, K., Honda, C., & Hayakawa, K. (2014). Common genetic factors 
influence hand strength, processing speed, and working memory Journal of 
Epidemiology, 24, 31-38. 
Ogden, C. L., Carroll, M. D., McDowell, M. A., & Flegal, K. M. (2007). Obesity among 
adults in the United States—no change since 2003–2004. NCHS data brief no 1. 
Hyattsville, MD: National Center for Health Statistics; Available 
from: http://www.cdc.gov/nchs/data/databriefs/db01.pdf   
Osika, W., & Montgomery, S. M. (2008). Physical control and coordination in childhood 
and adult obesity: Longitudinal birth cohort data. British Medical Journal, 337, 
a699. doi: 10.1136/bmj.a699 
Owsley, C., Sloane, M., McGwin, G., & Ball, K. (2002). Timed instrumental activities of 
daily living tasks: Relationship to cognitive function and everyday performance 
assessments in older adults. Gerontology, 48, 254-265. 
Pa, J., Possin, K. L., Wilson, S. M., Quitania, L. C., Kramer, J. H., Boxer, A. L., Weiner, 
M. W., & Johnson, J. K. (2010). Gray matter correlates of set-shifting among 
neurodegenerative disease, mild cognitive impairment, and healthy older adults. 
International Journal of the Neuropsychological Society, 16, 640-650. 
Palacios-Ceña, D., Jiménez-García, R., Hernánez-Barrera, V., Alonso-Blanco, C., 
Carrasco-Garrido, P., & Fernández-de-las-Peñas, C. (2012). Has the prevalence of 
disability increased over the past decade (2000-2007) in elderly people? A 
Spanish population-based study. JAMA, 13, 136-142. 
Palmer, B. W., & Dawes, S. E. (2010). Cognitive aging: From basic skills to scripts and 




emotional aging (pp. 37-54). Arlington, VA: American Psychiatric Publishing, 
Inc.  
Pannacciulli, N., Del Parigi, A., Chen, K., Le, D. S. N. T., Reiman, E. M., & Tataranni, P. 
A. (2006). Brain abnormalities in human obesity: a voxel-based morphometric 
study. NeuroImage, 31(4), 1419-1425. 
Pasinetti, G. M., Wang, J., Porter, S., & Ho, L. (2011). Caloric intake, dietary lifestyles, 
macronutrient composition, and Alzheimer’s disease dementia. International 
Journal of Alzheimer’s Disease, 806293. 
Peila, R., White, L. R., Masaki, K., Petrovtich, H., & Launer, L. J. (2006). Reducing the 
risk of dementia: Efficacy of long-term treatment of hypertension. Stroke, 37, 
1165-1170. 
Pelusi, C., & Pasquali, R. (2012). The significance of low testosterone levels in obese 
men. Current Obesity Reports, 1, 181-190. 
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. 
B., … & Wallace, R. B. (2008). Prevalence of cognitive impairment without 
dementia in the United States. Annals of Internal Medicine, 148, 427-434. 
Posner, H. B., Tang, M. X., Luchsinger, J., Lantigua, R., Stern, Y., & Mayeux, R. (2000). 
The relationship between hypertension in the elderly to AD, vascular dementia, 
and cognitive function. Neurology, 58, 1175-1181. 
Priller, C., Bauer, T., Mitteregger, G., Krebs, B., Kretzschmar, H. A., & Herms, J. (2006). 
Synapse formation and function is modulated by the amyloid precursor protein. 




Prince, M., Acosta, D., Ferri, C. P., Guerra, M., Huang, Y., Llibre Rodriguez, J. J., … & 
Liu, Z. (2012). Dementia incidence and mortality in middle-income countries, and 
associations with indicators of cognitive reserve: a 10/66 Dementia Research 
Group population-based cohort study. Lancet, 380 (9836), 50-58.  
Rantanen, T., Guralnik, J. M., Foley, D., Masaki, K., Leveille, S., Curb, J. D., & White, 
L. (1999). Midlife hand grip strength as a predictor of old age disability. JAMA, 
281, 558–560. 
Rejeski, W. J., Marsh, A. P., Chmelo, E., & Rejeski, J. J. (2010). Obesity, intentional 
weight loss and physical disability in older adults. Obesity Reviews, 11, 671-685. 
Raji, C. A., Ho, A. J., Parikshak, N. N., Becker, J. T., Lopez, O. L., Kuller, L. H., … & 
Thompson, P. M. (2010). Brain structure and obesity. Human Brain Mapping, 31, 
353-364.  
Rastas, S., Pirttila, T., Mattila, K., Verkkoniemi, A., Juva, K., Niinisto, L.,… & Sulkava, 
R. (2010). Vascular risk factors and dementia in the general population aged > 85 
years: Prospective population-based study. Neurobiology of Aging, 31, 1-7.  
Razay, G., Williams, J., King, E., Smith, A. D., & Wilcock, G. (2009). Blood pressure, 
dementia, and Alzheimer’s disease: the OPTIMA longitudinal study. Dementia 
and Geriatric Cognitive Disorders, 28, 70-74. 
Rebok, G. W., & Folstein, M. F. (1993). Dementia. Journal Neuropsychiatry Clinical 
Neuroscience, 5(3), 265-276. 
Rebok, G. W., Parisi, J. M., & Kueider, A. M. (2014). Stressors and vulnerabilities in 
middle and old age: Opportunities for prevention. In Z. Sloboda & H. Petra (Eds). 




Rejeski, W. J., Marsh, A. P., Chmelo, E., & Rejeski, J. J. (2010). Obesity, intentional 
weight loss and physical disability in older adults. Obesity Reviews, 11, 671-685. 
Reinert, K. R. S., Po’e, E. K., & Barkin, S. L. (2013). The relationship between executive 
function and obesity in children and adolescents: a systematic literature review. 
Journal of Obesity, Article ID 820956, doi:10.1155/2013/820956 
Reitz, C., Tang, M. X., Manly, J., Schupf, N., Mayeux, R., & Luchsinger, J. A. (2008). 
Plasma lipid levels in the elderly are not associated with the risk of mild cognitive 
impairment. Dementia and Geriatric Cognitive Disorders, 25, 232-237. 
Reitz, C., Luchsinger, J., Tang, M. X., Manly, J., & Mayeux, R. (2005). Impact of plasma 
lipids and time on memory performance in healthy elderly without dementia. 
Neurology, 64, 1378-1383. 
Reitz, C., Tang, M. X., Luchsinger, J., & Mayeux, R. (2004). Relation of plasma lipids to 
Alzheimer disease and vascular dementia. Archives of Neurology, 61, 705-714. 
Rey, A. (1941). L’examen psychologique dans les cas d'encéphalopathie traumatique. 
(Les problems.) [The psychological examination in cases of traumatic 
encepholopathy. Problems]. Archives de Psychologie, 28, 215-285. 
Richmond, R., Law, J., & Kay-Lambkin, F. (2011). Higher blood pressure associated 
with higher cognition and functionality among centenarians in Australia. 
American Journal of Hypertension, 24, 299–303. 
Rios, M. (2013). BDNF and the central control of feeding: Accidental bystander or 
essential player? Trends in Neurosciences, 36, 83-90. 
Roberts, R. O., Geda, Y. E., Knopman, D. S., Christianson, T. J. H., Pankratz, V. S., 




diabetes mellitus with mild cognitive impairment. Archives of Neurology, 65, 
1066-1073. 
Romas, S. N., Tang, M. X., Berglund, L., & Mayeux, R. (1999). APOE genotype, plasma 
lipids, lipoproteins, and AD in community elderly. Neurology, 53, 517-521. 
Rönnemaa, E., Zethelius, B., Sundelof, J., Sundlstrom, H., Degerman-Gunnarsson, M., 
Berne, C., Lanndelt, I., & Kilander, L. (2008). Impaired insulin secretion 
increases the risk of Alzheimer’s disease. Neurology, 71, 1065-1071. 
Ruis, C., Biessels, G. J., Gorter, K. J., van den Donk, M., Kappelle, L. J., & Rutten, G. E. 
H. M. (2009). Cognition in early stage of Type 2 diabetes. Diabetes Care, 32, 
1261-1265. 
Ruitenberg, A., Skoog, I., Ott, A., Aevarsson, O., Witteman, J. C. M., Lernfelt, B., … & 
Breteler, M. M. B. (2001). Blood pressure and risk of dementia: Results from the 
Rotterdam Study and the Gothenburg H-70 Study. Dementia and Geriatric 
Cognitive Disorders, 12, 33-39. 
Sabia, S., Kivimaki, M., Shipley, M. J., Marmot, M. G., & Singh-Manoux, A. (2009). 
Body mass index over the adult life course and cognition in late midlife: the 
Whitehall II Cohort Study. American Journal of Clinical Nutrition, 89, 601-607.  
Sallinen, J., Stenholm, S., Rantanen, T., Heliövaara, M., Sainio, P., & Koskinen, S. 
(2010). Hand-grip strength cut points to screen older persons at risk for mobility 
disability. Journal of the American Geriatrics Society, 58, 1721-1726. 
Salthouse, T. A., Atkinson, T. M., & Berish, D. E. (2003). Executive functioning as a 
potential mediator of age-related cognitive decline in normal adults. Journal of 




Salthouse, T. A. (2000). Age and measures of processing speed. Biological Psychiatry, 
54, 35-54. 
Salthouse, T. A., Hambrick, D. Z., & McGuthry, K. E. (1998). Shared age-related 
influences on cognitive and noncognitive variables. Psychology and Aging, 13, 
486-500. 
Sauvaget, C., Tsuji, I., Aonuma, T., & Hisamichi, S. (1999). Health-life expectancy 
according to various functional levels. Journal of the American Geriatric Society, 
47, 1326-1331. 
Schaie, K. W. (2005). Developmental influences on adult intelligence: The Seattle 
longitudinal study. New York: Oxford Press University. 
Schultz. Y., Kyle, U. U., & Pichard, C. (2002). Fat-free mass index and fat mass index in 
Caucasians aged 19-98y. International Journal of Obesity, 26, 953-960. 
Schwartz, D. H., Leonard, G., Perron, M., Richer, L., Syme, C., Veillette, S., Pausova, Z., 
& Paus, T. (2013). Visceral fat is associated with lower executive functioning in 
adolescents. International Journal of Obesity, 37, 1336-1343. 
Selkoe, D. J., Podlinsy, M. B., Joachim, C. L., Vickers, E. A., Lee, G., Fritz, L. C., & 
Oltersdorf, T. (1988). Beta-amyloid precursor protein of Alzheimer disease occurs 
as 110- to 135- kilodalton membrane-associated proteins in neural and nonneural 
tissues. Proceedings of the National Academy of Science, 85, 7341-7345. 
Sellbom, K. S., & Gunstad, J. (2012). Cognitive function and decline in obesity. Journal 




Shaw, J. & Tiggemann, M. (2004). Dieting and working memory: preoccupying 
cognitions and the role of the articulatory control process. British Journal of 
Health Psychology, 9, 179–185. 
Shinkai, S., Watanabe, S., Kumagai, S., Fujiwara, Y., Amano, H., … & Shibata, H. 
(2000).Walking speed as a good predictor for the onset of functional dependence 
in a Japanese rural community population. Age and Ageing, 29,441–446. 
Skoranski, A. M., Most, S. B., Lutz-Stehl, M., Hoffman, J. E., Hassink, S. G., & Simons, 
R. F. (2013). Response monitoring and cognitive function in childhood obesity. 
Biological Psychology, 92, 199-204. 
Smith, E., Hay, P., Campbell, L., & Trollor, J. N. (2011). A review of the association 
between obesity and cognitive function across the lifespan: Implications for novel 
approaches to prevention and treatment. Obesity Reviews, 12, 740-755. 
Snow, R. (2010). The metabolic syndrome: Controversy and value of using a medical 
home model in chronic disease prevention. Journal of the American Osteopathic 
Association, 110, eS14-eS17. 
Solomon, A., Kivipelto, M., Wolozin, B., Zhou, J., & Whitmer, R. A. (2009). Midlife 
serum cholesterol and increased risk of Alzheimer’s and vascular dementia three 
decades later. Dementia and Geriatric Cognitive Disorders, 28, 75-80.  
Spira, A. P., Rebok, G. W., Stone, K. L., Kramer, J. H., & Yaffe, K. (2011). Depressive 
symptoms in oldest-old women: Risk of mild cognitive impairment and dementia. 




Stalvey, B., Owsley, C., Sloane, M. E., & Ball, K. (1999). The life space questionnaire: a 
measure of the extent of mobility of older adults. Journal of Applied Gerontology, 
18, 479–498. 
Stevens, P. J., Syddall, H. E., Patel, H. P., Martin, H. H., Cooper, C., & Sayer, A. A. 
(2012). Is grip strength a good marker of physical performance among 
community-dwelling older people? The Journal of Nutrition, Health, and Aging, 
16, 769-774. 
Stewart, S. T., Cutler, D. M., & Rosen, A. B. (2009). Forecasting the effects of obesity 
and smoking on US life expectancy. New England Journal of Medicine, 361, 
2252-2260. 
Stewart, R., Masaki, K., Xi, W. L., Peila, R., Petrovitch, H., White, L. R., & Launer, L. J. 
(2005). A 32-year prospective study of change in body weight and incident 
dementia: the Honolulu-Asia Aging Study. Archives of Neurology, 62, 55-60. 
Stewart, R., Prince, M., & Mann, A. (1999). Vascular risk factors and Alzheimer’s 
disease. Australian and New Zealand Journal of Psychiatry, 33, 809-813. 
Strachan, M. W. J., Price, J. F., & Frier, B. M. (2008). Diabetes, cognitive impairment, 
and dementia. British Medical Journal, 336, 6. 
Sturm, R., Ringel, J. S., & Andreyeva, T. (2004). Increasing obesity rates and disability 
trends. Health Affairs, 23, 199-205. 
Sturman, M. T., de Leon, C. F., Bienias, J. L., Morris, M. C., Wilson, R. S., & Evan, D. 
A. (2008). Body mass index and cognitive decline in a biracial community 




Sullivan, P. W., Ghushchyan, V. H., & Ben-Joseph, R. (2008). The impact of obesity on 
diabetes, hyperlipidemia, and hypertension in the United States. Quality of Life 
Research, 17, 1063-1071. 
Swan, G. E., & Carmelli, D. (2002). Evidence for genetic mediation of executive control: 
a study of aging male twins. Journal of Gerontology Series B Psychological and 
Social Sciences, 57(2), 133-143.  
Swan, G. E., Reed, T., Jack, L. M., Miller, B. L., Markee, T., Wolf, P. A., DeCarli, C., & 
Carmelli, D. (1999). Differential genetic influence for components of memory in 
aging adult twins. Archives Neurology, 56, 1127-1132. 
Syddall, H. E., Martin, H. J., Harwood, R. H., Cooper, C., & Sayer, A. A. (2009). The 
SF-36: a simple, effective measure of mobility-disability for epidemiological 
studies. Journal of Nutrition, Health, and Aging, 13(1), 57-62. 
Szewieczek, J., Dulawa, J., Gminski, J., Kurek, A., Legierska, K., Francuz, T., … & 
Hornik, B. (2011). Better cognitive and physical performance is associated with 
higher blood pressure in centenarians. Journal of Nutrition, Health and Aging, 15, 
618–622. 
Tabert, M. H., Albert, M. S., Borukhova-Milov, L., Camacho, Y., Pelton, G., Liu, X. 
Stern, Y., & Devanand, D. P. (2002). Functional deficits in patients with mild 
cognitive impairment: Prediction of AD. Neurology, 58, 758-764. 
Taekema, D. G., Ling, C. H. Y., Kurrle, S. E., Cameron, I. D., Meskers, C. G. M., … & 
Maier, A. B. (2012). Temporal relationship between handgrip strength and 




Taekema, D. G., Gussekloo, J., Maier, A. B., Westendorp, R. G. J., & de Craen, A. J. M. 
(2010). Handgrip strength as a predictor of functional, psychological and social 
health. A prospective population based study among the oldest old. Age and 
Ageing, 39, 331-337. 
Tan, Z. S., Seshadri, S., Beiser, A., Wilson, P. W., Kiel, D. P., Tocco, M., D’Agostino, R. 
B., & Wolf, P. A. (2003). Plasma total cholesterol level as a risk factor for 
Alzheimer disease: The Framingham Study. Archives of Internal Medicine, 163, 
1053-1057. 
Tang, M. X., Cross, P., Jacobs, D. M., Small, S., Bell, K., Merchant, C., & …Mayeux, R. 
(2001). Incidence of AD in African-Americans, Caribbean Hispanics, and 
Caucasians in northern Manhattan. Neurology, 56, 49-56. 
Taras, H., & Potts-Datema, W. (2005). Obesity and student performance at school. 
Journal of School Health, 75, 291-295. 
Taylor, D. H., Schenkman, M., Zhou, J., & Sloan, F. A. (2001). The relative effect of 
Alzheimer’s disease and related dementias, disability, and comorbidities on cost 
of care for elderly persons. Journal of Gerontology Psychological and Social 
Science, 56, S285–S293. 
Thurstone, L. L. & Thurstone, T. G. (1949). Examiner Manual for the SRA Primary 
Mental Abilities Test (Form 10-14). Chicago: Science Research Associates. 
U.S. Census Bureau (2011). Statistical abstract of the United States: 2011 (130th 




Vailas, L. I., & Nitzke, S. A. (1998). Self-reported versus measured weight and height in 
an older adult meal program. Journals of Gerontology Series A: Biological 
Sciences and Medical Sciences, 53, M481-M483. 
van den Kommer, T. N., Dik, M. G., Comijs, H. C., Fassbender, K., Lutjohann, D., & 
Jonker, C. (2009). Total cholesterol and oxysterols: Early markers for cognitive 
decline in elderly? Neurobiology of Aging, 30, 534-545. 
van Vliet, P. (2012). Cholesterol and late-life cognitive decline. Journal of Alzheimer’s 
Disease, 30, S147-S162. 
Verbrugge, L. M., & Jette, A. M. (1994). The disablement process. Social Science and 
Medicine, 38(1), 1-14. 
Verhaaren, B. F. J., Vernooij, M. W., de Boer, R., Hofman, A., Neissen, W. J., van der 
Lugt, A., & Ikfram, M. A. (2013). High blood pressure and cerebral white matter 
lesion progression in the general population. Hypertension, 61, 1354-1359. 
Verhaeghen, P., Borchelt, M., & Smith, J. (2003). Relation between cardiovascular and 
metabolic disease and cognition in very old age: Cross-sectional and longitudinal 
findings from the Berlin Aging Study. Health Psychology, 22, 559-569. 
Verdejo-García, A., Pérez-Expósito, M., Schmidt-Río-Valle, J., Fernández-Serrano, M. 
J., Cruz. F., Pérez-García, M., … & Campoy, C. (2010). Selective alterations 
within executive functions in adolescents. Obesity (Silver Spring), 18, 1572–1578. 
Vincent, H. K., Vincent, K. R., & Lamb, K. M. (2010). Obesity and mobility disability in 
older adults. Obesity Reviews, 11, 568-579. 
Visser, M., Goodpaster, B. H., Kritchevsky, S. B., Newman, A. B., Nevitt, M., Rubin, S. 




infiltration as predictors of incident mobility limitations in well-functioning older 
persons. Journals of Gerontology: Medical Sciences, 60A, 324-333. 
Volkow, N. D., Wang, G. J., & Baler, R. D. (2011). Reward, dopamine and the control of 
food intake: Implications for obesity. Trends in Cognitive Science, 15, 37-46. 
Volkow, N. D., Wang, G. J., Telang, F., Fowler, J. S., Goldstein, R. Z., Alia-Klein, N., 
Logan, J., Wong, C., Thanos, P. K., Ma, Y., & Pradhan, K. (2009). Inverse 
association between BMI and prefrontal metabolic activity in healthy adults. 
Obesity (Silver Spring), 17, 60-65. 
Waldstein, S. R., & Katzel, L. I. (2006). Interactive relations of central versus total 
obesity and blood pressure to cognitive function. International Journal of Obesity, 
30, 201-207. 
Wang, G., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusil, N., & 
Fowler, J. S. (2001). Brain dopamine and obesity. The Lancet, 357, 337-354. 
Ward, M. A., Carlsson, C. M., Trivedi, M. A., Sager, M. A., Johnson, S. C. (2005). The 
effect of body mass index on global brain volume in middle-aged adults: a cross 
sectional study. BMC Neurology, 5, 23. 
Waters, D. L., & Baumgartner, R. N. (2011). Sacropenia and obesity. Clinical Geriatric 
Medicine, 27, 401-421. 
Wechsler, D. (1981). Wechsler Adult Intelligence Scale-Revised. San Antonio, TX: The 
Psychological Corporation.  
Willeumier, K. C., Taylor, D. V., & Amen, D. G. (2011). Elevated BMI is associated 
with decreased blood flow in the prefrontal cortex using SPECT imaging in 




Wilson, B., Cockburn, J., & Baddeley, A. (1985). The Rivermead Behavioural Memory 
Test. Hampshire, UK: Thames Valley Test. 
White, H., Pieper, C., & Schmader, K. (1998). The association of weight change in 
Alzheimer’s disease with severity of disease and mortality: a longitudinal 
analysis. Journal of the American Geriatric Society, 46, 1223-1227. 
Whitfield, K. E., Allaire, J. C., & Wiggins, S. A. (2004). Relationships among health 
factors and everyday problem solving in African Americans. Health Psychology, 
23, 641-644. 
Whitmer, R. A. (2007). The epidemiology and adiposity and dementia. Current 
Alzheimer Research, 4, 117-122. 
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005). Midlife 
cardiovascular risk factors and risk of dementia in late life. Neurology, 64, 277-
281. 
Willeumier, K. C., Taylor, D. V., & Amen, D. G. (2011). Elevated BMI is associated 
with decreased blood flow in the prefrontal cortex using SPECT imaging in 
healthy adults. Obesity, 5, 1097-1097. 
Wolff, J. L., Starfield, B., & Anderson, G. (2002). Prevalence, expenditures, and 
complications of multiple chronic conditions in the elderly. JAMA, 162, 2269-
2276. 
Wolinsky, F. D., Unverzagt, F. W., Smith, D. M., Jones, R., Wright, E., & Tennstedt, S. 
L. (2006). The effects of ACTIVE cognitive training trial on clinically relevant 





Wong, E., Stevenson, C., Backholer, K., Mannan, H., Pasupathi, K., Hodge, A., Freak-
Poli, R., & Peeters, A. (2012). Adiposity measures as predictors of long-term 
physical disability. Annals of Epidemiology, 22, 710-716. 
Wood, K. M., Edwards, J. D., Wadley, V. G., Clay, O. J., Ball, K. K., & Roenker, D. 
(2005). Sensory and cognitive predictors of functional ability in older adults. 
Gerontology, 51, 131–141. 
Woollacott, M., & Shumway-Cook, A. (2002). Attention and control of posture and gait: 
a review of an emerging area of research. Gait & Posture, 16(1), 1-14. 
Wray, L. A., & Blaum, C. S. (2001). Explaining the role of sex on disability: a 
population-based study. Gerontologist, 41, 499–510. 
Wu, W., West, S. G., & Taylor, A. B. (2009). Evaluating model fit for growth curve 
models: Integration of fit indices from SEM and MLM frameworks. 
Psychological Methods, 14, 183-201. 
Xu, W. L., Atti, A. R., Gatz, M., Pedersen, N. L., Johannsson, B., & Fratiglioni, I. (2011). 
Midlife overweight and obesity increase late-life dementia risk. A population-
based twin study. Neurology, 76, 1568-1574.  
Xu, W., Caracciolo, B., Wang, H-X., Winbald, B., Bächman, L., Qiu, C., & Fratiglioni, 
L. (2010). Accelerated progression from mild cognitive impairment to dementia 
in people with diabetes. Diabetes, 59, 2928-2935. 
Xu, J. Q., Kockanek, K. D., Murphy, S. L., & Tejada-Vera, B. (2010). Deaths: Final data 
for 2007, National Vital Statistics Report, 58(19). Hyattsville, MD: National 




Yaffe, K., Kanaya, A., Lindquist, K., Simonsick, E. M., Harris, T., Shorr, R. I., Tylavsky, 
F. A., & Newman, A. B. (2004). The metabolic syndrome, inflammation, and risk 
of cognitive decline. JAMA, 292, 2237-2242. 
Yaffe, K., Barrett-Connor, E., Lin, F., & Grady, D. (2002). Serum lipoprotein levels, 
statin use, and cognitive function in older women. Archives of Neurology, 59, 
378-384. 
Yang, W., Kelly, T., & He, J. (2007). Genetic epidemiology of obesity. Epidemiologic 
Reviews, 29, 49-61. 
Zamboni, M., Mazzali, G., Zoico, E., Harris, T. B., Meigs, J. B., Di Francesco, V., … & 
Bosello, O. (2005). Health consequences of obesity in the elderly: a review of 
four unresolved questions. International Journal of Obesity (London), 29, 1011-
1029. 
Zelinski, E. M., & Gilewski, M. J. (2003). Effects of demographic and health variables on 
Rasch scaled cognitive scores. Journal of Aging and Health, 15, 435-464. 
Zhang, Y., Zhang, X., Zhang, J., Liu, C., Yuan, Q., Yin, X., … & Wang, J. (2014). Gray 
matter volume abnormalities in type 2 diabetes mellitus with and without mild 
cognitive impairment. Neuroscience Letters, 6, 1-6. 
Zhang, J., Muldoon, M. F., & McKeown, R. E. (2004). Serum cholesterol concentrations 
are associated with visuomotor speed in men: Findings from the third National 
Health and Nutrition Examination Survey, 1988-1994. American Journal of 
Clinical Nutrition, 80, 291-298. 
Zoico, E., Di Francesco, V., Guralnik, J. M., Mazzali, G., Bortolani, A., Guariento, S., … 




obesity and different body composition indexes in a sample of healthy elderly 
women. International Journal of Obesity and Related Metabolic Disorders, 28, 
234-241. 
Zuliani, G., Cavalier, M., Galvani, M., Volpato, S., Cherubini, A., Bandinelli, S., … & 
Ferrucci, L. (2010). Relationship between low levels of high-density lipoprotein 
cholesterol and dementia in the elderly. The InChianti Study. Journals of 








aseline characteristics of participants by body m

























































































































































































































2; class I obese 35-39.9 kg/m









































Table 6. Parallel process grow
th m































-0.08 (0.02) ** 
0.0002 (0.02) 
     Slope w
ith slope 
0.29 (0.06) ** 
0.28 (0.05) ** 
-0.28 (0.07) ** 







     B
M








-0.21 (0.04) ** 
-0.21 (0.04) ** 
-0.22 (0.04) ** 




0.07 (0.03) * 
-0.15 (0.04) ** 
0.08 (0.04) * 
     C




















-0.19 (0.04) ** 
0.57 (0.05) ** 
-0.07 (0.04) 
R
e-test effect on intervention group 
0.32 (0.04) ** 
0.65 (0.04) ** 
-0.80 (0.02) ** 
0.08 (0.04) * 
M


































(10); *p <.01 **p <.0001 
N
ote: Low
er scores on the speed com








Table 7. Parallel process grow
th m





































0.29 (0.06) ** 
0.29 (0.05) ** 
-0.35 (0.10) ** 







   B
M









-0.20 (0.04) ** 
-0.20 (0.04) ** 
-0.21 (0.04) ** 




0.07 (0.04) * 
0.08 (0.03) * 
-0.16 (0.04) ** 
0.09 (0.04) * 
   C























-0.14 (0.04) ** 
0.62 (0.07) ** 
-0.02 (0.04) 
R
etest effect on intervention group 
0.32 (0.05) ** 
0.64 (0.04) ** 
-0.82 (0.02) ** 
0.05 (0.04) 










-0.21 (0.02) ** 
-0.21 (0.02) ** 
-0.19 (0.02) ** 




-0.39 (0.02) ** 
-0.32 (0.02) ** 
0.50 (0.02) ** 





-0.10 (0.03) * 
-0.13 (0.04) ** 
-0.15 (0.03) ** 




-0.30 (0.04) ** 
-0.23 (0.05) ** 
-0.01 (0.03) 
-0.25 (0.04) ** 









-0.08 (0.02) ** 
-0.07 (0.02) ** 
-0.09 (0.02) ** 




-0.14 (0.02) ** 
0.06 (0.02) * 
-0.06 (0.03) * 


























-0.15 (0.02) ** 
-0.15 (0.02) ** 
-0.16 (0.02) ** 




0.21 (0.02) ** 
0.31 (0.02) ** 
-0.10 (0.02) ** 












-0.13 (0.05) ** 
-0.03 (0.04) 
0.02 (0.03) 
















0.21 (0.02) ** 
0.22 (0.02) ** 
0.21 (0.02) ** 




-0.07 (0.02) ** 
-0.06 (0.02) * 
0.08 (0.02) ** 















-0.11 (0.04) * 










0.18 (0.02) ** 
0.18 (0.02) ** 
0.18 (0.02) ** 




-0.05 (0.02) * 
-0.08 (0.02) ** 
0.05 (0.02) * 





-0.08 (0.04) * 
-0.07 (0.03) * 
-0.08 (0.03) * 

















-0.16 (0.02) ** 
-0.13 (0.02) ** 
-0.17 (0.02) ** 




0.31 (0.02) ** 
0.43 (0.02) ** 
-0.20 (0.02) ** 













-0.11 (0.04) * 
0.02 (0.03) 
0.002 (0.04) 
   M
M









-0.07 (0.02) ** 
-0.05 (0.02) * 
-0.09 (0.02) ** 




0.52 (0.01) ** 
0.52 (0.01) ** 
-0.36 (0.02) ** 


























































er scores on the speed com








aseline characteristics of participants by sex-specific grip strength tertiles 
 
G




































































































































































































   C









   C
















































































2; class I obese 35-39.9 kg/m















































Table 9. Covariate effects on longitudinal mediation of grip strength on weight-related 
changes in cognition 
 Memory Reasoning Speed† DSST 
 Estimate Estimate Estimate Estimate 
Age on     
GS intercept -0.23*** -0.23*** -0.23*** -0.23*** 
Cognition intercept -0.35*** -0.30*** 0.51*** -0.01 
GS slope -0.18*** -0.17*** -0.18*** -0.19*** 
Cognition slope -0.38*** -0.25*** 0.25*** -0.02 
Sex on     
GS intercept 0.70*** 0.70*** 0.70*** 0.70*** 
Cognition intercept -0.21*** -0.04** -0.01 -0.05 
GS slope 0.38*** 0.37*** 0.37*** 0.36*** 
Cognition slope -0.18** -0.34 0.11 -0.18* 
Race on     
GS intercept -0.20*** -0.20*** -0.20*** -0.20*** 
Cognition intercept 0.21*** 0.26*** -0.12*** 0.18* 
GS slope -0.02 -0.03 -0.004 -0.03 
Cognition slope 0.04 0.06 -0.06 -0.23** 
Years of education on     
GS intercept 0.02 0.02 0.02 0.02 
Cognition intercept 0.20*** 0.31*** -0.09*** 0.06 
GS slope 0.01 -0.01 0.02 0.02 
Cognition slope 0.09* -0.10* -0.04 0.06 
MMSE on     
GS intercept 0.03* 0.03* 0.03* 0.03* 
Cognition intercept 0.37*** 0.33*** -0.21*** 0.20** 
GS slope -0.01 -0.02 0.00 -0.03 
Cognition slope 0.01 0.01 -0.14** -0.03 
Diabetes on     
GS intercept -0.07*** -0.07*** -0.07*** -0.07*** 
Cognition intercept -0.04** -0.01 0.08*** -0.03 
GS slope -0.02 -0.02 -0.02 -0.02 
Cognition slope -0.08* -0.07 0.02 -0.05 
Hypertension on     
GS intercept -0.02 -0.02 -0.02 -0.02 
Cognition intercept 0.02 -0.01 0.004 0.09 
GS slope -0.04 -0.04 -0.04 -0.06 
Cognition slope 0.02 -0.01 0.04 -0.08 
χ2 (df) 623.2 (131) 968.4 (131) 952.9 (131) 593.7 (121) 
RMSEA/SRMR 0.04/0.03 0.05/0.04 0.05/0.05 0.03/0.05 
CFI 0.98 0.97 0.95 0.95 
†Note: Lower scores on the speed composite represent better performance 
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Figure 4. Parallel process latent growth model for the mediating effect of grip strength on 
memory 
 
Legend. Mediation model with handgrip strength as a mediator of the relationship between BMI 
at baseline and memory performance. Observed variables, error terms, and structural paths from 
covariates to each growth curve factor were omitted from this figure for presentation purposes. 







Figure 5. Parallel process latent growth model for the mediating effect of grip strength on 
reasoning 
 
Legend. Mediation model with handgrip strength as a mediator of the relationship between BMI 
at baseline and reasoning performance. Observed variables, error terms, and structural paths from 
covariates to each growth curve factor were omitted from this figure for presentation purposes. 








Figure 6. Parallel process latent growth model for the mediating effect of grip strength on 
speed 
 
Legend. Mediation model with handgrip strength as a mediator of the relationship between BMI 
at baseline and processing speed performance. Observed variables, error terms, and structural 
paths from covariates to each growth curve factor were omitted from this figure for presentation 
purposes. Dashed red arrows represent the statistically significant mediating pathways.  *p<.05; 






Figure 7. Parallel process latent growth model for the mediating effect of grip strength on 
digit symbol 
 
Legend. Mediation model with handgrip strength as a mediator of the relationship between BMI 
at baseline and Digit Symbol Substitution Task (DSST) performance. Observed variables, error 
terms, and structural paths from covariates to each growth curve factor were omitted from this 
figure for presentation purposes. Dashed red arrows represent the statistically significant 
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